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SUM1\'IARY 
Rotaviruses are the single most important etiological agent of 
severe diarrhoea in infants and young children in both developed and 
developing countries. The World Health Organisation has identified the 
development of a rotavirus vaccine as a priority area for routine 
childhood immunisation to control rotavirus infections. However, the 
candidate vaccine strains have not been very successful. The main aim of 
this project was to map rotavirus virulence to its gene segments. Such 
studies can help in developing better vaccines for the control of rotavirus 
induced diarrhoea. 
A three step approach was undertaken (i) development of an 
animal model, (ii) construction and characterisation of reassortants 
between rotavirus strains of different virulence, (iii) mapping virulence to 
rotavirus gene segments. 
The mouse model developed revealed that the outcome of rotavirus 
infection was influenced by viral dose and viral strain as well as by host 
age and host strain. Homologous murine rotavirus strain was found to be 
most virulent. Among the heterologous strains studied, the OSU strain 
was found to be most virulent and UKtc strain the least virulent. The CD- 
1 strain of mouse was found to be the most susceptible to virus infection 
and C57/BL the least susceptible. 
A very simple and rapid nucleic acid extraction method has been 
developed that requires only one centrifugation step and circumvents the 
use of any hazardous organic chemicals, which can be applied to very 
large numbers of samples saving time and labour. 
Rotavirus reassortants were constructed in a variety of ways and 
their genotype determined from relative mobility of their gene segments 
on polyacrylamide gels and restriction enzyme digestion of PCR 
amplified products. Twenty two reassortants (2%) were identified out of 
more than 1100 progeny clones examined and these reassortants belonged 
to 15 different genotypes. Possible reasons for obtaining this low number 
of reassortants are discussed. No reassortant could be identified between 
a murine rotavirus and other heterologous rotavirus strains. Preliminary 
sequence of VP7 gene of murine rotavirus strains, EDIM and EBR, was 
found to be different to the published rotavirus sequences including the 
recently published five murine rotavirus strains. 
The virulence mapping studies conducted in mice with some of the 
22 reassortants obtained in the present study showed that gene 4 of the 
OSU and UKtc strains was involved in virulence. Segment 5 of OSU 
strain and segments 5, and 8 of UKtc strain may also be involved in 
virulence. 
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Chapter 1 
Rotaviruses 
1.1 Economic importance 
Diarrhoea, a multifactorial disease, is the principal cause of 
mortality in infants and young children in the developing countries in 
Asia, Africa, and Latin America where the syndrome accounts annually 
for 3-5 billion cases and approximately 5-10 million deaths (Institute of 
Medicine, 1985; Walsh and Warren 1979). Another estimate which 
reviewed data from several longitudinal studies in children revealed that 
4.6 million diarrhoea deaths and 744 million to 1 billion episodes of 
diarrhoea occurred in children less than 5 years of age in developing 
countries, excluding China (Snyder and Merson, 1982). In developed 
countries diarrhoeal deaths occur infrequently but morbidity from 
diarrhoeal illness is high (Institute of Medicine, 1986; Rodriguez et al., 
1987). Acute diarrhoeal syndrome is recognised as being second in 
frequency only to the common cold among the illness affecting US. 
families under epidemiological surveillance (Cukor and Blacklow, 1984). 
Rotavirus induced gastro-enteritis is a global disease problem, 
which affects primarily infants and young children and also the neonates 
of a wide variety of mammals and birds including all the major domestic 
livestock. Rotaviruses cause 35-50% of the severe diarrhoeal episodes in 
infants and young children in both developed and developing countries 
(Kapikian and Chanock, 1990). As a consequence they are estimated to 
cause about a million deaths in the underdeveloped countries (Institute of 
Medicine, 1986; WHO, 1989) and be responsible for an estimated 
economic burden of 500 million to 1 billion dollars annually. in the 
developed world (Offit et al., 1991; Glass et al., 1994). In addition to the 
medical problems they cause, rotaviruses are major veterinary pathogens 
with one estimate holding them to be responsible for losses to the British 
dairy industry alone of millions of pounds annually due to animal wasting 
and death (Johnson and McCrae, 1989). 
1.2 Historical Background 
Rotavirus genus of the Reoviridae family was established as a 
separate genus by the International Committee on Taxonomy of Virus at 
the Fourth International Congress for Virology in 1978 (Mathews, 
1979a). In early publications, members of the genus were referred to as 
'orbivirus-like' (Bishop et al., 1973; Middleton et al., 1974), 'infantile 
gastro-enteritis virus [orbivirus group]' (Petric et al., 1975), 'reovirus- 
like agents' (Fernelius et al., 1972; Kapikian et al., 1974), 'Duovirus' 
(Davidson et al., 1975) besides 'rotavirus' (Flewett et al., 1974). 
The earliest reported work on what was probably rotavirus gastro- 
enteritis was done by Light and Hodes (1943,1949). They isolated a 
filterable agent from the stools of infants with gastro-enteritis and showed 
that it produced diarrhoea in newborn calves. About 30 years later, 
rotavirus particles were detected by electron microscopy in that 
lyophilised material (Hodes, 1977). After the work of Light and Hodes, 
other viruses with characteristics of Reoviridae were isolated from faecal 
specimens, including the viruses causing epizootic diarrhoea of infant 
mouse or 'EDIM' (Cheever and Muller, 1947; Kraft, 1957; Banfield et 
al., 1968), SA11 from vervet monkeys (Malherbe and Harwin, 1963) 
and '0' agent from the intestinal washings of cattle and sheep (Malherbe 
and Strickland-Cholmley, 1967). These viruses were subsequently shown 
to be rotaviruses. 
Mebus et al., (1969) reported experimental production of 
diarrhoea in colostrum-deprived calves by inoculating them with bacteria- 
free filtrates of diarrhoeic faeces. Virus particles 65 nm in diameter were 
found in large numbers in the faeces of infected animals. In 1971, Mebus 
et al., reported successful cultivation of Nebraska calf diarrhoea virus 
(NCDV) in primary foetal bovine cell culture. Further characterisation of 
2. 
the virus showed that it was similar to the reovirus group in its 
morphology and some of its chemical properties but was serologically 
unrelated to reovirus types 1 and 3 (Fernelius et al., 1972; Welch and 
Twiehaus, 1973). 
The early work in animals received little attention until electron 
microscopic examination of biopsy material from children with acute non- 
bacterial gastro-enteritis revealed the presence of orbivirus-like particles 
within epithelial cells of the duodenal mucosa (Bishop et al., 1973). This 
first report was rapidly followed by others in which virus particles 
morphologically indistinguishable from calf reo-like virus were detected 
in the faeces of children with gastro-enteritis in England (Flewett et al., 
1973), Australia (Bishop et al., 1974), Canada (Middleton et al., 1974), 
and the U. S. A. (Kapikian et al., 1974). 
1.3 Properties of rotavirus 
1.3.1 Morphology 
Rotaviruses have a distinctive morphological appearance by 
negative-stain electron microscopy. The term rotavirus is derived from 
the Latin word 'rota', which means wheel, and was suggested because the 
sharply defined circular outline of the outer capsid gives the appearance 
of the rim of a wheel placed on short spokes, radiating from a wide hub 
(Flewett et al., 1974). Three types of particles (double-shelled, single- 
shelled and core) have been observed by electron microscopy (Estes and 
Cohen, 1989). The double-shelled particles also called 'complete' or 
'smooth' particles, have a diameter of - 70 nm (Figure 1) and exhibit T 
= 131 icosahedral symmetry (Ludert et al., 1986; Roseto et al., 1979; 
Prasad et al., 1988). Particles lacking the outer shell are called 
'incomplete' or 'single-shelled' particles and those lacking both of these 
shells are called 'core' particles. Some tubular structures and 
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Figure 1: Electron micrographs of (a) double-shelled and (b) single- 
shelled rotavirions embedded in vitreous ice. Arrows indicate presence of 
the spikes on the surface. The scale bar represents 100 nm. 
Adapted from Prasad et al., (1988). 
4 
disorganised sheets are frequently observed in rotavirus preparations 
which probably result from the abnormal assembly of viral capsid 
proteins (Chasey and Labran, 1983). Based on the radial density profile 
computed from the three dimensional density map of the mature virion, 
Prasad and Chiu, (1994) have proposed that the infectious virus particle is 
a triple-shelled structure with an inner VP2 shell, an intermediate VP6 
shell, and an outer shell of VP4 and VP7. The VP2 shell lies between the 
radii of 210 and 265 °A. The existence of this shell has been further 
substantiated by the self-assembly of baculovirus-expressed VP2 into 
shells with a radius of ---265 °A (Labbe et al., 1991). However, for the 
present study virion particles having VP2 and VP6 shells will be 
considered as - single-shelled and virion particles having VP2, VP6, VP4, 
and VP7 shells will be considered as double-shelled. 
The three-dimensional structure of rotavirus was first determined by 
cryoelectron microscopy and computer image processing techniques 
(Figure 2) (Prasad et al., 1988). Subsequent studies provided additional 
evidence for the identification of topographical features of the viral 
structural proteins (Prasad et al., 1990; Yeager et al., 1990; Shaw et al., 
1993). A total of 132 aqueous channels perforate the VP7 outer shell that 
are in register with VP6 inner shell. Twelve type I channels are located 
along the icosahedral 5-fold axes. Sixty type II channels are located at the 
6-co-ordinated positions immediately surrounding the 5-fold axes. The 60 
remaining type III channels are located at the other 6-co-ordinated 
positions that neighbour the icosahedral3-fold axes. These channels are 
thought to be involved in importing the metabolites required for RNA 
transcription and exporting the nascent RNA transcripts for subsequent 
virus replication. Studies on non-protease treated particles revealed the 
presence of sixty spikes situated at an edge of the type II channels 
surrounding the 5-fold axes (Prasad et al., 1988). These spikes are 4.5- 
5 
Figure 2: Surface representations of the 3-dimensional structures of 
double ((a) and (b)) and single-shelled ((c) and (d)) rotavirions along the 
icosahedral 5-fold axis ((a) and (c)) and along the 3-fold axis ((b) and 
(d)). Three type of channels (designated I, II, III in (a) and (c) showing 
just one of each type) are found at all 5 and 6 co-ordinated positions 
(designated as 5 and 6, respectively in (b) and (d)) spanning the outer and 
inner shell proteins. The protein spikes are seen situated at an edge of 
type II channels surrounding the 5-fold positions in the double-shelled 
rotavirus. 
Taken from Prasad et al., (1988). 
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6.0 nm in length with a globular knob at the distal end and a 
bilobed structure at the other end (Yeager et al., 1990). They have now 
been shown to be made up of VP4 (Prasad et al., 1990). 
1.3.2 Genome structure 
The rotavirus genome consists of 11 segments of double-stranded 
RNA that range in molecular weight from approximately 2X 105 to 2.2 
X 106 daltons (Rodger et al., 1975; Newman et al., 1975; Kapikian and 
Chanock, 1990). The segments can be divided into four-size classes 
(groups I- IV) based on contour-length measurements of the RNAs by 
EM and electrophoretic patterns in polyacrylamide gel electrophoresis 
(PAGE) (Kalica et al., 1976; Barnett et al., 1978). The usual 
electropherotypic pattern of the segments in Group A rotaviruses is 
4,2,3,2 (Clarke and McCrae, 1981; Pedley et al., 1983). However, in 
non-group A rotaviruses, or group A rotaviruses that show 
rearrangements within individual segments, a different migration pattern 
is seen. 
Slight changes in the migrational positions of individual RNA 
segments have been attributed to genomic variation being generated either 
by simple point mutations resulting in possible antigenic drift events or 
through the occurrence of genome segment reassortment events between 
genetically distinct virus strains. In addition to minor changes in the 
rotavirus genome profile, two more profound type of changes have been 
reported. In the first, the tight triplet of RNA segments (genes 7 to 9) is 
reduced to a doublet with the displaced segment in some cases migrating 
more slowly on PAGE and in other cases migrating more rapidly (Pedley 
et al., 1983; 86). In the second type of gross abnormality either 
additional RNA segments are present on the genome profile or a 
particular RNA segment has disappeared from its normal migrational 
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position and been replaced by an RNA migrating much more slowly 
(Hundley et al., 1987; Scott et al., 1989; Tian et al., 1993). 
The complete nucleotide sequence of all 11 RNA segments of 
both the simian SA11 and bovine UKtc strains of virus have been 
determined. The segments range in size from 667 (segment 11) to 3302 
base pairs (segment 1). Each RNA segment starts with a 5' guanidine and 
ends with a 3' terminal cytidine. Conserved non-coding sequences occur 
at both 5' and 3' ends (Clarke and McCrae, 1983; McCrae and 
McCorquodale, 1983) surrounding the open reading frame and are 
thought to contain signals important for genome transcription, replication, 
and possibly assembly of the genome segments. All rotavirus genes are 
A+T rich and the codon usage is biased against CGN and NCC (Estes 
and Cohen, 1989). 
1.3.3 Physicochemical properties 
Different particles possess different biophysical and biochemical 
properties. Double-shelled rotavirus particles have a density of 1.36 g/ ml 
in CsCI and a sedimentation coefficient of 520-530S in sucrose, whereas 
single-shelled particles with a density of 1.38g/ ml will sediment at 380- 
400S. Core particles have a density of 1.44 g/ ml in CsCI and have a 
sedimentation coefficient of 280S (Tam et al., 1976; Bican et al., 1982 ). 
The infectivity of the virion depends on the integrity of the outer capsid 
and treatments with chelating agents (EDTA, EGTA) convert double- 
shelled particles into single-shelled particles resulting in the loss of 
infectivity. The loss of the outer capsid also activates the endogenous 
RNA polymerase. Core particles can be produced by disruption of single- 
shelled particles with chaotropic agents (sodium thiocyanate or calcium 
chloride). This latter change is associated with a loss of polymerase 
activity (Bican et al., 1982; Cohen et al., 1979). 
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Virus infectivity and particle integrity are resistant to fluorocarbon 
extraction and exposure to ether, chloroform, or deoxycholate, and pH 
over the range of 3-10 (Tam et al., 1976; Estes et al., 1979). All 
rotaviruses are stable at -70°C, and retain infectivity at 40C or even at 
20°C, when stabilised by 1.5 mM CaCl (Shirley et al., 1981). Snodgrass 
and Herring, (1977) found formalin and lysol, which is an iodophore 
preparation (but not chlorine) to be useful disinfectants. Ethanol, 95 % 
was the most effective disinfectant (Tan and Schnagl, 1981). 
1.4 Gene protein assignments 
The proteins encoded by each of the 11. genome segments of UKtc 
and SA11 rotaviruses are shown in Table 1. These assignments have been 
made by in vitro translation using mRNA or denatured dsRNA, (Dyall- 
Smith et al., 1981; Mason et al., 1980; 83; McCrae and McCorquodale, 
1982) and by analysis of reassortant viruses (Gombold et al., 1985; 
Greenberg et al., 1981; Liu et al., 1988; Offit and Blavat, 1986). The 
absolute order of migration of cognate genes may differ for different 
rotavirus strains. Consequently, the identification of cognate genes must 
be based on hybridisation with gene-specific probes (Dyall-Smith et al., 
1983), reassortänt analysis (Gombold et-al., ' 1985; Gombold and Ramig, 
1986), or protein identification based on biochemical or immunological 
identification of the protein synthesised in a cell-free translation system 
programmed with denatured dsRNA or sequence homology (Green et al., 
1987; 88). The virus genome encodes six structural and six non-structural 
proteins. The conflicting conclusions regarding the number and location 
have now largely been resolved when it was recognised that post 
translational modifications such as glycosylation, trimming of 
carbohydrate residues, and proteolytic cleavages occur following 
polypeptide synthesis (Estes et al., 1983; Holmes, 1983). 
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Table 1: Gene-protein assignments of UKtc strain of bovine 
rotavirusa 
Genome Length Protein product Deduced Approximate Location/Comments 
segment (base pairs) molecular % of capsid 
weight protein 
(daltons) 
1 3302 VP1 125,005 2 Inner core protein 
RNA polymerase? 
2 2687 VP2 102,431 15 Inner core protein, RNA 
binding, Leucine zipper 
3 2591 VP3 88,000 0.5 Inner core protein 
Guanyl transferase 
4 2362 VP4 86,751 1.5 Outer capsid protein, 
Haemagglutinin, 
Neutralisation antigen 
5 1611 VP5 58,654 Non-structural protein 
(NS53/NSPI)b Zinc fingers 
6 1356 VP6 44,816 51 Inner capsid protein, Group & 
Subgroup antigen 
7c 1104 VP8 36,700 Non-structural protein 
(NS35/NSP2)b 
8c 1059 VP7 33,919 30 Outer capsid protein, 
Neutralisation antigen 
9c 1062 VP9 34,600 Non-structural protein 
(NS34/NSP3)b RNA binding 
10 751 VP10 20,290 Non-structural protein, 
(NS28/NSP4)b Morphogenesis 
11 667 VP11 21,725 Non-structural protein 
(NS26/NSP5)b 
VP11* 11,000 Non-structural protein 
(NS 11 /NSP6? )b 
aAdapted from Desselberger and McCrae, (1994). bThe text in parenthesis is the equivalent 
nomenclature used for SA 11 rotavirus. CIn SA 11 strain, the segments 7,8, and 9 code for 
NS34/NSP3, NS35/NSP2, and VP7 proteins, respectively. 
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1.5 Rotavirus proteins 
1.5.1 Core proteins 
1.5.1.1 VP1 
This is a 125K basic protein which forms - 2% of the virion mass 
(Cohen et al., 1989; Estes and Cohen, 1989). It is considered to be the 
RNA dependent RNA polymerase based on sequence analysis (Cohen et 
al., 1989; Mitchell and Both, 1990a) and photoaffinity labelling 
experiments with azido-ATP (Valenzuela et al., 1991). It often fails to 
react with hyperimmune sera to purified virus particle (Ericson et al., 
1982) or convalescent sera (Offit et al., 1983). However, expressed VP1 
is both antigenic and immunogenic (Cohen et al., 1989). 
1.5.1.2 VP2 
This is a 92K protein which is the most abundant component of the 
core and forms 15 % of the mature virion mass (Estes and Cohen, 1989). 
There has been one report which found it to be myristylated (Clark and 
Desselberger, 1988). It forms the innermost of the three protein layers 
described by Shaw et al., (1993). It possesses nucleic acid binding 
activity in a nucleotide sequence-independent manner, but has higher 
affinity for ssRNA than dsRNA (Boyle and Holmes, 1986). It has a 
'leucine zipper' between amino acids (aa) 517 and 636, which is a feature 
of nucleic acid-binding proteins (Landschulz et al., 1988; Kumar et al., 
1989). VP2 is highly immunogenic, and serum antibodies to this protein 
are a good indicator of prior infection (Svensson et al., 1987). 
1.5.1.3 VP3 
This is a 88K basic protein present in the viral core and normally 
comigrates with the protein product of segment 4 of SA11(Liu et al., 
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1988). Previous studies have concluded that the gene 3 product was a 
structural protein (Smith et al., 1980) coding for VP4 in SA11 strain, a 
non-structural protein (Arias et al., 1982), or a structural protein that was 
translated poorly in vitro and was synthesised and processed rapidly 
(McCrae and McCorquodale, 1982). It has been shown to be associated 
with guanylyltransferase activity (Pizarro et al., 1991; Liu et al., 1992). 
1.5.2 Outer capsid proteins 
1.5.2.1 VP4 
VP4 is the 84-88K nonglycosylated protein product of gene 
segment 4 and was formally known as VP3 in the SA11 strain (Estes et 
al., 1983; Liu et al., 1988). It is present on the outer capsid as spikes 
made up of dimers of VP4. There are sixty spikes per virion that 
constitute 1.5 % of virion protein (Prasad et al., 1988; Anthony et al., 
1991). 
VP4 is associated with a number of properties such as 
haemagglutination (Kalica et al., 1983; Prasad et al., 1990; Fiore et al., 
1991; Shaw et al., 1993), cell attachment (Ruggeri and Greenberg, 
1991), growth restriction in cell culture (Greenberg et al., 1983a; Ramig 
and Galle, 1990), protease enhancement of viral infectivity (by cleavage 
of VP4 into VP8* and VP5*) (Chen et al., 1989; Estes et al., 1981), 
viral virulence (Offit et al., 1986), neutralisation and protective immune 
responses (Offit and Blavat, 1986; Hoshino et al., 1988). 
The neutralisation studies of rotavirus VP4 has revealed eight areas 
on the linear sequence that are involved in neutralisation. VP8* contains 
the location of greatest sequence diversity and serotype-specific 
neutralisation epitopes, whereas cross-reactive epitopes have been 
mapped to VP5* (Shaw et al., 1986; Burns et al., 1988; Mackow et al., 
1988a; Taniguchi et al., 1988a; Larralde et al., 1991). Furthermore, 
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immunoblot and hybridisation data led to the conclusion that a particular 
region in VP8* extending from as 84 through 180 (region B) may be 
involved in the VP4 serotype and subtype specificities of VP4 (Larralde 
and Gorziglia, 1992) 
1.5.2.2 VP7 
This protein is encoded by gene segment 9 of SA11, OSU and 
EDIM, gene segment 8 of UKtc and B223, and gene segment 7 of rhesus 
rotavirus (Estes and Cohen, 1989). There are 780 copies of VP7 in the 
virion which form the smooth rippled outer capsid of the virion (Prasad et 
al., 1988). It is a glycoprotein that contains only N-linked high-mannose 
oligosaccharide residues, these are added cotranslationally as the protein 
is inserted into the membrane of rough endoplasmic reticulum (RER). 
VP7 is an integral membrane protein with a luminal orientation whose 
oligosaccharides are modified by trimming which occurs in the RER 
(Ericson et al., 1983; Kabcenell and Atkinson, 1985). There are 1-3 
glycosylation sites depending on virus strains (Estes and Cohen, 1989). 
The open reading frame (ORF) codes for 326 amino acids 
containing two hydrophobic domains (H 1 and H2) near the N terminus, 
each preceded by a methionine (Both et al., 1983a). Signal peptide 
cleavage occurs between Ala (50) and Gln (51), downstream of the H2 
hydrophobic domain (Stirzaker et al., 1987). Removal of residues 47-61 
results in the secretion of VP7 into the medium (Poruchynsky et al., 
1985; Whitfield et al., 1987). However, another deletion that removes 
only residues 51-61 is not secreted (Poruchynsky et al., 1985). The H2 
signal peptide plays a key role in targeting of VP7 in the RER and the 
signal peptide and a region which lies within residues 62-111 of VP7 
together are sufficient for retention of the protein in RER (Stirzaker and 
Both, 1989). 
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Nine discrete variable regions designated VR1- VR9 of amino acid 
sequence have been identified among the VP7s from different serotypes 
that are highly conserved within a serotype (Green et al., 1987; 1988; 
1989) . Three variable regions viz. VR5, VR7, and VR8 correlate with 
the neutralisation epitopes identified by Dyall-Smith et al., (1986) 
(designated regions A, B, and C) in mapping studies of neutralising 
monoclonal antibody escape mutants. It has been suggested that these 
VP7 antigenic sites are in close proximity and are highly dependent on 
the conformational structure of VP7 (Dyall-Smith et al., 1986; Mackow 
et al., 1988b; Taniguchi et al., 1988b). Cross-reactive epitopes are 
located only in VR5, whereas serotype-specific epitopes are located in 
VR5, VR7, or VR8 (Mackow et al., 1988b; Taniguchi et al., 1988b). 
There is some evidence that suggests that calcium ions bind to 
VP7, and this may be important in maintaining the stability of the virion 
(Cohen et al., 1979; Shahrabadi et al., 1987). VP7 is the major 
neutralisation antigen and may be involved in cell-binding (Sabara et al., 
1985; Fukuhara et al., 1988). However, VP4 (Ruggeri and Greenberg 
1991) and NS35 (Bass et al., 1990) have also been documented as being 
involved in cell binding. 
1.5.3 Inner Capsid Proteins 
1.5.3.1 VP6 
VP6 is the nonglycosylated major inner capsid protein which has a 
molecular weight of 41-45K and forms 50% of the virion mass (Estes and 
Cohen, 1989). It was found to be myristylated in one report (Clark and 
Desselberger, 1988). Biochemical and 3-dimensional structural analysis 
has shown that it exists as trimeric units on single-shelled particles and in 
the infected cells (Gorziglia et al., 1985; Sabara et al., 1987; Prasad et 
al., 1988). Treatment with chaotropic agents selectively removes VP6 
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from the single-shelled particles producing core particles which lack RNA 
transcriptase activity. Viral transcriptase activity can be restored by the 
addition of VP6 to the core particles, indicating that VP6 is structurally 
required for viral transcriptase activity (Bican et al., 1982; Sandino et 
al., 1986). The domains for both trimerisation and assembly into single- 
shelled particles are located within the highly conserved regions of VP6 
but may overlap (Clapp and Patton, 1991). 
VP6 is highly antigenic and immunogenic and contains rotavirus 
group and subgroup determinants. Most diagnostic assays employ 
antibodies directed against VP6 to detect the rotavirus particles. Deduced 
amino acid sequences of VP6 show that more than 90% of the amino 
acids are conserved among the four subgroups. However, subgroup I and 
II epitope-specific monoclonal antibodies reacted only with the trimeric 
form of the VP6 indicating its conformational nature (Gorziglia et al., 
1988a). 
1.5.4 Non-structural proteins 
1.5.4.1 VP5/NS53/NSP1 
This is a basic protein made at low levels early in the infectious 
(Johnson and McCrae, 1989). Although it has been shown to bind zinc, it 
has not been demonstrated that this binding activity is due to the putative 
zinc fingers which remain conserved despite extensive sequence diversity 
(Mitchell and Both, 1990b). 
1.5.4.2 VP8/NS35/NSP2 
This is a basic protein encoded by genome segment 8 in the SA 11 
strain of rotavirus and has been considered by some to be the cellular 
attachment protein (Bass et al., 1990; Estes and Cohen, 1989). It is 
localised in the viroplasm (Petrie et al., 1984), is a major component of 
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the replicase particles and possesses RNA-binding activity (Kattoura et 
al., 1992). 
1.5.4.3 VP9/NS34/NSP3 
This is a slightly acidic protein encoded by genome segment 7 of 
the SA11 rotavirus (Estes and Cohen, 1989). The domain responsible for 
oligomerisation and interaction with viral RNA has recently been 
characterised. This protein is speculated to have a role in replication 
(Mattion et al., 1992). 
1.5.4.4 VP10/NS28/NSP4 
This is encoded by genome segment 10, and is a protein of 175 
amino acids containing three hydrophobic domains, H1, H2, and H3 
(Both et al., 1983b; Baybutt and McCrae, 1984). It is an integral 
membrane glycoprotein of the ER, and is rich in high mannose 
oligosaccharides (Kabcenell and Atkinson, 1985). The signal peptide 
remains uncleaved (Both et al., 1983b; Kabcenell and Atkinson, 1985). It 
acts as the receptor for budding ss-particles (Au et al., 1989; Meyer et 
al., 1989). Glycosylation of NS28 is required for removal of the transient 
envelope from the budding particles (Ericson et al., 1983). 
1.5.4.5 VP11/NS26/NSP5 
The primary translational product of gene 11 has a molecular 
weight of 26K. It undergoes post-translational modification, 
phosphorylation (Welch et al., 1989) and O-linked glycosylation 
(Gonzalez and Burrone, 1991). The O-linked glycosylation is responsible 
for the observed molecular weight of 28K. Segment 11 also encodes for a 
second out of frame ORF that can be expressed in vitro to produce a 11K 
polypeptide (Mattion et al., 1991). 
16 
1.6 Classification of rotaviruses 
Rotavirus is one of the six genera within the family Reoviridae as 
classified by the International Committee of Taxonomy of Viruses 
(Mathews, 1979b, 1982). Orthoreovirus, Orbivirus, Cypovirus, 
Coltivirus, Aquareovirus, Phytoreovirus and Fijivirus are the other genera 
of Reoviridae. Classification of rotavirus into various Groups, Subgroups, 
and serotypes is summarised in Table 2. 
1.6.1 Rotavirus Groups 
Rotavirus have been classified into various Groups on the basis of 
fulfilment of at least two of the three criteria namely : i) antigenic 
distinction ii) RNA genome profile distinction in polyacrylamide gels and 
iii) differences in the fingerprints of RNA segments (Pedley et al., 1983). 
The Group antigen lies on VP6 polypeptide. Five distinct groups (A to E) 
have been described (Bridger, 1987; Pedley et al., 1983; 1986; McCrae, 
1987). Group A, B, and C have been found in both human and animals, 
group D, and E have been found only in animals. 
1.6.2 Rotavirus Subgroups 
Early reports argued that it was possible to classify virus serotypes 
by non-neutralisation assays such as complement fixation and ELISA with 
selected post infection sera (Yolken et al., 1978; Zissis and Lambert, 
1978,1980). However more rational analyses have revealed that these 
tests do not recognise the same antigens detected in serum-neutralisation 
tests and therefore they do not identify serotypes (Kapikian et al., 1981). 
It has now been recognised that ELISA and immune adherence 
haemagglutination assay (IAHA) can be used to distinguish a subgroup 
antigen that is encoded by sixth gene segment (Kalica et al., 1981). At 
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Table 2: Classification of rotavirusesa 
Serologic division Protein responsible Numbers 
Groups VP6 5 
Subgroups VP6 4 
G Serotypes VP7 14 
P Serotypes VP4 11 
aAdapted from Kapikian and Chanock, (1990) and Hoshino and 
Kapikian, (1994). 
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present there are four subgroups in group A rotaviruses namely subgroup 
I, subgroup II, subgroup I+ II, and non-I non-II (Greenberg et al., 1983a; 
Hoshino et al., 1987a; Svensson et al., 1988). 
1.6.3 Serotypes 
Rotavirus serotypes have been determined by i) neutralisation 
assays in cell culture such as inhibition of cytopathic effect, plaque 
reduction and fluorescent foci inhibition (Hoshino et al., 1984; Sato et 
al., 1982; Taniguchi et al., 1985), ii) solid-phase immune electron 
microscopy (SPIEM) (Gerna et al., 1985), iii) ELISA employing serotype 
specific monoclonal antibodies (Taniguchi et al., 1985; Coulson et al., 
1987; Beards, 1987; Unicomb et al., 1989), iv) nucleic acid hybridisation 
under stringent conditions (Lin et al., 1987; Flores et al., 1989a) and v) 
sequencing (Green et al., 1988; 1989). In the earlier studies, the major 
neutralisation antigen was shown to be VP7, an outer capsid 
glycoprotein, and it was therefore considered to be the determinant of 
rotavirus serotype (Kalica et al., 1981). A reciprocal 20-fold or greater 
difference in serum neutralising antibody titre has been taken as the 
criterion to distinguish serotypes (Hoshino et al., 1984; Wyatt et al., 
1982). Hoshino et al., (1984) proposed a unified serotyping scheme based 
on the observation of shared neutralisation epitopes between human and 
animal rotaviruses in cross-neutralisation studies. Currently 14 VP7 
serotypes among animal and human rotavirus have been defined (Table 3) 
(Browning et al., 1991a, b; Shen et al., 1993; Hoshino and Kapikian, 
1994). 
VP4 has also been demonstrated to induce the production of 
neutralisation antibodies (Offit and Blavat, 1986; Greenberg et al., 
1983a, b) and appears to be important in immune response to rotavirus 
infection (Matsui et al., 1989). At least 11 VP4 P serotypes (based on 
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Table 3: Serotypic and genotypic classification of Group A 
rotavirus VP7a 
VP7 G typeb, c Prototype strain 
(name/ species) 
GI Wa / human 
G2 S2 / human 
G3 SA11 / simian 
G4 Gottfried / porcine 
G5 OSU / porcine 
G6 NCDV / bovine 
G7 Ch2 / chicken 
G8 B37 / human 
G9 W161 / human 
G10 B223 / bovine 
G11 YM / porcine 
G12 L26 / human 
G13 L338 / equine 
G14 F123 / equine 
aAdapted from Browning et al., (1991b) and Hoshino and Kapikian., 
(1994). bVP7 G serotypes determined by reciprocal cross neutralisation. 
CIn addition VP7 genotype has been determined by comparative amino 
acid sequence analysis and/ or nucleic acid hybridisation. Genotyping has 
been used to distinguish among rotavirus strains and, where evaluated, 
has correlated with serotyping differences by neutralisation. 
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neutralisation assays), and 19 VP4 genotypes (determined by comparative 
amino acid sequence analysis and/or nucleic acid hybridisation) present 
among animal and human rotavirus strains have been reported (Table 4) 
(Estes and Cohen, 1989; Qian and Green, 1991; Hardy et al., 1992; Shen 
et al., 1993; Hoshino and Kapikian, 1994). The neutralisation 
specificities of VP4 and VP7 can segregate independently due to the 
segmented nature of rotavirus genome (Hoshino et al., 1985). A binary 
system of classification has been suggested and it has been proposed that 
VP7 serotypes be referred to as G serotypes (for glycoprotein) and VP4 
serotypes be referred to as P serotypes (for protease-sensitivity) (Estes 
and Cohen, 1989). 
Strains within a serotype which vary in their capacity to be 
neutralised by serotype-specific monoclonal antibodies have been termed 
'monotypes' analogous to 'subtypes' defined by polyclonal hyperimmune 
antisera (Coulson, 1987; Coulson et al., 1987; Liprandi et al., 1991; 
Green et al., 1992). 
1.7 Epidemiology 
Rotaviruses have been detected throughout the world wherever 
they have been sought (Kapikian and Chanock, 1990). Even the most 
isolated human populations have antibodies as evidence of past infections, 
and occasional epidemics occur (Foster et al., 1980). Rotaviruses have 
been associated with acute gastro-enteritis and diarrhoea in a wide range 
of mammalian (Flewett and Woode, 1978; Estes et al., 1983) and avian 
species (McNulty et al., 1978; 1979). 
The route of transmission is generally faecal-oral but a respiratory 
route has also been suggested (Ward et al., 1986; Gurwith et al., 1981) . 
The rotavirus is relatively resistant to environmental factors but 
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Table 4: Serotypic and genotypic classification of Group A rotavirus 
VP4a 
VP4 P serotypeb VP4 genotypec Strain 
l Ad 8 Wa 
lBd 4 DS-1 
2A 6 M37 
2B 6 Gottfried 
3A 9 K8 
3B 14 Mc35 
4 10 69M 
5A 3 K9 
5B 3 MMU 18006 
6 1 NCDV 
7 5 UKtc 
8 11 B223 
9 7 OSU 
10 16 Eb 
11 18 PA169 
2 SA11 
12 F123 
13 MDR-13 
15 Lp 14 
17 993/83 
19 L338 
aAdapted from Hoshino and Kapikian, (1994). bVP4 P serotype determined by reciprocal or 
one-way cross neutralisation. cVP4 genotype determined by comparative amino acid sequence 
analysis and/ or nucleic acid hybridisation. dLetters indicate subtypes within a serotype. 
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contaminated water is unlikely to play a significant role in transmission 
(Smith and Gerba, 1982). 
In temperate countries, rotavirus gastro-enteritis shows a definite 
seasonal pattern, with the peak incidence during the winter months 
(Bryden et al., 1975), whereas in tropical climates, rotavirus infections 
occur throughout the year (Heiber et al., 1978). 
Rotavirus gastro-enteritis mainly affects children from 6 months to 
2 years of age. Both males and females are susceptible. Malnutrition is 
thought to play an important role in increasing the severity of the clinical 
manifestations (Kapikian and Chanock, 1990). Group B rotavirus can 
produce diarrhoea in adults. 
Molecular epidemiology of rotavirus strains has mainly been done 
by comparison of the electrophoretic migration patterns of the segmented 
genomic dsRNAs. Analysis of the RNA electropherotypes provides some 
evidence for the genetic diversity and heterogeneity of the rotaviruses 
circulating in the population (Estes et al., 1984). 
1.8 Clinical features 
Rotavirus infection produces a variety of disease patterns varying 
from subclinical infection, to mild diarrhoea, to a severe and fatal 
dehydrating illness. After an incubation period of 1-2 days, vomiting and 
then diarrhoea occurs with a mild fever. The diarrhoea lasts for 3-4 days 
and moderate dehydration is common (Kapikian and Chanock, 1990). 
Death when it occurs is usually due to severe dehydration (Rodriguez et 
al., 1987). 
1.9 Diagnosis 
The clinical manifestations of rotavirus illness are not sufficiently 
distinctive to permit diagnosis on this basis alone. The diagnosis is 
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usually made by detection of virus, viral antigen, or nucleic acid in faeces 
and/ or the demonstration of a virus specific serological response 
(Kapikian and Chanock, 1990). Detection of rotavirus in the faeces by 
electron microscopy is the gold standard test (Flewett et al., 1974b). 
Rotavirus antigen can be detected in the faeces by a variety of tests such 
as ELISA (Yolken et al., 1978), counter-immuno-electrophoresis test 
(Grauballe et al., 1981), immune adherence haemagglutination test 
(Kapikian et al., 1981), reverse passive haemagglutination assay, solid- 
phase radioimmun assay (Middleton et al., 1977), latex agglutination 
test (Ushijima et al., 1986), coagglutination test (Kang et al., 1985). 
Similarly, serological responses can be demonstrated by a variety of tests 
(Estes et al., 1983; Kapikian and Chanock, 1990). 
Detection of rotavirus in stools can also be carried out by 
molecular biological techniques (Flores et al., 1983; Pedley and McCrae, 
1984; Lin et al., 1987; Xu et al., 1990). 
1.10 Treatment 
The primary aim of treatment of rotaviral gastro-enteritis is the 
replacement of fluids and electrolytes lost by vomiting and diarrhoea. 
This can be done either by intravenous fluid administration or by giving 
oral rehydration therapy. Several broad-spectrum antiviral agents have 
been examined as inhibitors of rotavirus replication in vitro (Kitaoka et 
al., 1986). In animal experiments several antiviral drugs showed some 
initial promise for the specific treatment of rotavirus infection but have 
not been actively pursued (Smee et al., 1982). 
1.11 Immune response and immunity to rotaviruses 
Protective immunity to rotavirus gastro-enteritis can be induced. 
However, for several reasons the mechanisms of rotavirus immunity are 
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not fully understood. Firstly, in most studies measurement of immune 
response has been done on sera rather than intestinal washings or 
coproantibodies, despite the fact that circulating antibodies are not 
correlated with protection in man and animals (Woode et al., 1975; 
Snodgrass and Wells, 1976; Bishop et al., 1983; Ward et al., 1986). 
Secondly, the extent of antigenic diversity among rotaviruses in natural 
conditions is not well known. Thirdly, there is difficulty in ascertaining 
the state of immune response as well as of infection in man and animals. 
Therefore what we actually measure in natural conditions may be a 
primary, secondary or subsequent immune response and/or infection. 
1.11.1 Humoral immune response 
Although antibodies to most rotavirus proteins can be detected 
after infection (Svensson et al., 1987), a protective effect has only been 
reproducibly demonstrated with antibodies to the outer capsid proteins, 
VP4 and VP7 (Hoshino et al., 1988; Mackow et al., 1990; Matsui et al., 
1989; Offit et al., 1986b). VP4 and VP7 segregate independently 
(Hoshino et al., 1985a) and the location of a number of homotypic and 
heterotypic neutralisation epitopes on them has been defined (Dyall-Smith 
et al., 1986; Mackow et al., 1988a, b; Taniguchi et al., 1988a, b). Studies 
on the relative immunogenicities of VP4 and VP7 have yielded 
conflicting results. VP7 appears to be immunodominant in 
hyperimmunised animals, while the VP4 protein was found to be 
immunodominant in humans who had been orally inoculated with virus 
(Clark et al., 1990; Perez-Schael et al., 1990; Ward et al., 1988c) or 
after natural infection (Ward et al., 1993). In contrast, vaccination of 
infants with the WC3 vaccine elicited neutralising antibody responses 
almost solely to VP7 (Ward et al., 1990c). Likewise, immune responses 
to epitopes on VP7 showed significant correlations to protection against 
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rotavirus infection or disease in adults challenged with a virulent serotype 
1 human rotavirus (Green and Kapikian, 1992). 
A wide variety of animal models and a substantial number of 
distinct rotavirus strains have been used in both passive and active 
models of immunity to study protection from rotavirus infection. The 
importance of local immune mechanisms in mediating protection has been 
shown by a number studies (Bishop et al., 1983; Bridger and Oldham, 
1987; Hoshino et al., 1988; Losonky et al., 1986; Offit and Clark, 
1985a; Snodgrass and Wells, 1976; 1978; Snodgrass et al., 1984; Torres 
and Ji-Huang, 1986; Woode et al., 1983). The presence of neutralising 
antibodies in the intestinal tract has also been correlated with protection 
against rotavirus infection in these studies. However, mechanisms other 
than humoral immunity such as cell mediated immunity may also play a 
role in preventing and resolving infection (See cell mediated immune 
response). The serological specificity of immunity appears to be rather 
complex. There are data that demonstrate both the presence (Bishop et 
al., 1986; Hoshino et al., 1988; Matsui et al., 1989; Offit et al., 1986b; 
Torres and Ji-Huang, 1986; Vesikari et al., 1987; Wyatt et al., 1979; 
1983) and the absence of heterotypic immunity (Bohl et al., 1984; 
Losonsky et al., 1986; Murakami et al., 1986; Offit and Clark, 1985b; 
Woode et al., 1983). Homotypic immunity appears to be the rule 
following active infection or passive immunisation. 
1.11.2 Cell mediated immune response 
A role for the cell-mediated immune response (CMI) in protective 
immunity was postulated on the basis of observations in human infants 
and in calves that heterologous protection against challenge occurred in 
the absence of serotype-specific neutralising antibodies (Bridger and 
Oldham, 1987; Woode et al., 1987; Clark et al., 1988; Ward et al., 
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1992). There are several pieces of evidence supporting a role for 
rotavirus-specific cytotoxic T lymphocytes (CTLs) in protection against 
disease. Rotavirus-specific CTLs generated after inoculation of mice with 
bovine, simian or human rotavirus cross-react with target cells infected 
with different rotavirus serotypes (Offit and Dudzik, 1988; Offit and 
Svoboda, 1989). Rotavirus-specific CTLs have been detected at the 
intestinal mucosal surface after oral inoculation of mice with rotavirus 
(Offit and Dudzik, 1989), and virus-specific CTLs passively protect mice 
against rotavirus-induced gastro-enteritis or chronic rotavirus shedding 
(Dharakhul et al., 1990; Offit and Dudzik, 1990). 
Cross-reactive rotavirus-specific CTLs generated in mice after oral 
inoculation with rotavirus recognised VP7 (Offit et al., 1991; 1994; 
Dharakhul et al., 1991; Franco et al., 1993) or VP1, VP4, VP6 and VP7 
(Dharakhul et al., 1991). Quantitative differences in the generation of 
serotype-specific and cross-reactive CTLs have been found after oral 
inoculation of two candidate rotavirus vaccine strains RRV and WC3. 
Thus, RRV elicited the production of predominantly strain-specific CTLs, 
WC3 elicited mainly cross-reactive CTLs (Offit and Svoboda, 1989). The 
rotavirus-specific CTLs can be induced both at the mucosal and non- 
mucosal surface after oral or intraperitoneal inoculation (Offit et al., 
1994). An immunodominant cytotoxic T cell epitope on VP7 protein 
which overlaps the H2 signal peptide has recently been identified (Franco 
et al., 1993). 
1.12 Rotavirus vaccinology 
1.12.1 The need for a rotavirus vaccine 
The economic importance of rotavirus is well established. (see 
section 1.1). The development and application of an effective rotavirus 
vaccine should have a major public health impact by lowering the overall 
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diarrhoeal disease morbidity and mortality. De Zoysa and Feachem, 
(1985) estimated that a vaccine with 100% efficacy administered to all 
infants under 6 months of age in the developing world would decrease the 
occurrence of diarrhoeal episodes by 5% and the mortality by 16 % 
thereby reducing the number of deaths by 160 000 per year. Under more 
realistic conditions, in which a vaccine has 80 % efficacy and only 45 % 
coverage of the same age groups, they estimated a reduction of diarrhoeal 
morbidity by about 1.8 % and mortality by 6% per year. The impact of 
the vaccine on diarrhoeal morbidity in developed nations would be much 
more pronounced since the relative role of rotavirus in comparison to 
other agents as a cause of severe diarrhoea is greater in developed 
countries than in developing countries. 
1.12.2 Factors to be considered when planning a rotavirus 
vaccination strategy 
Several factors must be considered for developing and deploying a 
successful rotavirus vaccine: the need to induce a local, mucosal immune 
response; the presence of maternal antibody either in colostrum or by 
transplacental transfer, as well as other nonspecific inhibitors in breast 
milk and serum that could interfere with vaccine efficacy (Edelman et al., 
1989); the presence of multiple virus serotypes circulating in the 
population (Green et al., 1990; Kapikian et al., 1986; Lanata et al., 
1989; Snodgrass et al., 1984), the compatibility between various 
vaccination regimens implemented in young children; and concurrent 
infections by rotavirus and other enteropathogens (Edelman et al., 1989). 
Strategies for vaccinating humans have been aimed to-date at 
children less than 2 years of age (Green et al., 1990). In animals the 
susceptible age for virus disease is 3-30 days. Therefore a strategy of 
dam vaccination, to raise protective antibody levels that can passively 
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immunise suckling neonates, (Saif et al., 1983; Wyatt et al., 1983) has 
been employed. 
1.12.3 Approaches for rotavirus vaccine development 
A variety of approaches have been proposed and/ or pursued for 
rotavirus vaccine development. These can be grouped into four broad 
categories. 
1.12.3.1 Live attenuated virus vaccines 
Major research efforts have been put into the development of live 
attenuated vaccines for a number of reasons. It is believed that they 
would have the best chance of stimulating local mucosal immunity after 
oral administration. They would retain the native antigenic 
characteristics, elicit a strong immune response, without causing clinical 
disease. Three classes of live attenuated vaccine are currently under 
consideration: live attenuated or naturally avirulent strains; live attenuated 
heterologous strains; and attenuated, genetically reassorted (human x 
animal) strains. 
The first live rotavirus vaccine was a calf rotavirus vaccine given 
orally to calves at birth (Mebus et al., 1973). The Wa human rotavirus 
strain passaged in piglets and then in African green monkey kidney cells 
was the first live attenuated vaccine tested in human volunteers. 
However, the testing of this vaccine has been stopped due to elevations of 
the serum transaminase levels in the volunteers (WHO, 1984). 
A naturally attenuated rotavirus nursery strain, M37, was 
developed as a candidate rotavirus vaccine in the USA (Flores et al., 
1986). However, it does not provide heterotypic protection and is 
presently being formulated with other live attenuated candidates (Flores et 
al., 1990). 
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Live attenuated, heterologous strains of rotavirus from non-human 
hosts are also being evaluated for their potential in the so called Jennerian 
vaccines. Three such vaccine candidate are RIT 4237 (isolate of bovine 
NCDV origin), WC3 (bovine origin), and MMU 18006 (RRV-1 strain of 
rhesus monkey origin). All of the above described vaccines are effective 
only in the developed countries and are much less effective in developing 
countries. Moreover, they provide only homologous protection. 
Reassortants that are attenuated may be the solution to the problem 
of achieving heterotypic protection. Single gene substitution rotavirus 
reassortants have been produced in which the VP7 of human serotypes 1, 
2,3, and 4 was incorporated into rhesus or bovine parent strains 
(Midthun et al., 1985). Naturally attenuated rotavirus nursery strains 
(Bishop et al., 1983; Flores et al., 1986) and cold adapted human strains 
(Matsuno et al., 1987) are also being considered as reassortant donor 
strains. Several RRV and WC3 reassortants are currently in phase I 
clinical trial testing for safety and immunogenicity (Flores et al., 1989b). 
The VP4 can also be substituted from the same serotype if single gene 
substitution reassortants prove less satisfactory or from a different 
serotype for heterotypic protection. Multivalent vaccines either a mixture 
of cell culture adapted rotavirus strains of different serotypes or gene 
substitution reassortants are also being tested (Perez-Schael et al., 1990). 
1.12.3.2 Inactivated vaccines 
It has recently been shown that parenteral administration of 
inactivated rotavirus vaccine induced active immunity and protection 
against a virulent rotavirus challenge in a rabbit model (Conner et al., 
1993). 
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1.12.3.3 Live vectored vaccines 
Oral rotavirus vaccines are currently under development using 
cloned rotavirus genes in attenuated enteric bacteria such as Salmonella 
or E. coli (WHO, 1986). The advantages of using such bacteria are 
many: the bacteria will colonise the gut without causing disease, reduced 
chance of neutralisation by antirotavirus antibodies in the gut, reduced 
chance of reversion or reassortment. However, the disadvantage of 
prokaryotic expression systems is that these can not glycosylate or post- 
translationally modify the proteins and consequently protein folding is 
frequently incorrect. Also, epitopes on VP7 are known to be 
conformational (Dyall-Smith et al., 1986). 
1.12.3.4 Subunit vaccines 
Subunit vaccine candidates are based on individual rotavirus 
antigens, either produced in culture by cells containing cloned rotavirus 
DNA or prepared synthetically. In vaccine formulations these antigens 
may either be used alone or in combination to produce immunity to a 
broad spectrum of rotaviruses. 
1.12.3.4.1 Cloned rotavirus proteins 
Both VP4 and VP7 have been cloned into prokaryotic and 
eukaryotic expression vectors. The use of prokaryotic expressed protein 
has met with limited success (Arias et al., 1987; McCrae and 
McCorquodale, 1987). 
Rotavirus proteins have also been expressed in other systems, such 
as vaccinia and baculovirus (Andrew et al., 1987; Estes et al., 1987; 
Mackow et al., 1989). There are a number of advantages of using 
baculovirus expression vectors. They are not pathogenic to vertebrates 
and do not use transformed cells or transforming elements, and the 
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abundant expression of recombinant proteins (Lucknow and Summers, 
1988). Unfortunately, protein glycosylation by baculovirus is not always 
identical to mammalian processed proteins and the difference in the 
carbohydrate composition may affect the folding and presentation of the 
recombinant molecules. Individual rotavirus proteins from various strains 
have also been expressed in vaccinia virus and tested in vitro and in vivo 
for both humoral and cellular immune response with varying degrees of 
success (Offit et al., 1994). 
1.12.3.4.2 Synthetic Vaccines 
Another approach to the development of rotavirus subunit vaccine 
involves the identification and synthesis of protective epitopes. Peptides 
from the cleavage region of VP4 induced neutralising monoclonal 
antibodies (nmAb's) (Streckert et al., 1988), whereas peptides of VP7 did 
not induce nmAb's (Gunn et al., 1985; Streckert et al., 1986), and mAb 
to VP7 did not bind to synthetic VP7 peptides (Streckert et al., 1986; 
Taniguchi et al., 1988a). However, heterotypic passive protection was 
shown to be induced by VP7 peptide (amino acids 275-295) and VP4 
peptide (amino acids 232-255) either alone or in combination, when 
conjugated to expressed VP6 (Ijaz et al., 1991), which is yet to be 
confirmed by others. The synthetic peptides are attractive candidates for 
use in vaccines, however, they must be conjugated to large carrier 
proteins or polymers suitable for human and veterinary applications for 
producing acceptable levels of antibody titres or cellular immunity. 
1.12.4 Rotavirus vaccines : current position 
The current vaccine candidates and their respective stage of 
development are shown in Table 5. Some of the possible causes of failure 
of these vaccines are : failure to swallow the vaccine or emesis; gastric 
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acid; presence of maternal transplacental, or colostrum and milk 
antibodies; or presence of antibodies due to previous exposure; 
interference by replicating enterovirus in the bowel; changes in the 
cellular viral receptors with age, and rapid bowel transit time (Edelman et 
al., 1989). 
Recently, Glass et al., (1994) have reported that reassortant 
vaccines emerging from clinical trials are nearest to approval by the Food 
and Drug Administration for use in USA. Once approved, they could be 
incorporated into the routine schedule of childhood immunisation 
recommended by the Advisory Committee on Immunisation Practices. 
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Table 5: Summary of rotavirus vaccines currently under 
developments 
Vaccine type Designation Origin Delivery Development 
Phase 
Live WA Ent/ Par Discontinued 
attenuated 
M37 Nursery isolate Ent/ Par Completed 
Phase 1 
RIT 4237 NCDV Ent/ Par Completed 
Phase 1 
WC3 WC3 Ent/ Par Completed 
Phase 1 
MMU18006 RRV Ent/ Par Completed 
Phase 1 
Reassortants RRV Ent/ Par Early phase 1 
WC3 Ent/ Par Early phase 1 
Live bacterial E. coli/ Ent R/D 
vectored Salmonella 
Live viral Adenovirus Ent R 
vectored 
Recombinant Baculovirus Par R 
protein 
Viruslike Baculovirus Ent/ Par R/ D 
particles 
Peptide Par R 
a Taken from Redmond et al., (1993). 
Ent- enteric/ orally; Par- parenteral; R- research phase; D- preclinical development 
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Chapter 2 
Reassortment in rotaviruses 
2.1 Reassortment and reassortants 
When two closely related segmented viruses coinfect cells either in 
vivo or in vitro; then some of the progeny viruses will receive genome 
segments from both the parents producing what are termed reassortants. 
The process is called reassortment. Reassortants are genetic mosaics of 
coinfecting strains and can be identified by their particular array of 
genome segments, usually through their electrophoretic mobilities during 
polyacrylamide gel electrophoresis. The biological properties of 
reassortants will depend on which segments are inherited from which 
parent and the functional behaviour of each particular combination of 
segments and their protein products. 
2.2 Mechanism of genome assortment 
The rotavirus genome is made up of 11 segments of dsRNA. 
Isolated RNA is not infectious as the virus requires a virion associated 
RNA-dependent-RNA polymerase for replication. Plus strand RNA is 
transcribed from dsRNA and is indistinguishable from viral mRNA; it 
acts as the template for the synthesis of negative strand as well as being 
translated to generate the viral proteins. The low particle: pfu ratio that 
can be obtained with rotaviruses indicates that each progeny virion 
contains one copy of all 11 genomic RNA segments. The mechanism by 
which assortment of genome segments in a singly infected cell and 
reassortment in a mixedly infected cell occurs is not understood. The fact 
that rotaviruses contain two complete shells of protein made up of a total 
of six different proteins, bud through the endoplasmic reticulum as a step 
in morphogenesis, and have a genome that consists of 11 unique 
molecules of dsRNA indicate that there are a number of distinct 
intermediates formed during replication cycle. One such intermediate is 
the replicase particle, which has the capacity to synthesise all 11 
genomic dsRNA (Helmberger-Jones and Patton, 1986; Patton and 
Gallegos, 1988). However, it has not yet been possible to separate 
replicase particles into subsets, each responsible for a different genome 
segment. This strongly suggests that replication follows assortment i. e. 
assortment occurs with single stranded plus sense RNA and not the 
dsRNAs. It further indicates that the recognition signals for assortment/ 
packaging lie on viral mRNAs. The fact that reassortant viruses are 
readily formed in coinfected cells suggests that, during genome 
assortment and the assembly of the replicase particles, the viral mRNAs 
that are destined to serve as templates for replication are assorted 
independently. Successful reassortment between different strains of 
viruses should logically require that they share common recognition 
signals for assortment/ packaging. 
It seems likely that two signals will be required for the assortment/ 
packaging process to be completed successfully. First a recognition signal 
which facilitates the distinguishing of viral mRNAs from host mRNAs 
and a second, sorting signal, by which 11 rotavirus mRNAs are 
individually recognised. The 5'- and 3'- ends of dsRNA genome 
segments are conserved (McCrae and McCorquodale, 1983). These 
conserved sequences and the lack of a 3'- terminal poly (A) tail may help 
to differentiate the viral and host mRNAs during assortment. These 
terminal conservations cannot alone function as sorting signals as they are 
identical on all 11 species of viral mRNAs. However, it is possible that 
the sorting signals may be located near the 5'- and 3'- ends of viral 
mRNAs since these are also highly conserved (Clarke and McCrae, 1983; 
McCrae and McCorquodale, 1983) but in a segment specific fashion. The 
fact that rotaviruses with rearranged segments can form reassortants 
(Graham et al., 1987) indicates that the length of viral mRNA probably 
does not constitute part of the sorting signal. 
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2.3 Features of rotavirus reassortment 
Rotavirus reassortants have been produced in vitro (Greenberg et 
al., 1981; 1983a; Kalica et al., 1981; 1983; Offit et al., 1986; Liu et al., 
1988; Chen et al., 1989; Snodgrass et al., 1992), in vivo (Gombold and 
Ramig, 1986; 1989; Broome et al., 1993), and also have been reported to 
occur in nature (Clarke and McCrae, 1982; Hoshino et al., 1985a; 1987b; 
Ward et al., 1990a). Reassortants have been produced between two is 
mutants (Ramig, 1983), between two wild-type (Snodgrass et al., 1992), 
between is mutants and wild-type (Greenberg et al., 1981), and between 
wild-type and viruses with rearranged segments (Graham et al., 1987). 
Kinetic studies indicate that reassortment is an early event in the 
infectious cycle (Ramig, 1983; Gombold and Ramig, 1986). More than 
25% of the progeny clones were reassortants by 12 hr p. i. in in vivo 
experiments. The frequency of reassortment increased to 80-100% by 72- 
96 hr p. i. (Gombold and Ramig, 1986). The finding of a significant 
frequency of reassortant progeny (> 25 %) early in the infectious cycle in 
vivo was similar to early reassortment noted for mixed infection with 
rotavirus is mutants in vitro (Ramig, 1983; Gombold and Ramig, 1986). 
However, two important differences between in vivo and in vitro 
reassortment were noted. Significant numbers of reassortants were 
detected at 12 hr p. i. in vivo whereas the first significant reassortants 
were detected at 16 hr p. i. in vitro (Gombold and Ramig, 1986). This 
slight difference in the kinetics may simply reflect the adaptation of 
rotaviruses for replication in enterocytes compared with more restricted 
growth in cultured cells or the low temperature (31 °C) at which the in 
vitro experiments were conducted. The frequency of the reassortant 
progeny in vivo increased throughout the infectious cycle whereas 
maximal frequencies of reassortants were observed at the earliest time in 
standard in vitro crosses performed at a high m. o. i. (Ramig, 1983; 
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Gombold and Ramig, 1986). This observation suggests that either 
multiple cycles of replication occur in vivo or that certain genotypes have 
selective advantage in vivo or both (Gombold and Ramig, 1986). 
Reassortment is a random process, and reassortants with 2048 
different genotypes are possible in the reassortment process involving two 
different strains of rotaviruses. However, non-random segregation of 
genome segments may occur under certain circumstances (see later). 
2.4 Factors affecting reassortment or reassortant frequency 
2.4.1 Antigenic relatedness 
Reassortant frequencies varying from 0% to 100% in rotaviruses 
have been documented. The formation and detection of reassortants is 
probably most efficient when the coinfecting strains are closely related. 
This is expected since the genome segments or the proteins they encode 
must function together. Studies with influenza viruses have indicated that 
more closely the gene products are related, the more likely a replacement 
will be tolerated (Klenk and Rott, 1988). In rotaviruses, no reassortant 
has been isolated between rotavirus and reovirus. Both are different 
genera of Reoviridae. Similarly, no reassortants have been reported 
between rotaviruses belonging to different rotavirus groups (Yolken et 
al., 1988), and very few reassortants have been reported between 
different genogroups of rotaviruses (Nakagomi et al., 1989; Ward et al., 
1990a). The progeny of coinfection between subgroup I and subgroup II 
rotavirus strains yielded comparatively smaller % reassortants, <1% 
(Urasawa et al., 1986), < 3.5 % (Garbarg-Chenon et al., 1984), or 14 % 
(Ward and Knowlton, 1989). In contrast, coinfection with cultured cells 
with different pairs of subgroup II human rotaviruses resulted in high % 
(33-48%) of plaque picked colony being a reassortant (Ward et al., 
1988a). Reassortant frequency, between two serotype 3 strains, of 5% 
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(Broome et al., 1993), and 38-100% (Gombold and Ramig, 1986) have 
been reported from in vivo crosses. 
2.4.2 Host effects on rotavirus reassortment 
Specific host effects on reassortant genotypes have been observed 
following mixed infection of cells in vitro (Graham et al., 1987). Thus 
some reassortant genotypes could be isolated using either MA104 or 
BSC-1 cells, although the frequency of isolation of a given genotype was 
quite different between the two cell lines. By contrast other reassortant 
genotypes were isolated at a relatively high frequency on one cell line and 
not at all on the other (Graham et al., 1987). 
2.4.3 Effect of immune status of animal on reassortment 
Immune responses may modulate the frequency of reassortment by 
reducing the effective m. o. i. by neutralisation and other immune 
mechanisms, thereby preventing efficient mixed infection of enterocytes. 
No reassortant was detected among progeny clones examined from 
mixedly infected, homotypic immune mice (Gombold and Ramig, 1989). 
By contrast about 11 % were identified among progeny clones from 
mixedly infected, heterotypically immune mice. Reassortment was 
reduced more than 50-fold by homotypic immunity and approximately 
three fold by heterotypic immunity relative to the frequency observed in 
non-immune mice (Gombold and Ramig, 1986; 1989). 
2.4.4 Effect of multiplicity of infection (m. o. i. ) on reassortment 
M. o. i can affect the frequency of reassortment both in vitro (Ward 
et al., 1988a), and in vivo (Gombold and Ramig, 1989). In in vitro 
studies it was found to increase in parallel with m. o. i until an m. o. i of 
2.5-5.0 pfu/cell of each parent was attained. 
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2.4.5. Reassortment and superinfection exclusion 
The frequency of isolation of viruses with mixed electropherotypes 
from infected individuals is approximately 10% (Lourenco et al., 1981; 
Spencer et al., 1983; Nicolas et al., 1984), that indicates either 
simultaneous or sequential infection. However, if the infection is not 
simultaneous, the question arises of how much temporal separation 
between the two viruses is consistent with the production of reassortant. 
It has been shown that rotaviruses fail to establish superinfection 
exclusion (Ramig, 1990). Recently, it has been shown that reassortment 
in rotaviruses can occur in vivo, when as much as 24 hr separates the 
time of parental strain inoculation (Broome et al., 1993). This is in 
contrast to another member of the family Reoviridae, bluetongue virus 
(Ramig et al., 1989; El Hussein et al., 1989). 
2.5 Non-random segregation of genome segments 
Reassortment is a random process. However, if experiments are 
done under conditions where selective pressure could occur, then non- 
random segregation is both expected and observed (Graham et al., 1987). 
Thus, in a cross between natural genetically rearranged human rotavirus 
and bovine rotavirus, non-random selection of single gene segments 2,5, 
6,9, and 11 was observed. A gene association of 5+9 and a stronger 
selection for triple gene association among 5 +9 + 11 was also observed. 
The selection was linked with the parental gene constellation and host cell 
type used (Graham et al., 1987). 
Non-random segregation has also been observed in the absence of 
intentional selective pressure (Gombold and Ramig, 1986; Ward et al., 
1988a). Gombold and Ramig, (1986), using two heterologous viruses in 
mice, conducted a study wherein they obtained samples from mice at 
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several time points post infection. Although the gene segment 
reassortment was quite random overall, they found a compellingly non- 
random distribution of SA11 gene 5, and to a lesser degree SA11 gene 3 
in all the mice and at all time points examined. They also found the gene 
pair 5+3 to be strongly represented in their in vivo heterologous 
reassortant system. The selection for genome constellations more 
favourable than the parental constellations for replication in vivo may be 
the reason for this non-random segregation. 
In another study, coinfection with three different pairs of subgroup 
II human rotaviruses followed by multiple blind passages caused a 
reproducible selection of genome segments from each set of parents in 
progeny viruses (Ward et al., 1988a). One of the parents dominated in 
the final selection in each pair of viruses used. Although more segments 
were selected from the virus of a pair that grew to higher titre, certain 
segments were selected independently of the relative growth properties or 
m. o. i. of the coinfecting viruses; whereas selection of other segments was 
dependent on both (Ward et al., 1988a). Although the segment selection 
was reproducible for each pair of viruses, no obvious pattern was 
discernible regarding the particular segments selected. It was also 
observed that i) the selection of specific reassortants following coinfection 
was due to differences in the infectivities of progeny viruses and not in 
their assembly and, ii) the selection of new virus strains did not occur 
because the selected reassortants grew better than the parents but because 
they grew better than other reassortants (Ward et al., 1988a). 
2.6 Reassortment as a tool to identify rotavirus gene product 
and gene function 
Reassortment has proved to be the primary tool for the 
identification of gene function, and an alternative system to in vitro 
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translation for identifying gene product. Thus, segregation analysis has 
been used to map a number of phenotypes in rotaviruses. For example, 
reassortment has been used to identify VP4 as the rotavirus 
haemagglutinin determinant and determinant of protease-enhanced plaque 
formation (Kalica et al., 1983), VP6 as the subgroup antigen (Kapikian et 
al., 1981) rotavirus proteins as neutralisation antigens (Greenberg et al., 
1983a; Offit and Blavat, 1986), identifying determinants of viral 
virulence (Offit et al., 1986; Broome et al., 1993; Hoshino and Kapikian, 
1994), rescuing non-cultivable viruses (Greenberg et al., 1981), and 
mapping temperature-sensitive mutations (Gombold et al., 1985). 
2.7 Evolution of rotaviruses through reassortment 
Reassortant formation in cells coinfected with viruses having 
segmented genomes has been viewed as a potentially rapid mechanism of 
viral evolution (Chanock et al., 1983). Pandemics of influenza A virus 
have occurred every 10-20 years during this century through the 
emergence of human strains with new haemagglutination properties by a 
mechanism called antigenic shift. The antigenic shift event is believed to 
occur as a result of reassortment between human and animal or avian 
strains (Desselberger et al., 1978). 
In rotaviruses, the serotype 3 strains of human rotavirus are 
serotypically related to rotaviruses of several animal species and at least 
three strains of porcine rotavirus are classified with serotype 4 human 
strains (Hoshino et al., 1984). This sharing of antigenic determinants by 
rotaviruses isolated from different species may have resulted from 
reassortment. Furthermore, this process may have led to and could 
continue to lead to the production of new human rotavirus serotypes to 
which man has little if any immunity. The evidence for evolution of 
rotavirus through reassortment comes from the finding of naturally 
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occurring intertypic reassortants like M37 and SB-lA (Hoshino et al., 
1985a; 1987b) and isolation of natural reassortants of human rotaviruses 
belonging to different genogroups (Ward et al., 1990a) and a human 
rotavirus belonging to G10 serotype (Beards et al., 1992). 
Reassortment not only has the capability of shuffling previously 
recognised genes but also affecting the expression of those genes in subtle 
ways by masking or unveiling of epitopes. For example, in the case of 
neutralisation antigens, the simple direct expression of the parental 
antigenicity of a reassortant would have the potential to create new 
combinations of previously recognised antigens, but would be unlikely to 
create a virus recognised as a new serotype. However, it has become 
clear that recipient genetic background can affect the expression of 
antigenicity, through the interactions of the donor and recipient proteins 
(Chen et al., 1989; 1992; Kool et al., 1992). 
2.8 Limitations of reassortment 
Reassortment is a random process. The probability of getting the 
desired reassortants without any selection pressure is very low and 
therefore, identifying the desired reassortant is very time consuming. 
Also, reassortment experiments will not map phenotypes with precision 
greater than assigning them to a segment(s). The recipient genetic 
background can affect the expression of the phenotypes of donor 
segments (Chen et al., 1989; 1992; Kool et al., 1992). Therefore, the 
interpretation and application of results of reassortment mapping studies 
with one pair of parents and its comparison with a different pair of 
parents must be approached with caution. 
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Chapter 3 
Molecular basis of disease 
3.1 Molecular basis of viral disease 
Disease resulting from virus infection is a complex event 
depending on the close interaction of viral and host factors. In the 1880s, 
Robert Koch produced his postulates for correlating disease with micro- 
organisms in his 'Germ Theory Of Disease'. These criteria still hold good 
for associating a micro-organism with a disease. However, the central 
drive at present is to understand the disease at the molecular level. 
Technological developments over the last two decades have enhanced our 
understanding of the biochemical basis of heredity and have led to an 
increasing understanding of the organisation and regulation of eukaryotic 
genes, with much of this understanding being based on the analysis of 
viral systems. By contrast the complex nature of the interactions between 
viral agents and eukaryotic hosts that occur during the infectious process 
have hampered efforts to decipher the molecular mechanism involved in 
viral diseases. Thus, while many studies have been performed on the 
descriptive aspects of pathogenesis of viral diseases, little is known about 
the precise molecular events responsible. Recently, increased knowledge 
of the function of individual components of viruses and their interactions 
in the ultimate production of infection have begun to allow research 
directed towards defining molecular mechanisms of viral pathogenesis 
and pathogenicity/ virulence. 
3.2 What is virulence? 
Virulence or pathogenicity is defined as the capacity of a virus to 
produce disease in a particular host. It is often used incorrectly to refer 
to infectiousness (transmissibility) of a virus. Highly virulent viruses are 
not always readily transmissible from individual to individual (e. g. 
rabies), and readily transmissible virus are not necessarily very virulent 
(e. g. rhinovirus). A measure of the virulence is given by dose of the virus 
required to cause disease or death. This figure differs for different hosts 
because a wide range of factors, genetic and non-genetic, immunological 
and non-immunological, influence resistance of a host to a given virus. In 
fact, the virulence of a virus and susceptibility/resistance of the host 
cannot be considered in isolation as it is their interaction that is relevant. 
Serious disease or death can be caused by avirulent viruses if 
administered via an atypical route, or in a very large dosage, e. g. 
avirulent ectromelia virus given by the footpad route to susceptible Bagg 
mice. On the other hand, C57 B1 mice are resistant to even virulent 
ectromelia virus when given through footpad route (Schell, 1960). 
There is a wide range of pathogenicity/ virulence. At one extreme 
the infection is harmless, asymptomatic, with very low pathogenicity, 
e. g. cytomegalovirus in man. At the other extreme infection can lead to a 
rapidly or uniformly lethal disease, e. g. rabies is uniformly lethal in most 
vertebrates once the disease becomes apparent. Between these extremes 
are viruses that have a recognised clinical disease associated with them, 
e. g. poliomyelitis, but in which disease pattern ranges from asymptomatic 
infection to full blown clinical disease. 
3.3 Why study virulence? 
3.3.1 For developing better vaccines 
The ideal objective for prevention of viral disease is the 
eradication of the virus. Such an approach has been accomplished with 
the world-wide eradication of the virus responsible for smallpox. This 
was achieved by a highly successful campaign of surveillance and 
containment by vaccination in order to prevent its spread, rather than by 
universal routine immunisation. Because eradication is desirable does not 
mean it is always feasible. 
45 
At present, vaccines are the best tools for control and prophylaxis 
against viruses. The safety and efficacy records of the existing licensed 
virus vaccines are outstanding. Attenuating live viruses form the basis of 
many of the currently used vaccines for humans. However, the basis for 
attenuation of these viruses is poorly understood. Thus, occasional risk of 
reversion to virulence after poliovirus vaccine either in recipients or in 
susceptible contacts (WHO Consultative Group, 1982) or other side- 
effects such as rubella vaccine-associated arthritis in women (Chantler et 
al., 1982) or development of meningitis in children following live mumps 
virus vaccine (Forsey et al., 1990) have been reported. 
Attenuating live virus has traditionally been an empirical process, 
without the ability to control where mutations occur in the genome. 
Understanding of the mechanisms responsible for attenuation of viruses is 
important for prevention of viral disease. Current molecular techniques 
allow one to engineer specific mutation into the genome of most DNA 
viruses and some RNA viruses at any given site. Additional information 
will be helpful for designing new attenuated live vaccines. First, it will be 
important to identify the areas in the genome which are crucial for viral 
virulence. Second, selected sites within these areas, which are not critical 
for viral replication, should be located. Third, it would be important to 
verify that the mutations at these sites do not interfere with the 
development of the host's immune response to the virus. If such sites can 
be identified, then mutations could be engineered into the genome at these 
locations, resulting in attenuated viruses. Thus, a better understanding of 
the molecular basis of virulence may ultimately result in new candidate 
live virus vaccines. 
The same viral gene may have antigenic and virulence 
determinants (e. g. haemagglutinin in influenza and reo virus) which do 
not overlap. The understanding of virulence will provide necessary 
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information to manipulate the gene in such a way so as to reduce its 
virulence without affecting its antigenicity. 
3.3.2 A Penicillin!! for viral disease 
There is a wide range of viral infections where immune 
prophylaxis either by vaccine or gamma-globulins is impracticable or 
unavailable. While it is theoretically possible to make vaccine against 
any virus disease, there are often serious difficulties in practice due to a 
variety of reasons. Some viruses will grow to a very low titre or may be 
poorly antigenic. Human rhinoviruses are found in more than 100 
different serotypes and therefore, it is most unlikely that vaccination 
would be a successful procedure for prevention because of the specificity 
of the immune reaction. An alternative method of control is by antivirals. 
Viruses are obligate intracellular parasites which take genetic control of 
the host cell's metabolism to achieve their replication. A thorough 
understanding of the molecular and genetic determinants of virus 
replication and virulence may help to develop efficient antivirals which 
selectively inhibit or block viral biosynthesis but have little or no adverse 
effect on host cell biosynthesis or function. 
Thus, a better understanding of the molecular basis of virulence is 
important for the development of new viral vaccines and antivirals for 
prevention, control and eradication of viral diseases. 
3.4 Rotavirus virulence 
3.4.1 Why study rotavirus virulence? 
The economic importance of rotavirus is well established (see 
chapter 1). Rapid progress has been made in the characterisation of 
rotavirus genome and viral polypeptides, their antigenic properties, and 
immune responses to them. However, the important parallel area of 
47 
rotavirus virulence remains under-explored. Virtually nothing is known 
about the precise molecular mechanisms determining the relative capacity 
of rotaviruses to produce disease in an infected host. 
Understanding rotavirus virulence may help to control rotavirus 
disease by providing a direction for developing better vaccines. For 
example, if the protein involved in virulence is also found to be antigenic 
and immunogenic, then that can serve as a candidate for future vaccine 
development. The development of a rotavirus vaccine is a priority area of 
the WHO. However, the candidate rotavirus vaccines do not confer 
heterotypic immunity. This may be due to the multiplicity of serotypes. 
Fourteen G serotypes and 11 P serotypes (19 P types based on 
sequencing; Hoshino and Kapikian, 1994) have been reported and 
additional serotypes continue to be reported. Since VP4 and VP7 can 
segregate independently (Hoshino et al., 1985a; Offit and Blavat, 1986), 
there are 154 potential G/P serotype combinations at the moment. Also, 
the interaction between VP4 and VP7 may mask or unmask some 
neutralisation epitopes (Chen et al., 1992; Kool et al., 1992), thereby 
increasing the number of potential serotypes predicted by reassortment 
alone. 
An alternative (or a second defence strategy) for the control of 
rotavirus disease is by drug intervention. If a common pathway of disease 
production by different strains of rotavirus is found, antivirals may be 
developed that can be effective against all of them. The common 
mechanism of assortment in a singly infected cell or reassortment in a 
mixedly infected cell is one such pathway against which drugs and/ or 
vaccines may be developed. However, at present the mechanism of 
genome segment assortment is not known. The interaction of rotavirus 
proteins with host cell receptor is another area against which drugs may 
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be developed. However, the exact nature of the rotavirus receptor is not 
known. 
3.4.2 Pathogenesis and pathophysiology of rotaviruses 
The studies on pathogenesis and pathophysiology of rotavirus 
disease in humans is limited, but many detailed studies of natural and 
experimental rotaviral infections in other animals have been reported. 
The general pattern of infection involves virus penetration and infection 
of the differentiated enterocytes on the tips of the microvilli of small 
intestines (McNulty, 1978; Mebus et al., 1971; Mebus and Newman, 
1977; Theil et al., 1978). Rotaviruses multiply in the cytoplasm of these 
enterocytes and damage the absorptive cells, resulting in damage to both 
the digestive and absorptive functions. There is premature shedding of 
cells and shortening of villi leading to villus atrophy (Figure 3) (Starkey 
et al., 1986). The lysis of infected cells releases virus into the intestine, 
resulting in the large quantities of virus being detected in the faeces of 
infected subjects. 
The major pathophysiological mechanism for diarrhoea in rotavirus 
patients appears to be decreased absorption of salt and water related to 
the selective infection of absorptive intestinal villus cells, resulting in net 
fluid loss (Middleton, 1978). The replacement of the mature epithelial 
cells with immature cuboidal cells, that have retained their secretory 
activity as well as have reduced levels of disaccharidases, also increases 
the secretion. A secondary contribution comes from carbohydrate 
malabsorption which results in osmotic diarrhoea due to the presence of 
undigested lactose in the gut (Graham et al., 1982; Sack et al., 1982). 
Some reports have described replication of rotavirus in hepatocytes of 
mice under certain experimental conditions and unusual clinical 
conditions (Riepenhoff-Talty et al., 1987; Uhnoo et al., 1990). 
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I) 
Figure 3: Scanning electron micrograph of (a) control middle small 
intestine showing finger or cone-shaped normal villi with regular smooth 
appearance and (h) middle small intestine 48 hr after infection with 
EDIM virus showing the appearance of infected villus tips (medium and 
large arrows) and shrunken appearance of middle to base regions (small 
arrows) 
From Starkey et al., (1986). 
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3.4.3 Genes involved in rotavirus virulence 
Within the past few years, rotavirus strains have been recovered 
from new-born nurseries in which the virus has persisted and in which 
most of the infants failed to develop significant symptoms (Perez-Schael 
et al., 1984). Also infection of gnotobiotic calves with some bovine 
rotaviruses does not cause disease (Bridger and Pocock, 1986). It is 
possible that rotavirus strains which produce silent infection differ from 
the virulent strains as suggested by Perez-Schael et al., (1984), based on 
electropherotyping. A marked conservation of sequence in gene 4 was 
observed by RNA: RNA hybridisation for virus strains recovered from 
infants with asymptomatic infection, while a different set of gene 4 
sequences was conserved amongst virulent human isolates (Flores et al., 
1986). Sequence analysis confirmed and extended the observations made 
by RNA: RNA hybridisation suggesting that VP4 has an important role in 
virulence (Gorziglia et al., 1988b). However, the M37- like VP4 gene 
reported to occur only in strains of the virus recovered from 
asymptomatically infected neonates strains (Flores et al., 1986), has 
recently been recovered from neonates infected symptomatically (Gerna 
et al., 1990; Steele et al., 1993). The putative rotavirus strains studied by 
Gorziglia et al., (1988b) were not directly tested in an animal model or in 
a volunteer trial to determine whether these phenotypes were a genetic 
property of the viruses in question or due to host factors. 
Animal experiments for studying the genes involved in rotavirus 
virulence have produced conflicting results. The dose which causes 
diarrhoea in 50% of the inoculated animals is defined as 50% diarrhoea 
dose, (DD50). The difference in 50% diarrhoea dose, (DD50) between 
rotavirus strains is described as a difference in virulence (Offit et al., 
1986). In the suckling mouse model, the simian strain SA11 was found to 
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induce diarrhoea in 50% of the inoculated pups at 50-fold lower dose than 
did bovine strain NCDV. Analysis of the DD50 of a large number of 
SA11/ NCDV reassortants revealed that the virulence segregated with 
gene 4 of SA11 (Offit et al., 1986). 
3.4.4 Putative mechanisms of rotavirus virulence 
The trypsin cleavage site of surface glycoproteins is of 
considerable significance in the pathogenesis among the myxoviruses and 
paramyxoviruses, because one or two amino acid substitutions in this 
region of the haemagglutinin of influenza A virus or the fusion 
glycoprotein of Newcastle disease virus can bring about a marked change 
in virulence (Kawaoka and Webster, 1988; Toyoda et al., 1987). The 
trypsin activation of paramyxoviruses and orthomyxoviruses generates a 
highly conserved apolar amino terminus, and infectivity of these activated 
viruses can be blocked by oligopeptides that mimic this sequence 
(Richardson et al., 1980; Richardson and Choppin, 1983). 
In rotavirus, VP4 is cleaved into VP8* (28 kD) and VP5* (60 kD) 
polypeptides in the presence of trypsin and this cleavage results in 
enhanced viral infectivity (Clark et al., 1981; Espejo et al., 1981; Estes 
et al., 1981). Direct amino acid sequence analysis of VP4, VP5*, VP8* 
of the SA11 4fM strain identified the sites of trypsin cleavage as arginine 
241 and arginine 247, with the latter position being a preferred site 
(Lopez et al., 1985). Subsequent nucleotide sequence analysis across the 
region of gene 4 revealed the conservation of two arginines at the 
cleavage site. However, the new amino terminus generated in the VP4 of 
rotavirus is not hydrophobic; instead it contains many polar amino acids 
some of which may be charged at neutral pH. Therefore, the mechanism 
of activation of rotavirus infectivity is different from that postulated for 
other viruses. It is thought that cleavage of VP4 activates an early step in 
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the replication which may be triggered by one or both of the terminal 
regions generated by the cleavage or possibly by conformational changes 
that occur in the cleaved VP4 molecule. 
The cleavage of VP4 by trypsin has been shown to enhance 
internalisation of rotavirus (but not binding) into the cells which is an 
essential step in the replication process. Evidence has been put forward 
for both endocytosis and direct cell penetration of viral particles as being 
the normal route of viral infection (Clark et al., 1981; Petrie et al., 1984; 
Kaljot et al., 1988). It has been postulated that the VP4 cell membrane 
interactions may occur at a hydrophobic protein region distant from the 
cleavage site. This region (aa 384-401) is homologous to the internal 
fusion sites of Semliki Forest virus and Sindbis virus (Mackow et al., 
1988a). Conservation of sequence in this putative fusion region of VP4 of 
different rotavirus strains supports the *suggestion that it may play an 
important role in the replication cycle and hence virulence. 
VP4 in the virion can also be cleaved by chymotrypsin, generating 
a polypeptide with a molecular weight similar to that of VP5* but such 
cleavage does not enhance viral infectivity (Estes et al., 1981) and serves 
to illustrate the specificity of cleavage sites of VP4 for activation of 
infectivity. The region flanking the trypsin cleavage sites is relatively 
highly conserved in all strains and it may serve to hold the cleavage sites 
in the proper conformation for cleavage. The cleavage sites and 
intervening peptide are considered to have a role in virulence. 
However, other investigators have questioned the role of trypsin 
cleavage site in the rotavirus virulence on the basis of sequence analysis 
or studies with neutralisation escape mutants. Gottfried strain of rotavirus 
is virulent in pigs. However, its VP4 is more closely related to the VP4 
of the asymptomatic neonatal human rotaviruses than to the VP4 of 
symptomatic human or animal rotavirus strains based on amino acid 
53 
homology, identical potential trypsin cleavage sites, and similarity in the 
connecting peptide (Gorziglia et al., 1990b). 
The amino acid sequence of VP4 of two virulent NCDV bovine 
strains and an attenuated NCDV strain (RIT4237) differs in only five 
amino acids which are scattered throughout the protein but do not involve 
the trypsin cleavage site. It indicates that either a gene(s) other than VP4 
gene sustained mutations which are responsible for attenuation of the RIT 
strain or VP4 amino acid substitutions outside the cleavage region could 
affect the role of VP4 in determining the virulence phenotype (Nishikawa 
et al., 1988). 
Antigenic mutants of rhesus rotavirus selected with VP4 specific 
neutralising monoclonal antibodies directed against variable region do not 
demonstrate altered virulence in mice (Shaw et al., 1986). Also, among 
the rhesus rotavirus (RRV) variants selected by escape from broadly 
acting heterotypic neutralising anti-VP4 monoclonal antibodies or with 
homotypic anti-VP4 monoclonal antibodies, no mutants were identified in 
or near the trypsin cleavage site (Mackow et al., 1988a). 
VP4 and VP7 interact closely and such interaction may influence 
many more biological properties of these viruses than currently thought 
and recognised (Estes and Cohen, 1989). VP4 forms spikes on a smooth 
outer capsid formed by VP7 (Prasad et al., 1988). The region 
downstream from the long a helical stretch at the carboxy terminal of 
VP4 may contain sites of VP4 that closely interact with VP7 (Lopez et 
al., 1991). Whether or not these interactions have any role in virus 
infectivity and virulence has not yet been explored. 
3.4.5 Determinants of host range restriction of rotavirus 
Subgroup I human rotaviruses have been found to have short 
electropherotypes in all but a few cases (Nakagomi et al., 1987; Brown et 
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al., 1988). On the other hand, almost all known strains of animal 
rotavirus belong to subgroup I but have long electropherotypes (Kalica et 
al., 1978; Rodger and Holmes, 1979; Thouless et al., 1982; Albert et 
al., 1987), and subgroup I human isolates are not serotypically related to 
these animal strains (Hoshino et al., 1984). These observations indicate 
that animal rotaviruses do not readily infect humans. It is known, 
however, that vaccine strains of bovine (Clark et al., 1988) and simian 
(Losonsky et al., 1986; Anderson et al., 1986) rotaviruses will infect 
humans but the amount of virus shed appeared to be orders of magnitude 
less than can occur during infection with human strains (Ward et al., 
1984). Although reassortant formation between animal and human 
rotaviruses occurs readily in cultured cells after coinfection, evidence of 
reassortants between human and animal strains within natural human 
isolates has only recently been reported (Sukumaran et al., 1992; Das et 
al., 1993; Dunn et al., 1993). 
The host range restriction which is associated with the spread of 
the virus amongst the population, has been suggested not to be entirely 
related with virulence. The gene 5 which encodes the non-structural 
protein VP5 (NS53/NSP1) was indicated to be involved in host range 
restriction (Broome et al., 1993). Support for this experimental 
observation has come recently from the identification and characterisation 
of asymptomatic human rotavirus strains isolated from neonates in India, 
which had sequence homology of genes encoding VP4 and VP7 with 
bovine B223 strain (Sukumaran et al., 1992; Das et al., 1993; Dunn et 
al., 1993) but gene 5 sequence was representative of human rotavirus. 
The gene 5 selection of human rotavirus type over bovine rotavirus type 
presumably helped the Indian strains to survive and circulate in the 
population, albeit asymptomatically. The host range restriction was found 
to be associated with gene 4 in a virus overlay protein blot assay (Bass et 
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al., 1991). About 105-fold higher inocula of heterologous viruses are 
required to produce the disease in mouse (Greenberg et al., 1986) 
indicating host range restriction. 
3.4.6 Rotavirus receptor 
The specific cell and tissue tropism of rotavirus infection as well as 
the host range and host age restrictions could be partially mediated by 
specificity of interactions between rotavirus attachment proteins and host 
receptors. Reduced binding of rotavirus to adult mouse enterocytes as 
compared to those of suckling mice (Riepenhoff-Talty et al., 1982) has 
been reported. Two large molecular weight glycoproteins in murine 
intestinal brush border that specifically bind to infectious double-shelled 
rotavirus in a Western blot virus affinity overlay assay have recently been 
identified (Bass et al., 1991). Expression of these glycoproteins correlates 
with rotavirus cell and tissue tropism as well as the host range and host 
age restriction seen in rotavirus infection. However, the development of a 
similar assay for cultured cells was not successful (Bass et al., 1992a). 
The binding of rotaviruses to target cells is sensitive to neuraminidase 
treatment (Yolken et al., 1987; Bass et aL, 1991) indicating involvement 
of sialic acid. However, the exact nature of rotavirus receptor remains 
unknown. 
3.4.7 Limitations -on virulence studies in rotavirus 
There are two limitations on virulence studies. 
1. Lack of suitable animal model. 
2. Inability to manipulate the rotavirus gene(s) in vitro and then 
rescue this information into an infectious particle. 
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3.5 Determinants of poliovirus neurovirulence/ attenuation 
3.5.1 Introduction 
Poliovirus, a member of 'Picornaviridae family, is classified into 
three serotypes. The virion contains a single-stranded positive sense RNA 
molecule of 7.5 kilo bases coding for a large polyprotein from which 
viral capsid and non-structural proteins are derived. The"icosahedral viral 
capsid is made up of 60 copies of each of the four structural polypeptides: 
VP1, VP2, VP3 and VP4. The complete sequence of the viral genome is 
known and it is possible to construct viral recombinants and mutants by 
manipulating cloned infectious cDNA (Racaniello and Baltimore, 1981). 
3.5.2 Molecular basis of attenuation of poliovirus 
neurovirulence 
Poliovirus poliomyelitis has been greatly reduced due to the two 
excellent vaccines. One of these is Sabin's live attenuated preparation 
which contains all three viral serotypes. In the past the three Sabin 
vaccine strains have been extensively studied to obtain information on the 
mechanisms of attenuation. 
Analysis of viral proteins has been used to reveal differences 
between wild-types and attenuated viruses. While a difference in the 
amino acid sequence between a wild-type and attenuated viruses may be 
associated with virulence, this difference is not necessarily responsible 
for virulence (Diamond et al., 1985). These studies focus more on the 
surface proteins that react with antibodies or proteins that can be obtained 
in large quantities from virions. Therefore, the role of non-structural 
proteins as well as the non-coding regions of the genome may be 
overlooked. 
Differences in the RNA genomes of attenuated polioviruses and 
their neurovirulent parents were first detected by the method of RNAase 
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Ti oligonucleotide fingerprinting (Nomoto et al., 1979). A comparison of 
the genomes of the P1/Sabin vaccine strain and its neurovirulent parent, 
P1/Mahoney, indicated that the two viruses differ at approximately 35 
nucleotide positions. Complete nucleotide sequencing of their genomes 
showed that these two viral RNAs differ by 55 nucleotide substitutions 
out of the total genome length of 7441 (Nomoto et al., 1982), with the 
differences being scattered throughout the viral genome. This study 
showed that a relatively small number of mutations accompany the 
attenuation process, although they did not allow the precise localisation of 
the mutations responsible for the attenuated phenotype. A number of 
different approaches have been used to identify these mutations. These 
include the analysis of the sequences from the viral revertants, the 
construction of recombinant viruses containing regions of wild-type and 
attenuated genome, and more recently mutants produced by site-directed 
mutagenesis. 
Insights into the molecular basis of virulence has been gained by 
comparing nucleotide sequence between neurovirulent revertants and the 
attenuated parent virus. Nucleotide sequence analysis of the strain 
P3/119, isolated from a vaccine associated fatal case of poliomyelitis, and 
comparison of it with P3/Leon (neurovirulent progenitor) and P3/Sabin 
(vaccine strain) indicated it to be a true vaccine revertant. At 8 out of 10 
base positions that differed between P3/Sabin and P3/Leon, the sequence 
of P3/119 was identical to the vaccine strain. The only base in the non- 
coding region that had back-mutated to P/Leon sequence was 472 : which 
was C in P3/Leon, aU in P3/Sabin, and aC in P3/119 (Cann et al., 
1984). Back-mutation of nucleotide 472-to C was also observed in RNA 
from five other isolates of vaccine-associated cases of poliomyelitis 
(Evans et al., 1985). Nucleotide sequence comparison of P2/ Sabin and 
its revertants indicates that the reversion occurs by A-G mutation at 
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nucleotide 481 in the 5' non-coding region and Ile-Val mutation in VP1- 
143 (Macadam et al., 1991; Equestre et al ., 1991). Sequence analysis of 
neurovirulent derivatives of P1/Sabin suggests that as few as two 
mutations may be sufficient for reversion to neurovirulence 
(Christodoulou et al., 1990). 
The general approach used to identify mutations responsible for 
attenuation phenotype has been to construct viral recombinants between 
neurovirulent and attenuated strains and determine the neurovirulence of 
the recombinants in monkeys. By coinfecting cells with two genetically 
distinct viruses, Agol et al., (1985) obtained four recombinant 
polioviruses that were the mixtures of 5' half and 3' half in various 
combinations from the parents. Intracerebral inoculation of these 
recombinants into monkeys demonstrated that the 5' half of the genome 
was primarily responsible for viral virulence, the 3' half did contribute to 
virulence, but to a much lesser extent. The demonstration that poliovirus 
type 1 cDNA is infectious in cell culture (Racaniello and Baltimore, 
1981) provided a new method for preparing recombinant poliovirus. 
Subsequently, recombinants were constructed by exchanging DNA 
restriction fragments between infectious clones and recovering virus by 
transfection of cultured cells with recombinant plasmids. 
Analysis of the neurovirulence of recombinants between 
PI/Sabin and Pit Mahoney by intrathalamic inoculation of cynomolgus 
monkeys showed that the attenuating determinants are scattered 
throughout the genome. However, a strong attenuating mutation was 
located in the 5' non-coding region at nucleotide 480. Analysis of the 
recombinants between P3/Sabin and P3/Leon using intraspinal inoculation 
of monkeys indicated that two mutations accounted for the attenuated 
phenotype of P3/Sabin: a base change from C to U at nucleotide 472 in 
the 5' non-coding region, and a change from serine to phenylalanine at 
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nucleotide 2034 in the capsid protein VP3 (Westrop et al., 1989). 
Although recent evidence suggests that another mutation at nucleotide 
2493 in the capsid protein VP1 may also be involved (Tatem et al., 
1992). 
The type 2 vaccine strain (P2/Sabin) was derived from a 
naturally attenuated wild strain P2/712 (Sabin and Boulger, 1973) which 
meant that a different approach than described for type 1 and 3 had to be 
taken to analyse attenuating determinants. Analysis of neurovirulence in 
primates by recombinants between P2/Sabin and P2/117 (a neurovirulent 
derivative isolated from a vaccine associated case of poliomyelitis) 
indicated that mutation at nucleotide 481 is responsible for neurovirulence 
(Macadam et al., 1991). 
An alternative way of analysing poliovirus neurovirulence has 
been the conversion of vaccine strains into neurovirulent strains and 
conversely attenuating the neurovirulent strains by site-directed 
mutagenesis. Using site-directed mutagenesis of P2/Sabin strain, 
Macadam et al., (1993) have recently shown that mutations at just two 
positions, nucleotide 481 in the 5' non-coding region and amino acid 143 
in the VP1 capsid protein, resulted in a highly neurovirulent virus in 
monkeys. Other nucleotide changes may have weaker, phenotypic effects. 
These results are consistent with those reported in the mouse model by 
Ren et al. (1991). 
It, therefore, appears that all three poliovirus vaccine strains have 
in common at least one mutation in the 5' non-coding region around 
nucleotide 480, that can attenuate the neurovirulence of polioviruses 
inoculated into the central nervous system (CNS). of experimental 
animals. This attenuation may be due to reduced viral translation and 
failure to replicate efficiently or disruption of RNA secondary structure in 
this region (Skinner et al., 1989; Macadam et al., 1991; 1992). 
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3.5.3 Molecular determinants of host range restriction of 
poliovirus 
Humans are the only known natural hosts of poliovirus. 
Experimentally, poliomyelitis can be transmitted to chimpanzee, monkeys 
and mice by inoculation of poliovirus into CNS. Wild strains of all three 
serotypes are spontaneously neurovirulent in primates. In contrast, only a 
limited number of poliovirus strains are able to induce poliomyelitis in 
mice by intracerebral inoculation. A number of viral strains, such as 
P1/Mahoney strain are clearly host restricted and cause paralysis in 
primates but not in mice (La Monica et al., -1986). However, transgenic 
mice expressing human poliovirus receptor are susceptible to infection 
with all three serotypes of poliovirus (Ren et al., 1990; Koike et al., 
1991). These result show that the primary block to infection in normal 
mice by these strains is at the level of cell entry. 
The molecular basis of poliovirus neurovirulence in mice has shed 
light on the genetic determinants involved in host range restriction. The 
construction of viral recombinants between the mouse-adapted 
P2/Lansing and mouse-avirulent P1/Mahoney has revealed that the capsid 
coding region of the Lansing strain is responsible for its mouse- 
neurovirulent phenotype (La Monica et al., 1986). Further studies have 
shown the important role played by the B-C loop (amino acid 94-102) of 
the capsid protein VP1 in host range restriction (La Monica et al., 1987; 
Martin et al., 1988; Murrey et al., 1988; Couderc et al., 1991; Martin 
et al., 1991). Various single amino acid substitutions in the VP1 B-C 
loop of P2/Lansing reduce the pathogenicity of the virus in mice (La 
Monica et al., 1987). A significant finding concerning poliovirus host 
range is that variants of PI/Mahoney carrying VP l B-C loop of 
P2/Lansing are neurovirulent in mice (Martin et al., 1988; Murrey et al., 
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1988). As for P2/Lansing, amino acid changes in VP1 B-C loop of this 
mouse-adapted P1/P2 chimeric virus impairs its neurovirulence in mice 
(Couderc et al., 1991; Martin et al., 1991). More recently, 
neurovirulence determinants of P2 were identified by analysing mutants 
of P2/Lansing which had been attenuated by introducing mutations in the 
B-C loop and then passaged in mice. Mouse-selected mutants were 
subsequently found to be more virulent. The increased neurovirulence of 
these strains was mapped to two different suppressor mutations in the N 
terminus of VP1. Whereas the B-C loop of VP1 is highly exposed on the 
surface of the capsid, the suppressor mutations are in the interior of the 
virion. Moreover, the introduction of suppressor mutations into the 
genome of the mouse-avirulent P1/Mahoney resulted in neurovirulent 
viruses (Moss and Racaniello, 1991). These results demonstrate that the 
VP1 B-C loop of P2/Lansing is sufficient but not absolutely necessary to 
render P1/Mahoney neurovirulent for mice, indicating that mechanism of 
poliovirus adaptation to mouse is more complex. Recently, Couderc et 
al., (1993) isolated two mouse-virulent poliovirus type 1 Mahoney 
mutants in the mouse CNS after a single passage of P1/Mahoney 
inoculated by the intracerebral route. The nucleotide sequence of the 
mutant genomes were determined. Mutations were introduced into the 
parental P1/Mahoney genome by single-site mutagenesis. Mutated 
P1 /Mahoney viruses were then tested for their neurovirulence in mice. 
Both independentmutations in VP1 (Thr 22-Ile) and VP2 (Ser-Thr) 
conferred mouse virulent phenotype to the mouse-avirulent PI/Mahoney 
strain. Thus, Couderc et al., (1993) have identified a new mouse 
adaptation determinant on VP1 and they have also shown that at least one 
other capsid protein, VP2, could also express a mouse adaptation 
determinant. 
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3.6 Virulence determinants of Influenza A virus 
3.6.1 Introduction 
Influenza A, a member of Orthomyxoviridae family, is an 
enveloped virus. The genome consists of eight segments of single- 
stranded RNA of negative polarity. The mRNAs are transcribed from the 
virion RNA by a virion-associated-RNA-dependent-RNA-polymerase. 
The eight gene-segments code for eight structural (PB1, PB2, PA, HA, 
NA, NP, M1 and M2) and two non-structural proteins (NS 1 and NS2) 
(Lamb, 1983). At present there are 14 HA (haemagglutinin) and 9 NA 
(neuraminidase) subtypes of influenza A virus. 
Influenza A viruses have been isolated from humans, horses, pigs, 
mink, seals and whales as well as from a variety of different avian 
species. Although there is variation in the severity of illness in 
mammalian species, infection is usually localised to the respiratory tract. 
Majority of the avian influenza viruses also cause local infection in the 
respiratory tract or in the gut, which frequently remains asymptomatic. In 
contrast other avian strains are highly pathogenic causing fowl plague, a 
systemic infection which is often fatal. The avian system is particularly 
useful for virulence studies because a large number of naturally occurring 
strains can be analysed in their natural host (Schulman, 1983). 
Unlike poliovirus, infectious influenza viruses having all the genes 
derived from cDNAs can not be obtained. However, the particular 
genome organisation of influenza viruses permits genetic reassortment 
when a single cell is infected by two different parents. This approach has 
been used to segregate the virulence phenotype with gene segment(s). 
3.6.2 Influenza virus pathogenicity is multigenic 
Employing the highly virulent fowl plague virus (FPV) in in vitro 
crosses with non-pathogenic viruses of mammalian or avian origin, it was 
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demonstrated that the pathogenicity is of polygenic nature (Rott et al., 
1979). These findings were further confirmed by genetic analysis of a 
large number of reassortants obtained after mixed infection with is 
mutants of FPV and different human or animal influenza viruses 
(Scholtissek et al., 1977). 
The constellation of genes coding for viral RNA polymerase 
complex (PB1, PB2, PA, NP) appears to have an important role in 
virulence. When the complete set of these genes was derived from one or 
the other avian parent virus, the reassortant was; in general, pathogenic. 
In contrast all non-pathogenic reassortants had a mixed polymerase 
complex. This was the'case regardless of whether these genes ultimately 
came from pathogenic or non-pathogenic strains (Rott et al., 1979; 
Giesendorf et al., 1986). Reassortment, even between highly pathogenic 
strains may lead to pathogenic as well non-pathogenic reassortants (Rott 
et al., 1979). By contrast, virulent reassortants can be derived following 
mixed infection with two avirulent parents. Also, certain reassortants 
derived from crosses between a non-neuropathogenic FPV and a non- 
neuropathogenic human influenza virus have been shown to be highly 
virulent for mice (Scholtissek et al., 1979). It has been demonstrated that 
NA, M, and NS genes of WSN virus could contribute to neurovirulence, 
however, the NA gene is essential (Sugiura and Ueda, 1980). 
The human H1N1 prototype strain, A/FM/ 1 /47 (FM), was adapted 
to the mouse by serial lung passage to produce a virulent variant, FM- 
MA that had increased in virulence by 104.3-fold as measured by LD50" 
Segments 4,5,7, and 8 were identified as being associated with virulence 
in reassortant studies (Brown, 1990). Sequence analysis revealed single 
amino acid replacements in gene 4 and gene 7 to be responsible for the 
increased virulence (Smeenk and Brown, 1994). 
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3.6.3 Functional basis of virulence : role of individual gene 
segments - 
The results obtained with viral reassortants has revealed that the 
expression of virus pathogenicity is dependent upon the functional 
integrity of each gene and on a gene constellation optimal for infection of 
a given host. Changes that result in alterations in the function of any gene 
or in genome composition can cause alterations in pathogenicity. As a 
consequence virtually every gene product of influenza virus has been 
reported to contribute to pathogenicity, but evidence is steadily growing 
to assign a key role to haemagglutinin. 
Three different functions of haemagglutinin have been shown to 
play a role in influenza virus pathogenicity. First, antigenic shift and drift 
in the virus allows it to infect individuals who are already immune to 
previous strains. Second, studies on receptor-binding sites also suggest 
that changes in this region of haemagglutinin of the virus can lead to 
changes in the pathogenicity. Third and most important is that the 
proteolytic cleavage of the haemagglutinin by trypsin-like proteases at 
arginine residues is indispensable for influenza virus to initiate infection. 
Since the activating proteases are cellular enzymes, the infected cell type 
determines whether the haemagglutinin is cleaved (Klenk et al., 1975; 
Klenk and Rott, 1980). The haemagglutinins of mammalian influenza 
viruses and non-pathogenic avian influenza viruses, which cause a local 
infection, are susceptible to proteolytic cleavage only in a restricted 
number of cell types. On the other hand, haemagglutinins of pathogenic 
avian influenza viruses among the H5 and H7 subtypes causing a systemic 
infection are cleaved by proteases present in a broad range of different 
host cells (Bosch et al., 1979). Thus, there are differences in the host 
range resulting from differences in haemagglutinin cleavability which can 
be correlated with the pathogenic properties of the virus. The difference 
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in cleavability is due to differences in the structure of cleavage site of the 
haemagglutinins. The HA1 and HA2 fragments of haemagglutinin of the 
apathogenic avian and of all mammalian influenza viruses are linked by a 
single arginine. This is in contrast to the pathogenic avian strains, which 
have a sequence of several basic amino acids at the cleavage site. This 
fact was derived from the comparisons of naturally occurring strains 
(Bosch et al., 1981; Garten et al., 1981; Klenk and Rott, 1988) and was 
corroborated when acquisition of high cleavability paralleled by an 
increase in the number of basic residues at the cleavage site was observed 
in studies on haemagglutinin mutants generated by site-directed 
mutagenesis (Kawaoka and Webster, 1989) or on virus mutant adapted to 
new host cells (Li et al., 1990). Determination of amino acid sequence at 
the HA cleavage site is essential for assessing the potential virulence of 
avian influenza virus isolates. The important role, in the cellular 
proteases-induced cleavage, of the first (Vey et al., 1992), second, and 
fourth (Kawaoka and Webster, 1988) basic residues from the carboxyl 
end of the HA1, and the irrelevance of the'third (Kawaoka and Webster, 
1988) basic residue, led (Vey et al., 1992) to recognise a conserved 
sequence motif Arg-xxx-Arg/Lys-Arg, found at the cleavage site of H7 
avian virus HAs. This is further supported (Walker and Kawaoka, 1993) 
for H5 avian influenza viruses. In order for a HA to be cleaved 
completely by the endogenous proteases in cell culture, at least six amino 
acids have to be present at the cleavage site if a carbohydrate side chain is 
nearby. Otherwise, only four amino acids are needed. Using reverse 
genetics, it has recently been demonstrated directly that the cleavability of 
haemagglutinin determines influenza virus virulence (Horimoto and 
Kawaoka, 1994). They have further proposed that viruses with the Arg- 
Arg/Lys-Arg-Lys-Thr-Arg motif (Wood et al., 1993) should be 
considered in the same category as virulent viruses with xxx-xxx- 
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Arg/Lys-xxx-Arg/Lys-Arg motif. The European Community definition of 
highly pathogenic avian influenza viruses for control purposes (Council of 
European Communities, 1992) specifies an intravenous pathogenic index 
(IVPI) in six week old chickens of 1.2 or higher out of a score of 3.00 (a 
score of 3.00 in this test indicates that all birds died within 24 hours of 
infection and 0.00 indicates that no bird died or showed any clinical signs 
over the observation period of ten days), or for H5 and H7 viruses if in 
vivo testing shows -a lower IVPI, then the presence of multiple-basic 
amino acids at the haemagglutinin cleavage site is sufficient. However, 
the highly pathogenic and avirulent isolates from a recent outbreak in 
turkeys in Norfolk, England in 1991/92 had the same cleavage site 
sequence with multiple-basic amino acids, but unlike the outbreaks of 
avian influenza in Pennsylvania in 1983, the effect of the multiple-basic 
amino acids was not masked by an adjacent oligosaccharide at asparagine 
11 (Wood et al., 1994) in avirulent strains. 
The second important determinant appears to be a carbohydrate 
side chain that is present in the vicinity of the cleavage site and interferes 
with the protease accessibility. Loss of this carbohydrate resulted in 
enhanced haemagglutinin cleavability and viral pathogenicity (Deshpande 
et al., 1987; Kawaoka et al., 1984), and the effect of steric hindrance 
was abolished when the number of basic amino acids at the cleavage site 
increased (Kawaoka and Webster, 1989; Ohuchi et al., 1989). It has also 
been observed that insertion of a relatively long foreign peptide composed 
of nonbasic amino acid residues renders 'a single arginine at the cleavage 
site susceptible to ubiquitous cellular proteases (Katchikian et al., 1989). 
There is evidence that mutations in sequences different from the cleavage 
site can also affect the activation of the molecule. Such a mutation has 
been found to be responsible for an altered protease sensitivity of the H3 
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haemagglutinin, which in turn resulted in a change in host cell range 
(Rott et al., 1984). 
Examination of the amino acids of the amino-terminal sequence of 
HA2 of several influenza A strains of human and avian origin has 
revealed a highly conserved region of 10 residues (Waterfield et al., 
1979). This sequence is homologous to the amino-terminus region of the 
fusion glycoprotein F of Sendai virus (a paramyxovirus), which mediates 
fusion of the Sendai virus envelope with the plasma membrane of the 
host, a function which is considered to be essential for virus infectivity 
(Gething et al., 1978). It has, therefore, been postulated that the 
infectivity of influenza virus is dependent on the fusion function of 
haemagglutinin analogous to that of Sendai virus fusion protein. 
Newcastle disease virus, another paramyxovirus, comprises of various 
strains which, like the avian influenza viruses, differ widely in virulence 
for chicken. Differences in the pathogenicity can be correlated to the 
cleavability of the F protein (Nagai et al., 1976) and recent sequence 
analysis has revealed that apathogenic strains have a single arginine 
residue and the pathogenic strains have paired basic residues at the 
cleavage sites (Toyada et al., 1987). 
While it is clear from the above studies that susceptibilities of the 
haemagglutinin of avian influenza viruses to cleavage is determined by 
the structure of the haemagglutinin, in other systems differences in the 
viral neuraminidase may determine whether or not cleavage of 
haemagglutinin occurs. Influenza A/WSN/33 (111N1) virus is unique in 
its capacity to undergo multi-cycle replication and to form plaques in 
MDBK cells. ' Analysis of reassortants demonstrated that this property is 
dependent on the'neuraminidase of the virus (Schulman and Palese, 
1977). Infectivity was found to be dependent on a cleaved haemagglutinin 
and that the infectivity of viruses lacking WSN neuraminidase can be 
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activated by in vitro treatment with trypsin. In related studies it was 
shown that the virulence for 1-day-old chickens (Bean and Webster, 
1978) and neurovirulence in mice (Sugiura and Ueda, 1980) can also be 
correlated with the possession of the WSN neuraminidase gene in certain 
reassortants. The nucleic acid sequence of the neuraminidase of WSN 
virus has been determined (Hiti and Nayak, 1982). It showed that a 
potential glycosylation site at position 130 conserved in other influenza 
viruses neuraminidase is absent in this strain. Using reverse genetics 
methods, recently it has been shown that the absence of this glycosylation 
site at position" 130 of the neuraminidase plays a key role in the 
neurovirulence of WSN virus in mice (Li et al., ', 1993a). 
3.7 Molecular basis of reovirus virulence 
Mammalian reoviruses, as members of the Reoviridae family, have 
icosahedral symmetry. The virion comprises of two protein shells 
wrapped around the segmented dsRNA genome. Each of the 10 genome 
segments represents a single gene which is transcribed and translated into 
a unique mRNA molecule and a primary polypeptide, respectively 
(McCrae and Joklik, 1978) with the exception of S1 which encodes two 
proteins al, and p14. 
The mammalian reoviruses are separable into three serotypes 
(Rosen, 1960). Although structurally quite similar; these serotypes 
interact with mammalian hosts with very distinct patterns of disease 
(Fields, 1981). 
The general approach to study reovirus virulence has been to 
inoculate prototype strains, especially the' laboratory strains Type 1 
(Lang), Type 2 (Jones); Type 3 (Dearing) and to compare their patterns 
of infections. If differences between the serotypes were detected then 
reassortants were generated and a genetic analysis performed to 
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determine if the observed differences were properties of one or more of 
the viral genes (Fields, 1982). 
Intracerebral inoculation of newborn mice with type 3 reovirus 
leads to the development of an acute encephalitis that is uniformly fatal 
and associated with specific viral replication in neurones (Margolis et al., 
1971; Raine and Fields, 1973). In contrast, inoculation of type 1 reovirus 
causes a non-lethal acute ependymitis without involvement of neurones 
(Kilham and Margolis, 1969). Localisation of different types of reovirus 
to different cells was responsible for difference in pathogenicity, which in 
turn was found to be determined in both cases by the al protein encoded 
by the S1 gene (Weiner et al., 1977; 1980) from reassortant analysis. 
Antigenic escape mutants selected using a monoclonal antibody 
directed at the major neutralisation site on al of type 3 reovirus provided 
further evidence for the critical role of the al protein in neurovirulence. 
Some of these variants were at least 4loglo less neurovirulent than the 
type 3 Dearing strain from which they were derived. Other variants were 
found to be essentially avirulent (LD50 > 107 PFU) and impaired in their 
capacity to grow in the brains of mice (Spriggs and Fields, 1982). 
Sequence analysis of the S1 genes of several of these variants indicated 
that they have single amino acid substitutions at amino acid positions 340 
or 419 of al protein within the predicted outward facing globular head of 
the protein. The significance of the single amino acid substitutions in al 
in producing attenuated neurovirulence and altered tropism has been 
confirmed in studies using a reassortant virus containing the Si gene 
derived from one of the al antigenic variants (Kaye et al., 1986). 
The Dearing strain of type 3 is highly lethal when inoculated 
intracerebrally into suckling mice, a typical LD50 being ---110910 
(Weiner et al., 1977). However, when this strain is given orally, even in 
doses of 107 PFU of purified virus, it is avirulent (Rubin and Fields, 
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1980). This quantity of type 3 virus fails to grow in intestinal tissue after 
oral inoculation directly into the stomach of newborn mice and is 
inactivated when mixed with intestinal homogenates. In contrast, reovirus 
type 1 (Lang) strain inoculated by the same route multiplies in the 
intestine, and then spreads to the brain where it produces a benign 
ependymitis similar to that which develops after intracerebral inoculation. 
Another difference between the two viruses is that the infectivity of type 
1 virus is unchanged or slightly enhanced by treatment with pancreatic 
protease chymotrypsin while that of type 3 is greatly reduced. A genetic 
analysis using reassortant viruses between type 1 and type 3 revealed that 
the ability to grow in the intestinal tissue and the response to pancreatic 
proteases are properties of M2 gene and hence µl/µ1C proteins (Rubin 
and Fields, 1980). 
In addition to determining growth in intestinal tissue, the M2 gene 
also plays a part in controlling the relative degree of neurovirulence of a 
natural isolate of type 3 reovirus (Hrdy et al., 1982). A large number of 
type 3 isolates were screened to ascertain their relative neurovirulence 
after intracerebral inoculation. One strain retained the neurotropism of 
type 3 (i. e. infection of neurone and not ependyma) but was markedly 
less virulent (LD50 of --104.5 compared with type 3 Dearing LD50 of 
- 101). Genetic analysis revealed that the attenuation in neurovirulence in 
this isolate was also related to its M2 gene. The results of these studies 
indicate that the nature of M2 gene is important in determining virulence 
after inoculation by the natural oral route and by the experimental 
intracerebral route. Therefore, the SI gene determines the cell and tissue 
tropism and the M2 gene determines the relative capacity to grow in the 
CNS as well as at mucosal surfaces (Hrdy et al., 1982). 
The results in the aforementioned studies with poliovirus 
recombinants and revertants, and reassortants of influenza and reo viruses 
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indicate that virulence is a multigenic trait, while certain genes may play 
a primary role in determining virulence, other genes contribute and may 
enhance or attenuate the virulence phenotype. All the three viruses, polio, 
influenza, and reo discussed above are RNA viruses. Poliovirus is a 
positive sense ssRNA virus and the availability of vaccine revertants and 
the ability to obtain infectious virus from cDNA clones has greatly 
contributed to the understanding of its virulence. Unlike poliovirus, 
influenza and reo viruses are segmented viruses. Influenza virus is an 
enveloped negative sense ssRNA virus, that is an important human 
pathogen and where the techniques of genetically manipulating the virion 
have recently been developed. On the other hand, reovirus is a non- 
enveloped dsRNA virus that does not cause any disease in humans and 
the techniques to rescue a gene into an infectious virus are not available. 
Studies with reassortants of both influenza and reo viruses have indicated 
that the virulence is multigenic. Different reovirus genes contribute to 
different aspects of its virulence, whereas in influenza virus though each 
gene has been known to be involved in virulence, however, the role of 
HA and to a lesser extent NA is known. 
Rotaviruses are segmented dsRNA viruses like reovirus but are 
important pathogens of humans, animals, and birds like influenza virus. It 
would be interesting to find out whether its virulence resembles influenza 
virus or reovirus or both or neither. 
3.8 Aims 
1. To establish a suitable animal model for monitoring rotavirus 
virulence. 
2. To construct and characterise rotavirus reassortants. 
3. To begin mapping of rotavirus virulence to its gene(s). 
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Chapter 4 
Materials and Methods 
4.1 Materials 
4.1.1 A list of the biochemicals, chemicals, and radiochemicals 
utilised in this study is given below : 
Amersham International plc. Amersham, Buckinghamshire : 
Amplify, 35S dATP, 32P dGTP 
BDH chemicals Ltd., Poole, Dorset : 
Boric acid, ß- mercaptoethanol, Bromophenol blue, Calcium 
chloride, Crystal violet, Dimethyl sulphoxide (DMSO), Glycerol, Liquid 
paraffin, Lithium chloride, Nonidet P-40 (NP40), Potassium chloride, 
Sodium chloride, Sodium dihydrogen phosphate, Sodium dodecyl 
sulphate (SDS), Sodium hydroxide, Tris-base, Triton-X 
Bio 101 Inc., Joshua Way, Vista CA : 
Gene Clean kit 
Bio-Rad Laboratories Ltd., BioRad house, Hemel, Hempstead, 
Hertfordshire :,. 
Ammonium persulphate, N, N'-methylene bisacrylamide, TEMED 
Boehringer Mannheim UK Ltd., Lewes,, East Sussex : 
Proteinase K 
Flow Laboratories Ltd. Scotland : 
GMEM 
FSE, Loughborough, Leicestershire : 
Acetic acid, Acrylamide, Ethanol, Formaldehyde, Formamide, 
Glycine, Magnesium chloride, Methanol, Phenol, Silver nitrate, Urea, 
Xylene cyanol 
Life Technologies Ltd. P. O. Box 35, Renfrewshire, Scotland : 
lkb DNA ladder marker, Restriction enzymes, Tissue culture 
plates 
Northumbria Biologicals Ltd., Cramligton, Northumberland : 
Foetal calf serum 
NBL Gene Sciences Ltd., Cramligton, Northumberland : 
Avian myeloblastosis reverse transcriptase (AMV RT) 
Polaroid UK Ltd., = St Albans, Hertfordshire : 
Type 665 (positive/negative) and 667 (positive) films 
Prolabo, Manchester : 
Diethyl ether 
Promega, Chilworth Research Centre, Southhampton : 
Taq DNA polymerase 
Sigma Chemical Co. Ltd., Poole, Dorset : 
Agarose medium EEO (type II), Ampicillin, Deoxynucleoside 
triphosphates, Dideoxynucleoside triphosphates, Dithiothreitol (DTT), 
Ethidium bromide, Gelatin, Kanamycin, Nystatin, Salmon sperm DNA 
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Whatman International Ltd., Maidstone, Kent : 
Filter paper number 1 
4.1.2 Media and solutions 
The following media and solutions were prepared by the media 
preparation staff in the Department of Biological Sciences, University of 
Warwick : 
2x Agar, 2x GMEM, 200 mM Glutamine, Neutral red, Phosphate 
buffer saline ([PBS], 8g NaCl, 0.2g KCI, 1.15g Na2HPO4,0.2g 
KH2PO4 per litre of sterile distilled water), Penicillin, Streptomycin 
(100g and 100,000,000 units respectively per 2 litre sterile distilled 
water), Trypsin solution (0.25% in versene), Versene 
4.2 Cells 
The continuous cell lines BSC-1 (derived from African green 
monkey kidney) and MA104 (derived from foetal rhesus monkey kidney) 
were grown as monolayers in Glasgow modified minimal essential 
medium with non-essential amino acids (GMEM), supplemented with 5% 
foetal calf serum (FCS), glutamine (4mM), penicillin (100 U/ml), and 
streptomycin (100 µg/ml). The split ratio for BSC-1 and MA104 cells 
was 1: 4, and 1: 5, respectively. 
4.3 Viruses 
The Compton UK tissue culture adapted (UKtc) bovine strain of 
rotavirus was originally obtained from M. Thouless. The OSU strain of 
rotavirus was originally obtained from Professor E. H. Bohl. The B223 
strain of bovine rotavirus was originally obtained from Dr D. -R. 
Snodgrass. Seed stock of UKtc, OSU, B223, and a Birmingham strain of 
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murine rotavirus (EBR) were provided by Professor M. A. McCrae. An 
EDIM isolate at passage 16 in MA104 cells was kindly provided by 
Professor R. L. Ward. 
4.4 Antisera and monoclonal antibodies 
Small quantity of the monoclonal antibodies '# 5632 specific for 
UKtc VP7 (Beards et al., 1992), and # 4907 specific for OSU VP7 
produced in mouse, and monospecific antiserum # 5925 specific against 
UKtc VP4 produced in rabbits by inoculating a reassortant containing 
UKtc VP4 gene on ST3 rotavirus background, were kindly provided by 
Dr D. R. Snodgrass, Mordun Research Institute, Edinburgh, UK. The 
bovine hyperimmune antiserum against UKtc was a kind gift of Dr J. C. 
Bridger, Royal Veterinary College, University of London, UK. 
4.5 Virus stocks 
Plaque purified stocks of UKtc, OSU, and B223 viruses were 
prepared in BSC-1 cells grown in 800-cm2 roller bottles on a rotating 
roller apparatus (Modular cell production, Model III). Confluent 
monolayers of BSC-1 cells were infected with a multiplicity of infection 
(m. o. i. ) of 0.1 plaque forming unit (pfu) per cell (McCrae and Faulkner- 
Valle, 1981). Infection'was allowed to proceed until at least 70 % of the 
cells showed a cytopathic effect (cpe) (3-6 days). The cultures were then 
freeze-thawed three times, sonicated for 20 seconds (sec) in a sonic 
waterbath (Townson and Mercer Ltd. Croyden, England), and 
centrifuged at 2000 rpm for 10 minutes (min) to remove cell debris. The 
resulting supernatant was concentrated 100 times by centrifugation (SW 
28 rotor, Beckman) at 22K at 40C for 2 hours (hr). The pellet was 
resuspended in virus resuspension buffer (50 mM Tris-HC1 pH 8.0,10 
mM NaCl, 1.5 mM ß-mercaptoethanol, 3mM CaC12) (McCrae, 1985). 
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The titre of virus stocks of UKtc, B223, and OSU was determined by 
plaque assay (see section 4.6) in BSC-1 cells (McCrae and Faulkner- 
Valle, 1981; Offit et al., 1983). The virus stocks were aliquoted (200 µl) 
and stored at -700C until use. 
Virus stocks of the EBR and EDIM strains of murine rotaviruses 
were prepared by inoculating 7 day old suckling CD-1 pups. The pups 
were sacrificed 48 hr post inoculation (p. i. ) and the entire gut was 
collected in ice-cold PBS. The intestines were processed as described 
below in section 4.18. The gut from one mouse was resuspended in a 
final volume of 3 ml PBS. This intestinal homogenate was stored at - 
700C and served as inoculum for further studies with murine rotaviruses. 
4.6 Plaque assay n 
The plaque assay was done according to previously published 
methods (McCrae and Faulkner-Valle, 1981; Offit et al., 1983) with 
minor modifications. Confluent BSC-1 cell monolayers in 12-well tissue 
culture plates were infected (in duplicate) with serial 10-fold dilutions of 
the trypsin-pretreated virus. After virus adsorption for 1 hr at 37°C, the 
plates were overlaid with a medium containing final concentrations of 1% 
agar, 2% FCS, 1 pg/ml trypsin. The plates were incubated in a humid 
atmosphere under 5% CO2 tension for six days. Then, the cells were 
fixed in formol saline (30% formaldehyde in PBS [v/v]) and stained with 
crystal violet (0.1 % [w/v] crystal violet in 20% ethanol [v/v]), and the 
titre determined (Reed and Muench, 1938). 
The plaque assays for plaque to plaque purification or for picking 
progeny clones following coinfection with parent viruses in reassortant 
construction experiments, were performed as above except that they were 
done in 6-well tissue culture plates and at the end of the 6 day incubation 
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they were stained with neutral red (5 % [v/v] in PBS) without prior 
fixation of the cells. 
4.7 Plaque reduction neutralisation assay (PRN) 
It was performed as described previously (Offit et al., 1983) with 
minor modifications. Serial 2-fold dilution of heat inactivated serum was 
mixed with 100 pfu of homologous virus and incubated in a waterbath at 
370C for 1 hr. The serum-virus mixture was inoculated onto BSC-1 cell 
monolayers and the test carried out as described under plaque assay. The 
neutralising titre of the serum was expressed as reciprocal of the highest 
dilution giving 50% reduction in the plaque counts. 
" 4.8 Extraction of rotavirus RNA from cells 
Rotavirus RNA from the infected cells was extracted as described 
previously (Ballard et al., 1992; Beards et al., 1992). Briefly, confluent 
monolayer of BSC-1 cells in one well of a six-well tissue culture plate 
was infected at a m. o. i. of 1 to 5. When the cells showed 50% cpe, they 
were harvested by scraping them into the medium and concentrated by 
centrifugation. The cell pellet was resuspended in lysis buffer (100 mM 
Tris-HC1 [pH 8.0], 50 mM NaCl, 10 mM EDTA, 0.5% Nonidet P-40), 
and-incubated at 40C for 10 min. Nuclei and unlysed cells were removed 
by centrifugation for 10 min at 2000 rpm at 4°C. The cytoplasmic extract 
present in the supernatant was then incubated at 370C with 200 µg/ml of 
proteinase K in the presence of 0.2% SDS for 3 hr before being extracted 
twice with phenol saturated with 50 mM Tris-HC1 buffer (pH 8.0). The 
residual phenol was removed by ether extraction (4x) and the nucleic acid 
was precipitated as described below. 
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4.9 Precipitation of nucleic acids 
Nucleic acids were precipitated by LiC1(final concentration 67 
mM) and 3 volumes of 100% ethanol. Following incubation at -700C for 
30 min, nucleic acid was pelleted by centrifugation at 10000 rpm for 10 
min. The pellet was washed with 80% ethanol, vacuum dried, and finally 
resuspended in sterile distilled water (50 µl for one well of six-well 
plate). 
The variations of this basic method of nucleic acid extraction and 
precipitation are described in detail in chapter 6. 
4.10 Extraction of rotavirus RNA from intestinal homogenates 
The intestinal homogenates were prepared as described in 4.18. 
The intestinal homogenates were extracted with phenol and then ether and 
the nucleic acid was precipitated as described in section 4.9 for infected 
cells. 
4.11 Oligonucleotide primers 
The primers used for amplification of VP7 genes are those 
described by Xu et al., (1990) : 5' CCC GGG ATC CAT GGC CQ 
CTT TAA AAG CGA GAA TTT 3' (5' end of gene) and 5' CGA TCG 
CGA ATT CTG CAG GTC ACA TCA TAC AAC TCT A 3' (3' end of 
gene). The primers used for the amplification of gene 11 were : 5' TCC 
GGA TCC AGA TCT GGC CAT GGC TTT TAA AGC GCT 3' (5' end 
of gene) and 5' GGG CCC GGG CAC GTG GCC AGC TGA AGG TCA 
CAA AAC GGG A 3' (3' end of gene). The virus specific sequences are 
underlined. Oligonucleotides were synthesised on an Applied Biosystems 
381A DNA synthesiser. 
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4.12 Reverse transcription and PCR amplification of rotavirus 
genes 
It was performed as described by Xu et al., (1990), with slight 
modifications. Typically, the RT-PCR amplification was carried out in a 
25 µl volume that contained 12.5 µl of sample mix (3-9 pl of RNA, 100 
ng of each primer, 10% DMSO) and 12.5 pl of 2x reaction mix. The 
final concentrations in the reaction were 30 mM Tris-HC1 buffer (pH 
8.3), 55 mM KCL, 3.5 mM MgCl, 20.25 mM of each deoxynucleotide 
triphosphate, 0.3 mM DTT, 0.5 mg/ml gelatin, 6U avian myeloblastosis 
virus reverse transcriptase, 1U Taq DNA polymerase. 
The sample mix was heated in a thermocycler (Perkin Elmer 
Cetus) to 940C for 2 min to denature the dsRNA and then cooled to 
42°C. An equal volume (12.5 µl) of the 2x reaction mix was added and 
the reactions were overlaid with mineral oil, and incubated at 420C for 
30 min followed by 460C for 10 min to generate cDNA copies of 
rotavirus dsRNA. This reverse transcription step was immediately 
followed by PCR amplification of cDNA using 20 cycles of a regime in 
which each cycle involved denaturation at 940C for 2 min, annealing at 
550C for 1 min, and synthesis at 700C for 2 min. 
Amplified bands were separated in 1% agarose gels and visualised 
by ethidium bromide staining. " On many occasions the RT-PCR amplified 
DNA was reamplified to generate more cDNA. The first PCR products 
were purified from agarose gels using silica based DNA binding Gene 
CleanTM kit according to manufacturer's recommendations, to produce 
a clean seed for a second PCR and also for direct sequencing of the PCR 
product. 
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4.13 Restriction enzyme digestion 
The restriction enzyme digestions were carried out according to 
the manufacturer's instructions. Buffers used were those supplied with the 
enzymes (as a lOx concentrate). Typically, the DNA was digested in a 20 
µl reaction volume containing appropriate buffer at 1x concentration. 
Enzyme (4-10 U) was added to no more than 10% of the final volume. 
The sample was incubated at 370C for at least 3 hr. Following digestion 
the DNA was analysed by agarose gel electrophoresis. 
4.14 Agarose gel electrophoresis 
Large and small (mini) horizontal agarose gels were used for 
analysis of DNA after RT-PCR, or PCR amplification, and restriction 
digestion. Typically, the concentration of agarose used was 1% (w/v) in 
lx TBE or TAE buffer (Sambrook et al., 1989), but concentrations 
between 0.6 - 1.5 % were also employed. The commercial apparatus used 
was Biorad and Uniscience for minigels and Sci-plas or Koch-Light Ltd 
(New Brunswick Scientific Co) for large gels. 
DNA samples for electrophoresis were prepared by adding 1 /5 the 
volume of 5x TBE agarose gel loading buffer (50% glycerol, 5x TBE, 
0.02 % bromophenol blue and 0.02 % xylene cyanol). The electrophoresis 
was carried out for 1 hr at 70 mA. DNA bands were stained with 
ethidium bromide (0.5 pg/ml) and then visualised on an ultraviolet (uv) 
illuminator and the gel photographed using a polaroid camera and # 665 
or # 667 type Polaroid films. 
4.15 Polyacrylamide gel electrophoresis (PAGE) of rotavirus 
dsRNA 
The viral genomic dsRNA was fractionated on vertical slab gels 
(1.5 x 200 mm) using'the Laemmli discontinuous buffer system 
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(Laemmli, 1970). The stacking gel consisted of the acrylamide monomer 
(5 % [w/v]), N, N'-methylenebisacrylamide (0.13 % [w/v]), 0.125 M Tris 
base (pH 6.8), N, N, N', N'-tetramethylenediamine (0.125 % [v/v]), 
ammonium persulphate (0.07% [w/v]), and SDS (0.2% [w/v]). The 
resolving gel consisted of the acrylamide monomer (6% [w/v]), N, N'- 
methylenebisacrylamide (0.16% [w/v]), 0.375 M Tris base (pH 8.8), 
N, N, N', N'-tetramethylenediamine (0.05% [v/v]), ammonium persulphate 
(0.07% [w/v]), and SDS (0.2% [w/v]). Approximately 50 µl of each 
sample in electrophoresis sample buffer (25mM Tris HCl [pH 6.8], 10% 
glycerol, 2% SDS, 5% ß- mercaptoethanol, bromophenol blue 0.02%) 
was loaded and electrophoresis was performed at 40C at 35 mA for 8 hr. 
4.16 Silver staining (SS) 
Following electrophoresis, the PAGE gels were stained with silver 
nitrate (Svensson et al., 1986) with minor modifications. Briefly, the gels 
were fixed with 40% (v/v) methanol with 10% (v/v) acetic acid in 
distilled water for 45 min, followed by 10 % (v/v) methanol with 0.5 % 
(v/v) acetic acid in distilled water for 45 min, and finally soaked in 11 
mM silver nitrate for 45 min. The gels were then washed with distilled 
water and developed with developer (0.75 M sodium hydroxide, 0.32% 
[v/v] formaldehyde), until the bands were clearly visible and the 
background was bright yellow. The reaction was stopped with 5% acetic 
acid and the gels photographed on a fluorescent light box. 
4.17 Mice 
Eight week old adult Balb/c mice were obtained from the Animal 
House, Department of Biological Sciences, University of Warwick, 
Coventry. Seven day old suckling pups of various inbred mouse strains 
(Balb/c [H-2d], C3H/HE [H-2k], C57/BL-6 [H-2b], or the outbred CD-1 
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strain were obtained from Charles River Breeding Laboratories. The 
animals were pre-bled randomly and screened for the presence of 
rotavirus specific antibodies by PRN. The adult mice or dams along with 
their litters were housed in a negative pressure isolation units in a 
Microisolator (Isotec Systems, Olac, Bicester) and given sterile food and 
water ad libitum. 
4.18 Inoculation of the animals 
Each animal was orally inoculated with 100 pl of inoculum that 
contained 10% blue food colouring dye (J. Sainsbury plc., London) which 
served as a marker for the site of the inoculum and passage of the 
inoculum through the intestine. The eight week old adult animals were 
inoculated by proximal oesophageal intubation using a 2" 18 gauge metal 
gavage (IMS, Cheshire), whereas in the 7 day old suckling pups the 
inoculum was directly deposited in the stomach through mouth using a 
silicone rubber (lmm diameter) attached to a 100 µl Hamilton syringe. 
The inocula were not trypsin activated prior to inoculation. At various 
times post inoculation the animals were observed for external signs of 
disease and a pair of mice was sacrificed at each time point. At the time 
of postmortem, the internal signs of disease (consistency of colon 
contents and distended colon, hepatomegaly) were noted and the 
combined small and large intestines were removed in 1 ml of ice-cold 
PBS and frozen. 
The disease in the experimental animals was scored as described 
previously (Gombold and Ramig, 1986) with minor modifications. On the 
score, - indicates no disease, + indicates semisolid faeces in the colon, 
+2 indicates slight diarrhoea with or without abdominal palpation, and 
+3 indicates overt diarrhoea. 
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The infectivity of the intestinal homogenates (see section 4.18) was 
determined by titration in plaque assay. Thirty day post inoculation sera 
were tested for the development of antibodies in PRN. A schematic of the 
study design for animal model development is shown in Figure 4. 
4.19 Preparation of the intestinal homogenates 
The intestines collected in ice-cold PBS were frozen-thawed three- 
times, homogenised by giving 50 strokes in Dounce Homogenisers 
(Jencons Ltd. ). The homogenates were transferred to a universal and 
sonicated for 20 sec in a sonic waterbath (Townson and Mercer Ltd, 
Croyden), and then centrifuged at 600 g for 10 min at 4°C. The 
supernatants were further microfuged for 5 min in 1.5 ml eppendorfs and 
supernatant made to a final volume of 3 ml in PBS that contained final 
concentrations of Nystatin (250 U/ml), Kanamycin (200 pg/ml), 
Ampicillin (1000 pg/ml). This intestinal homogenate was aliquoted (200 
µl) and stored at -700C until use. 
4.20 Generation of reassortants 
Reassortant viruses were derived by coinfection of BSC-1 cells 
with different pairs of rotavirus strains, each at a m. o. i. of 5 pfu per cell. 
After 48 hr of incubation at 37°C, the infected cultures were harvested by 
freezing and thawing. The cell debris was removed by centrifugation and 
the supernatant was plated on BSC-1 cells in 6-well cell culture plates 
under agar overlay. Plaques were randomly picked in 1 ml of GMEM for 
genotyping of the putative reassortants. Variations of this basic procedure 
are described in detail under chapter 7. 
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4.21 Genotypic analysis of reassortant viruses 
Individual progeny plaques were initially propagated once in 6- 
well plate and then in a 24-well plate before genotyping. However, in the 
later experiments the progeny clones were directly propagated in 24-well 
plates. 
Five hundred microlitre of inoculum from each plaque was used to 
infect one well of a 24-well cell culture plate. At the end of 5 days or 
when the cells showed about 60% cpe, the supernatant was collected for 
further passaging and the nucleic acid extracted by the optimised method 
(described in detail in chapter 6). Putative reassortants were genotyped by 
PAGE-SS and RT-PCR. 
4.22 Lipofection mediated transfection of rotaviruses 
It was done according to previously published report (Bass et al., 
1992a) with some modifications. Briefly, 1 ml of serum-free and 
antibiotics-free GMEM was vortexed with 15 pl LipofectinTM. Then, 
100 pl of rotavirus (107 pfu) or 1: 60 dilution of intestinal homogenate 
was vortexed along with the above mixture. Subsequently, 20 pg salmon 
sperm DNA was vortexed in the above mixture. This mixture was 
incubated at room temperature for 15 min. One well of a six-well BSC-1 
monolayer (80% confluent) was washed with serum-free and antibiotics- 
free GMEM. The mixture was added to the well of a six-well tissue 
culture plate and incubated at 370C for 4 hr under 5% C02 tension. At 
the end of incubation the mixture was replaced with 3 ml GMEM 
containing 5% FCS. After 18 hr the cells were harvested by scraping and 
freeze-thawing for titration, extraction of rotavirus RNA, and for picking 
progeny clones in plaque assay when the lipofection was performed with 
a pair of rotaviruses. 
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4.23 Sequencing 
The equivalent of 10 µl of PCR product was used for each 
sequencing reaction. The PCR product DNA was purified from untreated 
triphosphates, primers, and unexpected products by using Gene Clean 
kitTM following fractionation of the PCR product on 0.6% agarose gels 
in TAE buffer. The Taq polymerase step cycle DNA sequencing was 
carried out by dideoxynucleotide chain termination method (Sanger et al., 
1977), and was performed by Lesley Ward, Department of Biological 
Sciences, University of Warwick. 
Sequence comparisons were carried out using the Genetics 
Computer Group (GCG) set of programmes (Devereux et al., 1984). 
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Chapter 5 
Development of a murine model of rotavirus virulence 
5.1 Introduction 
Compared to some other areas of rotavirus biology, rotavirus 
virulence is under-explored. One of the main limitations on virulence 
studies has been the lack of a suitable animal model. While it can be 
described what happens during a virus disease, there is very little 
knowledge about the molecular events which distinguishes otherwise 
identical virulent and avirulent strains. Comparison of their nucleic acids 
by sequence analysis will show differences, but the essential problem still 
remains to correlate them with whatever controls virulence and then to 
understand in molecular terms how virulent virus strain interacts with its 
host to produce a violent end-result while an avirulent strain does not. 
Studies of viral genetics have given interesting results that increase the 
understanding of viral replication in cells and other in vitro phenomena, 
but little that helps in the understanding of virulence in the infected host. 
In this chapter, the development of a mice model for conducting 
future experiments with genetically manipulated viruses to study rotavirus 
virulence will be described. Three different rotavirus strains viz. UKtc 
(G6P7), B223 (G1OP8), and OSU (G5P9) were selected. The reasons for 
choosing UKtc were that it is a well characterised strain at the molecular 
level, grows to higher titres in cell cultures, and is an important pathogen 
of domestic cattle. The B223 strain was selected because it has been used 
in some of the classical experiments of rotavirus biology giving 
unexpected results (Chen et al., 1989; 92). The OSU strain was chosen 
because it an important virus affecting pigs. 
5.2 Why a mouse model? 
None of the animal models currently being used to study rotavirus 
infection are really suitable. Gnotobiotic calves, lambs, piglets have all 
been used in the study of rotavirus pathogenesis and infection (Hall et al., 
1976; Mebus et al., 1976; Snodgrass et al., 1977; Crouch and Woode, 
1978 ; Theil et al., 1978). However, the expense, the need for specialised 
facilities, the limited availability and the outbred nature of these animals 
are serious limitations to their widespread use. The use of rabbits as a 
model has advantages in terms of increased susceptibility, modest cost, 
availability of homologous cultivable virus strains, and also transplacental 
transfer of antibodies (Conner et al., 1988). However, the production of 
moderate disease is infrequent and severe clinical disease is not seen 
(Conner et al., 1988). The lack of frank diarrhoea in rabbits is due to the 
effective water absorptive capacity of the large intestine. Clinical signs 
are also difficult to interpret in rabbits because rabbits normally excrete a 
soft moist faeces (Hagen, 1974) that may be indistinguishable from a soft 
stool caused by rotavirus infection. Mice, because of their small size, 
ease of handling, low cost and inbred nature offer a number of 
advantages for use in studies on rotavirus infection. Large number of 
mice can be handled and thus the significance of the results obtained can 
be tested statistically. The inbred nature of the mice also excludes the 
variations in antigen presentation due to MHC restriction. However, only 
a few murine rotavirus strains have been adapted to growth in cell 
culture. Most heterologous rotavirus strains replicate inefficiently in the 
intestines of mice and require an input dose 5 or 6loglo higher than that 
of mice rotavirus in order to produce diarrhoea consistently (Greenberg et 
al., 1986). 
5.3 Establishment of seronegative status of adult mice and pups 
Serum immune response to rotavirus is a good indicator of 
previous infection (Conner et al., 1991). It was essential to establish the 
seronegative status of the animals used in the study in order to rule out 
the effect of prior antibodies on the outcome of infection and disease. 
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From each batch of mice, randomly selected adult mice and/ or pups 
were sacrificed. The serum of individual adult animals or pooled sera 
from pups was heat inactivated and tested for the presence of rotavirus 
antibodies by PRN. A neutralisation titre of the test samples was < 32, 
whereas that of the hyperimmune antiserum to UKtc was > 2048. The 
neutralisation antibody titre to rotavirus of > 50 has been considered to 
be positive (Offit et al., 1983; 84; Gouvea et al., 1986). Therefore, all 
the animals used in the present study were considered to be negative for 
the presence of rotavirus specific antibodies. 
5.4 Rotavirus virulence is age dependent 
5.4.1 Introduction 
Seronegative 8 week old adult Balb/c mice or seronegative litters 
of 7 day old suckling pups were orally inoculated with 109 pfu/ animal of 
the UKtc strain, 107 pfu/ animal of the B223 strain, or uninfected BSC-1 
cells administered in an equivalent volume. At various times post 
inoculation the animals were examined for clinical signs of disease. At 
each time point, a pair of animals was sacrificed and observed for 
internal signs of disease. The entire gut of sacrificed animals was 
aseptically collected in cold PBS for titration of virus infectivity. 
5.4.2 Results 
The 7 day old suckling Balb/c pups inoculated with 109 pfu of 
UKtc or 107 pfu of B223 developed mild diarrhoea, whereas the adult 
mice remained healthy and failed to develop diarrhoea with either virus 
(Figure 5). The mock infected animals also remained healthy (data not 
shown) throughout the course of the experiment. The onset of the 
diarrhoea with UKtc strain occurred at 24 hr p. i. and persisted for 2 days 
before waning. The severity of the diarrhoea ranged between +I to +3 
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Figure 5: Rotavirus virulence is age dependent 
Seronegative 7 day old suckling Balb/c pups or 8 week old adult Balh/c mice 
were orally inoculated with 109 pfu of UKtc or 107 pfu of B223 on day 0. At 
various times post inoculation the animals were examined for clinical signs of 
disease. At each time point, a pair of animals was sacrificed and observed for 
internal signs of disease. Plotted are the mean from 2 experiments and 
number of pups in each experiment (n) = 5-8. The standard deviation ranged 
from 0 to 6.4. 
91 
(see materials and methods for the definition of the score) and only about 
50% pups were affected. Overt diarrhoea was observed in a very few 
pups, but bright yellow opaque diarrhoea or semi-formed faeces were 
observed after gentle palpation of the abdomen in other affected pups. 
The onset, duration, and severity of diarrhoea in suckling pups infected 
with the B223 strain was similar to UKtc. However, the percentage of the 
pups affected was less. The extent of colon distension was greater in 
B223 infected pups than in pups infected with the UKtc strain. 
As discussed above, neither UKtc nor B223 strains were able to 
produce disease in adults, whereas diarrhoea was observed in neonates. 
Whether this difference is due to the difference in the ability of the virus 
to replicate in the two types of animals was investigated by infectivity 
titration of the intestinal homogenates taken at various times post 
inoculation. The virus titres in adult as well as neonates decreased rapidly 
during the first 12 hr, though the decline in the adult mice was more 
abrupt than observed in neonates with both strains (Figure 6). 
In the absence of evidence of either disease or virus replication in 
adult animals, an alternative approach was required to provide evidence 
that they had actually been infected by the virus. This was done by 
looking for immunological markers of infection i. e. seroconversion. The 
pre inoculation sera from both adult and neonates, had a titre of < 32 
whereas that of the hyperimmune bovine serum was > 2048. The serum 
titres from adults and pups 21 days p. i. both with UKtc and B223 were 
consistently higher than pre inoculation titres (Table 6). 
5.4.3 Discussion 
Diarrhoea can be induced by UKtc and B223 strains of rotavirus in 
7 day old suckling Balb/c pups but not in adult mice. The age dependent 
induction of diarrhoea in mice has been reported previously for 
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Figure 6: Replication of UKtc or B223 strain of rotavirus in the 
intestines of adult or 7 day old suckling pups. 
Seronegative 7 day old suckling Balh/c pups or 8 week old adult Balh/c mice 
were orally inoculated with 109 pfu of UKtc or 107 pfu of B223 on day 0. At 
each time point, a pair of animals was sacrificed and entire gut was 
aseptically collected in cold PBS. Titres of the infectious virus in the 
intestinal homogenates were determined by plaque assay at various times post 
inoculation. Plotted are the mean from 2 experiments and in each experiment 
n=2. The limit of virus detection in plaque assay was Ix 102. 
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Table 6: Relationship between viral dose and pathological, immunological 
response of UKtc strain of bovine rotavirus in Balb/c mice 
Dose of Neutralising anti body titres in Disease b Neutralising antib ody titres Disease b 
UKtc adult a in 7 day old suck ling, pupsa 
Preinoculation 21 days post Preinoculation 21 days 
inoculation post 
inoculation 
105 <32 128 Nil <32 128 12 
106 <32 128 Nil <32 128 23 
107 <32 512 Nil <32 256 30 
108 <32 1024 Nil <32 256 50 
109 <32 1024 Nil <32 256 50 
a Randomly selected animals were sacrificed and serum was collected. Heat inactivated serum 
was tested for the presence of neutralising antibodies by PRN. Titres are expressed as the 
reciprocal of the dilution giving 50 % reduction in the mean plaque count. 
b% animals showing diarrhoea on day 2. 
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homologous (Wolf et al., 1981; Eydelloth et al., 1984) and for 
heterologous rotavirus strains (Offit et al., 1984; Ramig, 1988; Jones, 
1993). The duration of diarrhoea and the percentage pups affected by the 
UKtc strain of rotavirus reported by Jones, (1993) was greater even 
though a lower dose (5x107 pfu) was used in that study. 
It is unlikely that the primary mucosal immune response initiated 
after UKtc or B223 inoculation of-adult animals is sufficiently large or 
produced at a rate that would be sufficient to control and prevent virus 
infection and replication. This was proposed for the EDIM virus model 
(Eydelloth et al., 1984). Also the difference in the age related 
susceptibility cannot be due to secondary immune response since both 
adult and pups used in the present study were seronegative. Therefore, 
non-susceptibility to UKtc or B223 induced disease in adults is likely to 
be a function of the gut epithelial cell. Intestinal maturation (Wolf et al., 
1981), expression of rotavirus-specific receptors on enterocytes 
(Riepenhoff-Talty et al., 1982; Bass et al., 1991), decreased efficiency in 
rotavirus antigen expression (Eydelloth et al., 1984), extra cellular 
proteolytic activation (Vonderfecht et al., 1988), or inactivation (Bass et 
al., 1992b) have been suggested as different factors for age dependent 
induction of disease in rotaviruses. 
In mice, the murine rotaviruses undergo an extended replication 
(Wolf et al., 1981; Riepenhoff-Talty et al., 1982; Little Shaddock., 
1982; Eydelloth et al., 1984) as compared to the short replication cycle 
observed with heterologous rotaviruses (Offit et al., 1984; Gouvea et al., 
1986) and therefore replication of heterologous rotaviruses is generally 
poor when compared with homologous strains (Greenberg et al., 1986). 
A sharp rise between 8 and 12 hr in virus infectivity in intestinal tissues 
has been taken as indicative of virus replication (Offit et al., 1984). 
However, no increase in virus titres was seen in adult or Balb/c pups 
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infected with UKtc or B223 strains of rotavirus. It is unclear from the 
infectivity titration curves whether the diarrhoea which occurred in pups 
was due to the input virus or undetected replication. Offit et al., (1984) 
were not able to recover any infectious rotavirus from the gut of mice 
inoculated with 5x106 pfu of NCDV when tested 4-72 hr p. i. The 
possibility of toxic viral action in the animals inoculated with higher 
doses has also been documented (Gouvea et al., 1986). Ramig, (1988) 
has reported that although some complete replication cycles do occur in 
the epithelial cells infected with heterologous rotavirus in neonatal mice, 
the majority of these infections are abortive i. e. many cells are infected 
but produce only very low levels of virus. This is indicated by shorter 
period of replication (when compared to the EDIM mouse model), the 
greater inoculum size required for heterologous rotaviruses to produce an 
equivalent titre to EDIM (Offit et al., 1984; Ramig, 1988) and the 
inability to detect morphologically heterologous rotavirus structures in 
murine ileal enterocytes (Ramig, 1988). 
The abrupt decrease in the infectivity present in the adult mouse 
intestines as compared to pups may be due to internalisation of majority 
of the virus by epithelial cells (Ramig, 1988) without subsequent 
production of infectious virus. 
The seroconversion observed in both adult and pups also indicates 
that internalisation of virus without subsequent production of infectious 
virus, occurred in adults. The seroconversion also indicates that adult 
mice were infected with rotavirus as has been reported by Ward et al., 
(1990b). Recently, similar findings have been observed (Bridger, 1994), 
who found age-dependent resistance to disease but not to infection in 
gnotobiotic calves inoculated with bovine rotaviruses. The observations 
on seroconversions in adult mice also questions the interpretation that the 
failure to detect diarrhoeal disease in infected adult animals is due to the 
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loss of viral receptors on enterocytes since exposure of the virus had 
resulted in infection, albeit asymptomatic (Sheridan et al., 1983). 
5.4.4 Conclusions 
Adult and 7 day old suckling Balb/c pups can be infected with 
heterologous rotavirus, but diarrhoea can only be induced in neonates. 
5.5 Rotavirus virulence is dose dependent 
5.5.1 Introduction 
To examine the dose dependency on disease potential and to 
establish a DD50 seronegative litters of 7 day old suckling pups of 
various mice strains were orally inoculated with various doses of UKtc, 
or B223, or OSU strains of rotaviruses. 
5.5.2 Results 
Seronegative litters of 7 day old suckling Balb/c pups were orally 
inoculated with B223 at doses of 103,104,105,106, or 107 pfu/ pup. 
Diarrhoea could not be induced in pups inoculated with a dose of less 
than 105 pfu/ pup. At 105 pfu negligible disease could be induced. The 
duration of diarrhoea induced at a dose of 106 and 107 pfu/ pup was first 
observed at 24 hr p. i. and lasted until 4 days p. i. The severity of 
diarrhoea ranged from +1 to +3 and not more than 35 % pups were 
affected (Figure 7). The infectivity titration curves are shown in Figure 8. 
Infectious virus could not be detected in the intestinal homogenates in any 
of the dose after 12 hr p. i. 
Dose response of UKtc in Balb/c pups is shown in Figure 9. Very 
little disease could be induced at doses 105 and 106pfu in Balb/c pups. 
The extent of diarrhoea at doses 108 and 109 pfu was very similar with 
50% pups showing diarrhoea 1-3 days p. i.; however, its severity was 
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Figure 7: Diarrhoea produced in 7 day old suckling Balb/c pups 
inoculated with various doses of B223 strain of rotavirus. 
Seronegative 7 day old suckling Balb/c pups were orally inoculated with 103 
pfu = A; 104 pfu = B; 105 pfu = C; 106 pfu = D; 107 pfu = E; of B223 
on day 0. At various times post inoculation the animals were examined tor 
clinical signs of disease. At each time point, a pair of animals was sacrificed 
and observed for internal signs of disease. Plotted are the mean from 2 
experiments and in each experiment n= 5-8. The standard deviation ranged 
from 0 to 9.9. 
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Figure 8: Replication of B223 strain of rotavirus in the intestines of 7 
day old suckling Balb/c mice pups inoculated with various doses. 
Seronegative 7 day old suckling Balh/c pups were orally inoculated with 103 
pfu = A; 104 pfu = B; 105 pfu = C; 106 pfu = D; 107 pfu = E; cif B223 
on day 0. At each time point, a pair of animals was sacrificed and entire gut 
was aseptically collected in cold PBS. Titres of the infectious virus in the 
intestinal homogenates were determined by plaque assay at various times post 
inoculation. Plotted are the mean from 2 experiments and in each experiment 
n=2. The limit of virus detection in plaque assay was 1x 102. 
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Figure 9: Diarrhoea produced in 7 day old suckling Balb/c pups 
inoculated with various doses of UKtc strain of rotavirus. 
Seronegative 7 day old suckling Balb/c pups were orally inoculated with 105 
pfu = A; 106 pfu = B; 107 pfu = C; 108 pfu = D; 109 pfu = E; of UKtc 
on day 0. At various times post inoculation the animals were examined for 
clinical signs of disease. At each time point, a pair of animals was sacrificed 
and observed for internal signs of disease. Plotted are the mean from 2 
experiments and in each experiment n= 5-8. The standard deviation ranged 
from 0 to 6.4. 
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greater with a dose of 109 pfu. Infectious virus could not be detected in 
the intestinal homogenates at any of the dose after 12 hr p. i. (Figure 10). 
The dose response of UKtc in CD-1 pups is shown in Figure 11. 
The onset of diarrhoea in both the doses, 107 and 109 pfu, occurred 24 
hr p. i. However, the incidence of diarrhoea reached a peak on day 3 at a 
dose of 107 pfu as compared to the peak observed at 36 hr p. i. with 109 
pfu. The severity, duration, and the percentage of pups affected were 
greater at a dose of 109 pfu. A slight increase in the virus titres in the 
intestinal homogenates was observed at 12 hr p. i. in the litters inoculated 
with 107 pfu, whereas the peak was observed at 36 hr in litters inoculated 
with 109 pfu of UKtc (Figure 12). 
The induction of diarrhoea by two different doses of OSU strain of 
rotavirus, 106 pfu and 107 pfu per pup in 7 day old suckling CD-1 or 
C3H/HE pups was also studied. In CD-1 pups using an infective dose of 
107 pfu/animal, the OSU strain induced overt diarrhoea (+3) in the 
majority of pups which started at 24 hr p. i. and reached a peak at 36 hr 
p. i. when 100% of the pups were found to be affected with disease 
symptoms still evident in 70% of infected animals at day 3 p. i. (Figure 
13). At the lower dose used (106 pfu/animal of OSU strain), the peak was 
observed at day 2 p. i., when about 60% of the pups were affected. The 
diarrhoea observed was bright yellow, opaque but in much larger volume 
than that observed with either UKtc or B223 strains. Infectivity titrations 
revealed a slight increase in virus titres at 12 hr p. i. when 106 pfu/animal 
of OSU was used for infection, with this increase being delayed until day 
2 p. i. at the higher dose examined (Figure 14). A large amount of liquid 
faeces together with distension of colon was observed in pups day 1 
through day 4 post inoculation. 
The OSU strain produced a biphasic diarrhoea in C3H/HE pups 
with both the doses of 106 and 107 pfu (Figure 15). The peak of 
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Figure 10 : Replication of UKtc strain of rotavirus in the intestines of 7 
day old suckling Balb/c mice pups inoculated with various doses. 
Seronegative 7 day old suckling Balh/c pups were orally inoculated with 105 
pfu = A; 106 pfu = B; 107 pfu = C; 108 pfu = D; 109 pfu = E; of UKtc 
on day 0. At each time point, a pair of animals was sacrificed and entire gut 
was aseptically collected in cold PBS. Titres of the infectious virus in the 
intestinal homogenates were determined by plaque assay at various times post 
inoculation. Plotted are the mean from 2 experiments and in each experiment 
n=2. The limit of virus detection in plaque assay was Ix 102. 
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Figure II : Diarrhoea produced in 7 day old suckling CD-1 pups 
inoculated with various doses of UKtc strain of rotavirus. 
Seronegative 7 day old suckling CD-1 pups were orally inoculated with 107 
pfu = A; 109 pfu = B; of UKtc on day 0. At various times post inoculation 
the animals were examined for clinical signs of disease. At each time point, a 
pair of animals was sacrificed and observed for internal signs of disease. 
Plotted are the mean from 2 experiments and in each experiment n= 5-8. 
The standard deviation ranged from 0 to 5.0. 
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Figure 12 : Replication of UKtc strain of rotavirus in the intestines of 7 
day old suckling CD-1 mice pups inoculated with various doses. 
Seronegative 7 day old suckling CD-1 pups were orally inoculated with 107 
pfu = A; 109 pfu = B; of UKtc on day 0. At each time point, a pair of 
animals was sacrificed and entire gut was aseptically collected in cold PBS. 
Titres of the infectious virus in the intestinal homogenates were determined 
by plaque assay at various times post inoculation. Plotted are the mean fron 2 
experiments and in each experiment n=2. The limit of virus detection in 
plaque assay was 1x 102. 
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Figure 13 : Diarrhoea produced in 7 day old suckling CD-I pups 
inoculated with various doses of OSU strain of rotavirus. 
Seronegative 7 day old suckling CD-1 pups were orally inoculated with 107 
pfu = A; 106 pfu = B; of OSU on day 0. At various times post inoculation 
the animals were examined for clinical signs of disease. At each time point, a 
pair of animals was sacrificed and observed for internal signs of disease. 
Plotted are the mean from 2 experiments and in each experiment n= 5-8. 
The standard deviation ranged from 0 to 5.7. 
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Figure 14 : Replication of OSU strain of rotavirus in the intestines of 7 
(lay old suckling CD-I mice pups inoculated with various doses. 
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B 
Seronegative 7 day old suckling CD-I pups were orally inoculated with 107 
pfu = A; 106 pfu = B; of OSU on day 0. At each time point, a pair of 
animals was sacrificed and entire gut was aseptically collected in cold PBS. 
Titres of the infectious virus in the intestinal homogenates were determined 
by plaque assay at various times post inoculation. Plotted are the mean from 2 
experiments and in each experiment n=2. The limit of virus detection in 
plaque assay was 1x 102. 
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Figure 15 : Diarrhoea produced in 7 day old suckling C3H/HE pups 
inoculated with various doses of OSU strain of rotavirus. 
Seronegative 7 day old suckling C3H/HE pups were orally inoculated with 
107 pfu = A; 106 pfu = B; of OSU on day 0. At various times post 
inoculation the animals were examined for clinical signs of disease. At each 
time point, a pair of animals was sacrificed and observed for internal signs of 
disease. Plotted are the mean from 2 experiments and in each experiment n= 
5-8. The standard deviation ranged from 0 to 6.4. 
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diarrhoea occurred at 36 hr p. i. when about 50% pups were affected. 
The severity of diarrhoea observed was less than that seen in CD-1 pups 
inoculated with the same doses of OSU. However, it was more than that 
observed with either UKtc or B223 strains of rotavirus. The duration of 
diarrhoea was from day 1 through day 6 p. i. except on day 4. 
Considerably higher titres were observed in the infectivity studies (Figure 
16). 
5.5.3 Discussion 
A dose response as determined by the percentage of pups affected 
was observed in all the rotavirus strains used indicating that rotavirus 
virulence is dependent upon the amount of virus to which an animal is 
exposed. Similar dose dependent diarrhoea in mice has been reported for 
the MET strain (Gouvea et al., 1986), EB, EW, and RRV strains 
(Greenberg et al., 1986), and SA11 (Offit et al., 1984; Greenberg et al., 
1986; Ramig, 1988). Diarrhoea of considerable severity was observed in 
7 day old CD-1 pups inoculated with 105 pfu of the B223 strain, along 
with viral replication at 36 hr p. i. by Ramig, (1988) which is in contrast 
to our observations. The DD50 of B223 strain in Balb/c pups could not 
be established. Therefore, another experiment of using different strain of 
mice was conducted (see later sections). 
Similarly the disease pattern in Balb/c pups inoculated with 107 
pfu was different from that reported by Jones, (1993). Replication of 
UKtc in Balb/c pups was not observed with any of the doses used. 
However, it was observed in CD-1 pups as indicated by slight increase in 
virus titre (Offit et al., 1984), though the titres were not above the input 
dose as observed with 1x102 pfu of SA11 in CD-1 pups (Ramig, 1988). 
The DD50 for UKtc was > 108, but the diarrhoea induced was very 
mild. 
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Figure 16 : Replication of OSU strain of rotavirus in the intestines of 7 
day old suckling C3H/HE mice pups inoculated with various doses. 
Seronegative 7 day old suckling C3H/HE pups were orally inoculated with 
107 pfu = A; 106 pfu = B; of OSU on day 0. At each time point, a pair of 
animals was sacrificed and entire gut was aseptically collected in cold PBS. 
Titres of the infectious virus in the intestinal homogenates were determined 
by plaque assay at various times post inoculation. Plotted are the mean from 2 
experiments and in each experiment n=2. The limit of virus detection in 
plaque assay was 1x 102. 
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A severe diarrhoea could be induced using the porcine OSU strain 
in the present study as compared to the observations of Ward et al., 
(1992). The OSU strain replicated in the intestines, however, the 
replication was abortive (Ramig, 1988) as the titres observed were less 
than the input dose. The DD50 for the OSU strain was 107 pfu. 
5.5.4 Conclusions 
Rotavirus virulence is dose dependent as severity of the disease 
decreased in parallel with the titre of the inoculum. 
5.6 Rotavirus virulence is dependent on virus strain 
5.6.1 Introduction 
The main objective of this study was to obtain rotavirus strains of 
varying virulence that would be used as parents in genetic manipulation 
experiments to probe the molecular basis of virus virulence. Three 
different rotavirus strains viz. UKtc (G6P7), B223 (G1OP8), and OSU 
(G5P9) were selected. 
A dose of 107 pfu of these strains was orally inoculated into 
seronegative 7 day old suckling pups of different mice strains. 
5.6.2 Results and discussion 
In general, the porcine OSU strain was found to be the most 
virulent of the strains used followed by bovine B223 and UKtc strains 
(Figures 17A-D). The onset of diarrhoea in all the strains occurred at 24 
hr p. i. and could be seen during the next 2-3 days except in C3H/HE 
mice strain in which the percentage of pups showing diarrhoea seemed to 
cycle over time (Figure 17C). It is not clear whether this represented 
multiple cycles of replication or physiologic responses to infection. The 
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Figure 17 : Diarrhoea produced by various strains of rotavirus in 7 day 
old suckling pups. 
Seronegative 7 day old suckling (A) CD-1; (B) Balb/c; (C) C3H/HE; (D) 
C57/BL, pups were orally inoculated with 107 pfu of various strains of 
rotavirus on day 0. At various times post inoculation the animals were 
examined for clinical signs of disease. At each time point, a pair of animals 
was sacrificed and observed for internal signs of disease. Plotted are the mean 
from 2 experiments and in each experiment n= 5-8. The standard deviation 
ranged from 0 to 9.9. 
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percentage of pups affected by B223 in C3H/HE pups appeared to be 
more, however, the severity in terms of overt diarrhoea and amount of 
stool was much less than OSU strain. In C57/BL negligible disease could 
be induced by B223 strain. Analysis of the kinetics of disease and the 
range of disease symptoms in 7 day old CD-1 suckling pups (Table 7) 
revealed the induction of overt diarrhoea (+3) from 36 hr p. i. through 3 
days p. i. in pups inoculated with the OSU strain of rotavirus. The effect 
of using various heterologous rotavirus strains for induction of diarrhoea 
in mice has been studied previously (Greenberg et al., 1986; Ramig, 
1988). The clinical symptoms with the B223 strain in CD-1 pups was 
similar to that reported by Ramig, (1988). However, 2loglp higher dose 
was used in that study. The OSU strain in present study was found to be 
more virulent than observed by Ward et al., (1992). 
5.6.3 Conclusions 
Among the strains used in the present study, the OSU strain was 
found to be most virulent and UKtc strain the least. 
5.7 Rotavirus virulence is dependent on host strain 
5.7.1 Introduction 
The results of the experiments conducted in the preceding sections 
indicated that the host strain influences the outcome of infection. The 
purpose of the following study was to examine the effect of host strain as 
well as to investigate if any virus-host combinations are greatly different 
in their virulence from other combinations. Each of the three virus strains 
(107 pfu of OSU or B223; 109 pfu UKtc) was orally inoculated in 7 day 
old suckling pups of three inbred and one outbred mice strain. The inbred 
mice strains used were C3H/HE (H-2k), Balb/c (H-2d), and C57/BL (H- 
2b); whereas CD-1 was the outbred strain. 
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Table 7: The kinetics of disease in 7 day old suckling CD-1 mice pups 
inoculated with various rotavirus strainsa 
Time post 
inoculation 
Range of dis 
UK c 
ease symptoms in pu 
B223c 
ps inoculated withb 
OSUc 
6 hr -/- -/- -/- 
12 hr' -/- -/- -/- 
24 hr ++/- +/+ ++/++ 
36 hr +/- + +/+ +++/++ 
2d +/- +++/+ +++/++ 
3d ++/+ ++/+ +++/++ 
4d + +/+ +/- +/- 
5d +/- -/- +/- 
6d -/- -/- -/- 
aSeronegative 7 day old suckling CD-1 pups were orally inoculated with 
107 pfu of various rotavirus strains on day 0. The incidence of diarrhoea 
in the animals was then monitored over the next 6 day period. 
bDisease was scored as defined in Materials and Methods. 
Q litters were studied separately, each consisted of 5-8 pups. 
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5.7.2 Results 
The B223 strain of virus induced negligible disease in C57/BL 
pups and somewhat more in Balb/c (Figure 18). However, the 
determination of DD50 in these two strains was not possible as less than 
50% of the pups showed diarrhoea. Diarrhoea induction in C3H/HE 
strain appeared to be cyclic. Whether this is due to multiple rounds of 
replication or just the physiologic response is not clear from the titration 
of infectivity in intestinal homogenates which revealed a delayed decline 
in virus titres as compared to other strains of mouse (Figure 19). The 
B223 strain in CD-1 pups showed a second peak in virus titres at around 
4 day p. i., however, in this case it was not accompanied by diarrhoea. 
The C3H/HE strain appeared to be most susceptible to UKtc strain 
followed by CD-1 strain of mouse (Figure 20). The replication pattern of 
the UKtc in various strains of mouse appeared to be similar to that 
observed with the B223 strain (Figure 21). 
The CD-1 strain of mice was most susceptible to the OSU strain 
with 100% of the pups affected at 36 hr p. i. (Figure 22). The duration of 
the overt diarrhoea was also greatest in this strain. The diarrhoea in 
C3H/HE strain though less severe than observed in CD-1 strain was 
biphasic. The infectivity titration curves also showed a second peak of 
virus replication (Figure 23). 
5.7.3 Discussion 
The present studies showed that rotavirus virulence is affected by 
the host strain used. The outcome of the infection can be viewed as the 
product of virus virulence and host resistance. A highly virulent strain of 
virus is less lethal for a highly resistant strain of animal than for a 
susceptible one; conversely, a relatively avirulent strain of virus may be 
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Figure 18 : Diarrhoea produced by B223 strain of rotavirus in 7 day old 
suckling pups of various mice strains. 
Seronegative 7 day old suckling pups of various mice strains were orally 
inoculated with 107 pfu of B223 strain of rotavirus on day 0. At various 
times post inoculation the animals were examined for clinical signs of 
disease. At each time point, a pair of animals was sacrificed and observed for 
internal signs of disease. Plotted are the mean from 2 experiments and in each 
experiment n= 5-8. The standard deviation ranged from 0 to 6.4. 
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Figure 19 : Replication of B223 strain of rotavirus in 7 day old suckling 
pups of various mice strains. 
Seronegative 7 day old suckling pups of various mice strains were orally 
inoculated with 107 pfu of B223 strain of rotavirus on day 0. At each time 
point, a pair of animals was sacrificed and entire gut was aseptically collected 
in cold PBS. Titres of the infectious virus in the intestinal homogenates were 
determined by plaque assay at various times post inoculation. Plotted are the 
mean from 2 experiments and in each experiment n=2. The limit of virus 
detection in plaque assay was 1x 102. 
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Figure 20 : Diarrhoea produced by UKtc strain of rotavirus in 7 day old 
suckling pups of various mice strains. 
Seronegative 7 day old suckling pups of various mice strains were orally 
inoculated with 109 pfu of UKtc strain of rotavirus on day 0. At various 
times post inoculation the animals were examined for clinical signs of 
disease. At each time point, a pair of animals was sacrificed and observed for 
internal signs of disease. Plotted are the mean from 2 experiments and in each 
experiment n= 5-8. The standard deviation ranged from 0 to 7.7. 
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Figure 21 : Replication of UKtc strain of rotavirus in 7 day old suckling 
pups of various mice strains. 
Seronegative 7 day old suckling pups of various mice strains were orally 
inoculated with 109 pfu of UKtc strain of rotavirus on day 0. At each time 
point, a pair of animals was sacrificed and entire gut was aseptically collected 
in cold PBS. Titres of the infectious virus in the intestinal homogenates were 
determined by plaque assay at various times post inoculation. Plotted are the 
mean from 2 experiments and in each experiment n=2. The limit of virus 
detection in plaque assay was 1x 102. 
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Figure 22 : Diarrhoea produced by OSU strain of rotavirus in 7 day old 
suckling pups of various mice strains. 
Seronegative 7 day old suckling pups of various mice strains were orally 
inoculated with 107 pfu of OSU strain of rotavirus on day 0. At various 
times post inoculation the animals were examined for clinical signs of 
disease. At each time point, a pair of animals was sacrificed and observed for 
internal signs of disease. Plotted are the mean from 2 experiments and in each 
experiment n= 5-8. The standard deviation ranged from 0 to 5.7. 
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Figure 23 : Replication of OSU strain of rotavirus in 7 day old suckling 
pups of various mice strains. 
Seronegative 7 day old suckling pups of various mice strains were orally 
inoculated with 107 pfu of OSU strain of rotavirus on day 0. At each time 
point, a pair of animals was sacrificed and entire gut was aseptically collected 
in cold PBS. Titres of the infectious virus in the intestinal homogenates were 
determined by plaque assay at various times post inoculation. Plotted are the 
mean from 2 experiments and in each experiment n=2. The limit of virus 
detection in plaque assay was Ix 102. 
120 
lethal for an unusually susceptible host. Susceptibility to viral infection is 
always, influenced and sometimes determined by the genetic constitution 
of the host. 
Heterologous OSU and UKtc rotavirus strains induced disease in 
C57/BL though to a lesser degree than that observed by Offit and 
Dudzik, (1990), who were able to induce diarrhoea in 100% of 
.7 
day old 
C57/BL pups at 4-5 day p. i. using a dose of 5x105 of RRV. The B223 
strain induced negligible diarrhoea in C57/BL pups, whereas C3H/HE 
pups were quite susceptible to the same strain of rotavirus. The results 
are similar to those obtained with Japanese encephalitis virus in mice 
(Miura et al., 1990) in which a single gene controls the resistance to 
Japanese encephalitis virus in mice. Likewise, the resistance of certain 
mice to influenza virus infection is controlled by the Mx gene, whose 
gene product is induced by a/ß interferons (Lindenmann, 1962; 64; 
Haller et al., 1979). Whether there is any genetic restriction of C57/BL 
on diarrhoea induction by B223 virus remains to be seen. 
The three inbred strains of mice showed quite different patterns of 
disease. Whether MHC haplotype has any influence on the outcome of 
the infection requires further analysis. It also indicates that protection 
studies with rotavirus vaccines candidates should be done in the outbred 
CD-i mice strain so that the results of these studies can be applied in a 
meaningful way for outbred animals and humans. 
5.7.4 Conclusions 
The CD-1 was found to be the most susceptible and C57/BL the 
least susceptible strain for infection with rotavirus. Productive replication 
usually leads to a second peak of disease which occurs 5-6 day post 
inoculation. The possibility of using Balb/c and C57/BL for conducting 
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virulence mapping studies was ruled out as DD50 could not be 
established in them. 
5.8 Overall conclusions 
A mouse model for monitoring rotavirus virulence has been 
developed. Virulence was not restricted to a given serotype(s). However, 
the porcine virus strain appeared to be more virulent than the bovine 
strains tested. Different host strains showed varying degrees of 
susceptibility to rotavirus induced disease. 
The genetic and molecular studies with genetically manipulated 
rotaviruses would be conducted using the CD-1 strain of mouse where 
interpretation of the clinical signs was easy. Also, in CD-1 pups the 
differences in the DD50 and percentage of pups affected by OSU were 
significantly greater than those observed with either UKtc or B223. 
However, the difference was only 2loglo. 
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Chapter 6 
Development of a simple and rapid method for nucleic 
acid extraction and genotyping 
6.1 Introduction 
Having developed the mouse model for monitoring rotavirus 
virulence (chapter 5), the next question to address was the identification 
of the viral gene(s) involved in this virulence. Such studies require a very 
large number of samples (genetically manipulated virus) to be screened 
(discussed in detail in chapter 7) to correlate phenotype with genotype. 
Consequently, a rapid screening assay needed to be developed, in which 
the manipulative steps are simple and minimum. In this chapter, the 
development of a simple and rapid nucleic acid extraction protocol and a 
simple assay for genotyping virus reassortants is described. 
or 
6.2 Nucleic acid extraction methods 
The UKtc strain of rotavirus was used to develop a simple and 
rapid method for extraction of viral nucleic acid. When the method was 
optimised, it was used to test the extraction of nucleic acid from two 
other strains i. e. OSU and B223. During the course of development, the 
presence of rotavirus specific RNA in the extracted material was 
determined by amplification of the gene encoding VP7 in RT-PCR. 
6.2.1 Conventional method of nucleic acid extraction 
The RNA was extracted by conventional method, but there were 6 
centrifugation steps: one for obtaining cell pellet, one for obtaining 
cytoplasmic extract after lysis with NP40, two at phenol extraction, and 
two during ethanol precipitation (see figure 24). This made the 
conventional method impractical for handling large number of samples. 
6.2.2 Nucleic acid extraction by boiling 
BSC-1 cells (106) were infected at a m. o. i. of 1 pfu/ cell. At about 
50% CPE the cells were harvested, boiled for 2 min. After a brief 
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centrifugation the supernatant was tested for the presence of rotavirus 
specific RNA. RNA was amplified (figure 25, lane E) on some occasions 
and not reproducibly. 
6.2.3 Nucleic acid extraction by sonication 
BSC-1 cells were infected and harvested as described in section 
6.2.2. Instead of boiling, the cells were sonicated for 30 sec in sonic 
waterbath and tested for the presence of rotavirus specific RNA. There 
was no evidence of rotavirus specific RNA in PCR. In another situation, 
boiling and sonication were combined without any improvement of results 
(data not shown). 
6.2.4 Nucleic acid extraction directly from individual plaques 
The UKtc strain of rotavirus was plaqued in BSC-1 cells. The 
virus plaques were picked using a pasteur pipette and resuspended in 100 
µl of PBS, freeze thawed 3 times and sonicated for 30 sec in a sonic 
waterbath. One half of this material was stored at minus 700C for 
subsequent virus amplification. The other half was phenol extracted and 
precipitated with ethanol in the presence of 10 gg yeast tRNA. The 
precipitates were washed with 70% ethanol before drying. The RNA was 
dissolved in water and used in PCR. There was no evidence of RNA as 
there was no amplification of gene 8 (Figure 25 lane F). 
6.2.5 Refinement of conventional extraction method 
A number of other methods used for extraction of nucleic acid from 
mammalian cells, fungus, plants were tried but were not successful (data 
not shown). It was then thought to refine and reduce steps involved in the 
conventional method. At first ethanol precipitation steps were omitted 
without any deleterious effect on extracted RNA (Figure 25 lane 
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Figure 25 : Amplification of UKtc gene 8 in RT-PCR from RNA 
extracted by various methods. 
BSC-1 cells were infected with UKtc strain of rotavirus. Viral RNA was 
extracted by various methods as described in Materials and Methods. 
Viral dsRNA was then detected by agarose gel electrophoresis and 
staining with ethidium bromide following RT-PCR ampliFication of gene 
8. 
Lane A= adeno control, lane B= RNA extracted by conventional 
method, lane C= no ethanol precipitation, lane D= no phenol step but 
deproteinisation with proteinase K followed by its inactivation at 80°C/ 
10 min, lane E= RNA extracted by boiling, lane F= RNA extracted 
directly from a plaque, lane M= ladder of DNA size markers. 
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Q. No RNA could be extracted when the phenol/ether steps were omitted 
(data not shown). It was felt that the SDS and proteinase K interfered in 
the PCR. This problem was overcome by deleting the addition of SDS 
and by heat inactivating the proteinase K. A series of reconstruction 
experiments were carried out in which the RNA extracted by the 
conventional method was mixed with proteinase K in proteinase K buffer 
or just the buffer. The mixture was heat inactivated in a waterbath for 
various lengths of time prior to attempting amplification of UKtc gene 8 
in RT-PCR. The mixture containing only the Proteinase K buffer left on 
ice prior to amplification in RT-PCR served as control to show that 
heating at 800C did not have any deleterious effect in PCR. And the 
mixture containing only the proteinase K buffer and heated at 800C for 
30 min was included to show that the proteinase K buffer itself was not 
inhibiting the PCR. It was found that proteinase K could be inactivated at 
800C in 10 min but not in 5 min, as determined by amplification of gene 
8 of UKtc in PCR (Figure 26). Therefore, four centrifugation steps were 
reduced without any deleterious effect on RNA extraction. 
In the conventional method, after the development of CPE the cells 
were scraped off and then centrifuged to obtain a cell pellet that was 
subsequently subjected to lysis with NP40. It was felt that this first 
centrifugation step could also be reduced by collecting the supernatant 
separately for further passage and adding the lysis buffer directly onto the 
monolayer in the tissue culture plates. This proved successful as there 
was sufficient RNA in the cytoplasmic extracts and the supernatant was 
found to contain sufficient virus to act as inoculum for subsequent 
passage (data not shown). Initially, plaques grown in 24-well plates were 
further amplified in 6-well plates before extraction of nucleic acid. 
However, it was found out that nucleic acid could directly be extracted 
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Figure 26 : Determination of the time required to inactivate 
proteinase K by heat. 
BSC-1 cells were infected with UKtc strain of rotavirus. Uktc RNA 
extracted by conventional method was mixed with proteinase K or only 
proteinase K buffer and the proteinase K was inactivated by heating at 
80°C for various times. Then VP7 gene was amplified in RT-PCR. 
Products of RT-PCR showing full length cDNA copies of VP7 were 
separated on 1.5% agarose gel which was stained with ethidium bromide. 
Lane A= adeno control, lane B= RT control of UKtc VP7 gene, 
lanes C-F shows amplification of VP7 gene after heat inactivation of 
proteinase K in 5 min (lane C), 10 min (lane D), 20 min (lane E), 30 min 
(lane F), or RNA+proteinase K buffer only, heated at 80°C for 30 min 
(lane G), or kept on ice before performing RT-PCR (lane H), lane M -- 
ladder of DNA size markers. 
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from the plaques grown in 24-well plates. This saved lot of time and 
labour. 
6.2.6 Optimised extraction method 
The nucleic acid extraction method optimised in the present study 
is described below. Rotaviruses were plaqued on BSC-1 cells. Individual 
plaques were picked and grown in 24-well dishes. Cytoplasmic extracts 
were prepared by NP40 lysis and deproteinisation was done by incubating 
the cytoplasmic extract with proteinase K. 
Comparison of the optimised method (Figure 27) with the 
conventional method (Figure 24) will reveal that this does not require the 
use of any hazardous organic chemicals and requires just one 
centrifugation step, which not only reduces the manual labour involved in 
screening large number of samples but also reduces the chance of cross 
contamination. 
This method was used to extract RNA from OSU and B223 strains 
of rotavirus as well as from genetically manipulated virus described in 
later studies. 
6.3 Genotyping assays 
6.3.1 Polymerase chain reaction 
6.3.1.1 Amplification of VP7 gene 
The extracted RNA was used in a coupled reverse transcription 
RT-PCR using primers complementary to the termini of gene 8 as 
described previously (Xu et al., 1990) with some modifications 
(described in materials and methods). Amplified DNA bands were 
fractionated on 1.5 % agarose gels and visualised by staining with 
ethidium bromide (Sambrook et al., 1989). The amplification of the VP7 
" gene (1062 bp band) from UKtc, OSU, and B223 strains of rotavirus is 
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shown in Figure 28. No band was detected in the material extracted from 
mock infected BSC-1 cells (Figure 28 lane E) or with UKtc RNA without 
gene 8 primers (Figure 28 lane F). 
6.3.1.2 Restriction enzyme analysis of amplified VP7 gene 
Digestion of cDNA copies of the amplified VP7 genes with 
BamHl and EcoR V endonucleases was used to differentiate the rotavirus 
strains. BamHl digested cDNA from the B223 strain gave bands of 628 
and 434 (Figure 29 lane D). But there were no BamH1 restriction sites in 
OSU or UKtc (Figure 29 lanes E&C, respectively). The digestion of 
amplified cDNA copies with EcoRV was more differentiating and gave 
bands of 760,216,87 bp in B223 (Figure 29 lane I), 513,464,86 bp 
bands in OSU (Figure 29 lane J), and 600,463 bp bands in UKtc (Figure 
29 lane G). The 87bp band and 86 bp band are not visible in the gel but 
are reported on the basis of sequence analysis. Control cDNA of VP7 
gene without any endonucleases from UKtc, OSU, B223 are also shown 
(Figure 29 lanes B, F, & H, respectively). Therefore, amplified cDNA of 
VP7 gene could be differentiated by BamH1 and EcoR V endonucleases, 
although they were amplified using same pair of primers. 
6.3.1.3 Amplification of other gene segments by' PCR 
Other genes could also be amplified using the RNA from the optimised 
extraction method. The amplification of gene segments 5,6,8,9, and 11 
from UKtc and OSU rotavirus strains is shown in Figure 30. Some of the 
non-specific bands are due mispriming and could be differentiated by 
restriction enzyme analysis. Amplification of VP7 gene served as 
controls. However, the amplification of two or more gene segments from 
a strain in the same tube was not as successful as when the gene segments 
were amplified singly (data not shown). 
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Figure 28 : Product of RT-PCR showing full length cDNA copies of 
VP7 gene. 
BSC-1 cells were infected with various strains of rotavirus. Viral RNA 
was extracted by optimised method. The VP7 gene was amplified in RT- 
PCR. Products of RT-PCR showing full length cDNA copies of VP7 
were separated on 1.5% agarose gel which was stained with ethidium 
bromide. 
Positive adeno DNA control (lane A), UKtc (lane B), OSU (lane C), 
B223 (lane D), negative controls (lanes E& F) are also shown, lane M= 
ladder of DNA size markers. 
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Figure 29 : Restriction patterns of VP7 gene copies of cDNA. 
The VP7 gene amplified in RT-PCR from the RNA extracted by 
optimised method from the BSC-1 cells infected with various strains of 
rotavirus was digested by different restriction endonucleases. After 
digestion of cDNA with endonucleases, electrophoretic separation was 
done on 1.5% agarose gel which was stained with ethidium bromide. 
Lane A= Adeno control; lane C= UKtc +BamHl ; lane D= 
B223 +BamH1; lane E= OSU +BamHl ; lane G=U Ktc +EcoR V; lane I 
= B223+EcoRV; lane J= OSU+EcoRV; Control cDNA copies without 
any endonucleases are also shown in lane B= UKtc; lane F= OSU; 
lane H= B223; lane M= ladder of DNA size markers. 
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Figure 30 : Product of RT-PCR showing full length cDNA copies of 
various genes of UKtc and OSU. 
BSC-1 cells were infected with UKtc or OSU strains of rotavirus. Viral 
RNA was extracted by optimised method. Various genes were amplified 
in RT-PCR. Electrophoretic separation was done on 1.5% agarose gel 
which was stained with ethidium bromide. 
Lane A= positive adeno DNA control; lane B= UKtc gene 8; lane C= 
OSU gene 9; lane D= UKtc gene 11; lane E= OSU gene 11; lane F= 
UKtc gene 9; lane G= OSU gene 5; lane H= OSU gene 6; lane I= 
OSU gene 8; lane J= UKtc gene 5; lane K= B223 gene 6; lane L= 
UKtc gene 5; lane M= ladder of DNA size markers. 
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6.3.2 Polyacrylamide gel electrophoresis 
The extracted RNA samples were also analysed by polyacrylamide 
gel electrophoresis. The fractionated dsRNA segments were visualised by 
silver staining. By employing a combination of coelectrophoresis and the 
running of parental strains on either side of the coelectrophoresed sample, 
the origin of about 6-7 segments could be identified. It was not possible 
to distinguish the parental origin of segments 2,3,8, and 11 between 
UKtc and B223 strains, and segments 2,7,8, and 11 between OSU and 
B223 strains. Also, segments 2,7,8,9, and 11 could not be 
differentiated between UKtc and OSU strains of rotavirus (Figure 31). 
6.4 Discussion 
Two viral strains can be differentiated antigenically (by 
monoclonal antibodies or hyperimmune sera), biologically (e. g. 
haemagglutination, plaque formation), or genetically (nucleic acid probes, 
PCR, sequencing). However, in order to correlate phenotype with 
genotype, the knowledge about the genetic make-up of the organism is 
necessary, to show that the phenotypes are genetically determined and not 
due to some non-genetic mechanisms such as complementation or 
phenotypic mixing in in vitro studies or due to host factors in in vivo 
studies. The phenotype- genotype correlation studies often involve 
screening of a very large number of samples. Therefore, both the nucleic 
acid extraction and genotyping assays should not only be rapid and simple 
but have the minimum manipulative steps. 
RNA has been isolated from purified rotavirus either by 
deprote inisation with phenol, or deproteinisation with proteinase K (Cash, 
1982), deproteinisation with both proteinase K and phenol (Lourenco et 
al., 1981), or simple lysis of the purified particles by boiling in buffer 
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Figure 31 : Electrophoretic profile of genomic RNA of rotavirus 
strains separated on polyacrylainide gel and silver stained. 
Viral RNA was extracted by optimised method from BSC-1 cells infected 
with various strains of rotavirus. Viral dsRNA were then detected by 
electrophoresis on a 6% polyacrylamide gel and silver staining as 
described in Materials and Methods. 
Lane A= UKtc; lane B= UKtc+OSU; lane C= OSU; lane D 
= OSU+B223; lane E= B223; lane F= B223 + UKtc; lane G= UKtc; 
lane M= ladder of DNA size markers. The parental origin of the gene 
segments in coelectrophoresed parents is indicated by a white dot on the 
side of parent. The gene segments are indicated on the left. 
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containing SDS and reducing agents, prior to analysis on gels (Croxson 
and Bellamy, 1981). 
The conventional nucleic acid extraction method that was being 
employed for extracting rotavirus genomic RNA at the beginning of this 
study required six centrifugation steps. The use of boiling (Ferre and 
Garduno, 1989), or extraction of nucleic acid directly from viral plaques 
(Pasamontes et al., 1991) have been described, but were unsuccessful for 
rotavirus RNA extraction in this study. Then it was thought to refine and 
reduce the steps involved in the conventional method. The method 
developed in present study does not require phenol extraction or ethanol 
precipitation steps. Bypass of ethanol precipitation following 
hydroxyapatite treatment of stools (Gouvea et al., 1991), or phenol/ 
chloroform extraction after treatment of stools with glass powder 
(Gentsch et al., 1992) for the extraction of rotavirus RNA have been 
reported. Bypass of phenol extraction (Edwards et al., 1991; Laird et al., 
1991) or various centrifugation steps (Laird et al., 1991) for DNA 
extraction from plants and mammalian cells have also been reported. 
Deproteinization by proteinase K followed by its inactivation by heating 
at 800C for 10 min was found to be sufficient for RNA extraction. Others 
have reported the inactivation of proteinase K in 10 min at 950C (Porter 
et al., 1991) or by the use of BSA (Laird et al., 1991). 
The final method developed for nucleic acid extraction requires 
just one centrifugation step and does not require the use of any hazardous 
organic chemicals. The RNA extracted by the method developed in this 
study was used to develop genotyping assays. The PCR provides a 
technique by which the nucleic acid in a sample can be specifically 
amplified by up to 106- fold prior to its detection (Saiki et al., 1985; 
Saiki et al., 1988). RT-PCR has been used for the detection of rotavirus 
(Xu et al., 1990; Gouvea et al., 1990; 1991). The nucleotide sequence of 
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all the gene segments of UKtc has been determined (Desselberger and 
McCrae, 1994). Initially a strategy was planned in which the strain origin 
of each viral RNA segment could be identified by first amplifying the 
gene by RT-PCR followed by restriction enzyme analysis of the amplified 
product or by a second nested PCR using strain-specific primers. 
However, this strategy of solely genotyping by PCR had to be abandoned 
as it was found to be economically and practically not feasible. Because, 
sometimes the gene could not be amplified and in other situations the 
sequence was not available for many genes of OSU and B223 to construct 
the primers, as the primers constructed for UKtc did not work on OSU or 
B223 probably due to sequence heterogeneity. However, PCR 
amplification followed by restriction enzyme analysis was useful for some 
genes. Restriction enzyme analysis of VP7 gene of human and animal 
rotaviruses has recently been applied to divide more than 200 strains into 
28 groups (Gouvea et al., 1993). The strategy of amplifying various 
genes together in the same tube to reduce the cost was abandoned as it 
was observed that various primers interfered with each other. Because, 
gene segments that gave good amplification singly were found to be 
amplified poorly when it was tried to amplify them together with other 
gene segments in the same tube. 
Rotavirus particles contain a genome of 11 segments of dsRNA 
that can be separated into distinct bands by gel electrophoresis and 
visualised by staining with either ethidium bromide or silver or 
alternatively by autoradiography after labelling the 3' end with 
32P 
(Clarke and McCrae, 1981; Herring et al., 1982). The gel electrophoretic 
pattern of the segments (electropherotype) is a reproducible characteristic 
of a virus strain. It has been used for rotavirus detection (Newman et al., 
1975; Rodger et al., 1975; Kalica et al., 1976; Clarke and McCrae, 
1981) as well as for genotyping rotavirus reassortants used in gene-coding 
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and gene function assignment studies (Greenberg et al., 1981; 1983a; 
Kalica et al., 1981; 1983; Offit et al., 1986; Gombold and Ramig, 1986; 
Urasawa et al., 1986; Ward et al., 1988a; Liu et al., 1988; Chen et al., 
1989; Snodgrass et al., 1992; Broome et al., 1993). One of the major 
advantage offered by PAGE-SS for genotyping is the simultaneous 
comparison of several gene segments between two strains of rotavirus. It 
was possible to differentiate about 6-7 segments between different strains 
used in this study by coelectrophoresis of their RNA followed by silver 
staining. Assignments of the gene segments by PAGE-SS were found to 
be correct when confirmed by RT-PCR on gene segment encoding VP7. 
6.5 Conclusions 
A very simple and rapid nucleic acid extraction method has been 
developed that can be applied to a very large number of samples saving 
time and labour. The nucleic acid extracted from genetically manipulated 
rotaviruses, constructed for conducting studies on virulence mapping, will 
be genotyped by using a combination of PAGE-SS and restriction enzyme 
analysis of RT-PCR amplified product. 
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Chapter 7 
Construction and characterisation of rotavirus 
reassortants 
7.1 Introduction 
Until the last two decades the only approach to correlate a 
virulence phenotype observed in nature with a particular microbe was by 
proving the Koch's postulates, i. e. isolating the microbe from the 
diseased host, growing it in the laboratory, infecting the host to observe 
same kind of clinical signs, and isolating the same organism from the 
artificially infected host. But, with the advances made in molecular 
biology, virulence phenotypes are not only correlated to the microbe but 
also to its gene(s) by the use of variants, mutants, or recombinants. 
The ultimate aim of this project was to identify the viral gene(s) 
determining rotavirus virulence. This could be achieved by th ^genetically 
manipulated rotaviruses. Theoretically, two categories of such viruses are 
possible. In the first category, an entire genome segment(s) is exchanged 
between two rotavirus strains by the process of reassortment. The second 
category involves the exchange of genomic segment(s) as such or 
modified by site-directed mutagenesis, between a rotavirus strain and 
cloned RNA segment derived from cDNA generated by reverse genetics. 
The second of these two possibilities remains at present only theoretical 
as strategies remain to be developed in rotavirus which allow gene rescue 
of cDNA's RNA in an infectious particle. This chapter describes the 
construction of rotavirus reassortants by the process of reassortment. 
7.2 Rotavirus reassortants are essential for mapping virulence 
to gene(s) 
The phenotype of a gene of a RNA virus can be studied by making 
cDNA copies of the gene and then putting them into a vector to get a 
clone. After transformation or transfection of suitable cells with the 
clone, recombinants are obtained. Using the recombinant virus or the 
expressed protein the phenotype is then correlated with the genotype. 
Reassortants generated by reassortment have proved to be the primary 
tool for the identification of gene function in rotaviruses and other 
segmented RNA viruses. When two closely related segmented viruses are 
allowed to infect mixedly either in vivo or in vitro, then some of the 
progeny viruses receiving genome segments from both the parents may be 
produced and are called reassortants (see section 2.6). An example of a 
reassortant is shown in Figure 32. In this figure UKtc and RRV represent 
two parents and in the middle is a reassortant which has derived its gene 
4 from RRV and the remaining 10 segments from UKtc parent. A viral 
phenotype such as haemagglutination can be studied either by 
recombinants or by reassortants between these two parents. The 
recombinants or reassortants containing gene 4 from RRV parent will be 
haemagglutinating, as well as the RRV parent, whereas those 
recombinants or reassortants having the gene 4 from UKtc parent will not 
haemagglutinate. Because only RRV parent is haemagglutinating. 
Similarly, recombinants of all genes from rotavirus parents can be made. 
However, it is not yet possible to manipulate a gene or a part of the gene 
in vitro and then rescue it into an infectious particle in rotaviruses. The 
classical reverse genetics is not yet possible to rescue a gene into an 
infectious rotavirus and infectious virus is required for studying rotavirus 
virulence. In the absence of having a genetically manipulated infectious 
rotavirus by reverse genetics and recombinant DNA techniques, rotavirus 
reassortants are the only means available, at present, for studying 
rotavirus virulence. 
7.3 Large number of reassortants need to be screened to map 
rotavirus virulence 
The rotavirus genome consists of 11 gene segments of which all 
but one (gene 11) are monocistronic (see chapter 1). Assuming that virus 
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FIGURE 32 :A SCHEMATIC SHOWING A GENE 4 
REASSORTANT BETWEEN UKtc AND RRV STRAINS OF 
ROTAVIRUS. 
UKtc REASSORTANT RRV 
Shown here is a rotavirus reassortant containing segment 4 from RRV 
rotavirus and remaining 10 segments from UKtc rotavirus. 
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virulence is completely determined by a single viral gene then the 
exchange of one segment at a time from one parent on the background of 
a second parent can be used to segregate virulence to individual gene 
segments by infecting suitable host with 22 reciprocal monotypic 
reassortants from two rotavirus parents differing in their virulence 
phenotype. However, because of the random nature of the reassortment 
process, a very large number of samples need to be screened to obtain the 
desired 22 reciprocal monotypic reassortants since in a cross between two 
rotavirus strains 2048 different genotypes are possible (Figure 33). 
Because, in rotaviruses each of the 11 segments, individually or in any 
combination of other segments of one parent can reassort with individual 
or in any combination of segments from the second parent. 
7.4 Construction and characterisation of rotavirus reassortants 
The Uktc, OSU, and B223 strains of rotavirus were used in pairs 
to generate reassortants by various methods. The reassortants were 
genotyped by PAGE-SS and restriction enzyme digestion of the amplified 
cDNA copies of the gene encoding VP7. Figure 34 shows that the results 
obtained with coelectrophoresis of the parental strains in PAGE-SS (see 
figure 31; chapter 6) can also be applied on rotavirus reassortants. 
7.4.1 Reassortant construction without any external selection 
pressure 
Putative reassortants were generated by coinfection of BSC-1 cells with 
different pairs of rotavirus strains (see Materials and Methods). The 
progeny clones were characterised by PAGE-SS of viral genomic RNA 
and restriction enzyme analysis of the amplified cDNA copies of VP7 
gene obtained in RT-PCR. Two reassortants (RS 11, and RS7) were 
isolated in the cross between UKtc and B223 out of 97 plaques, whereas 
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Figure 34 : Genotyping of rotavirus reassortants by polyacrylamide 
gel electrophoresis and silver staining. 
BSC-1 cells were infected with various rotavirus strains or reassortants. 
Viral RNA was extracted by the optimised method from infected BSC-1. 
Viral dsRNA was then detected by silver staining following fractionation 
by electrophoresis on a 6% polyacrylamide gel as described in Materials 
and Methods. The parental origin of the gene segments in reassortants is 
indicated by a white dot on the side of parent. The gene segments are 
indicated on the left. 
Lane A= UKtc; lane B= RS3; lane C= OSU; lane D= RS 1; 
lane E= B223. 
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of 110 plaques picked in a cross between UKtc and OSU, 4 reassortants 
were isolated (Table 8). All the reassortants obtained from UKtc and 
OSU cross had the same profile (RS3). The genotype of the reassortants 
is shown in Table 9, and Figure 35. Most of the progeny clones showed 
UKtc RNA profile. Out of 43 progeny clones between OSU and B223 
cross, 32 progeny clones showed OSU RNA profile, 7 showed B223 
profile, while the remaining 4 were reassortants (Table 8). The genotype 
of three of these reassortants (RS1, RS4, and RS5) is shown in Table 9, 
and figure 35, fourth having a genotype identical to RS 1. 
Multiple passages of coinfected cultures have been shown to result 
in large scale production of reassortants in the progeny by replacement of 
at least one segment from each parent (Ward et al., 1988a). Another 
experiment was conducted in which the coinfected material from first 
passage was given six further blind passages. Then plaques were picked, 
propagated, and characterised as described above. No reassortant virus 
was. isolated in any of the crosses. Again, UKtc was found in majority of 
the clones when it was one of the coinfecting parent, whereas OSU was 
dominant in the cross between OSU and B223 (Table 8). Since only a few 
reassortants could be isolated, it was considered necessary to apply some 
sort of external pressure for the generation of reassortants. 
7.4.2 Reassortant construction by differing multiplicity of 
infection 
Multiplicity of infection (m. o. i. ) has been shown to affect the 
frequency of reassortment (Gombold and Ramig, 1989). Also, changes in 
the relative m. o. i. of the coinfecting viruses have been found to alter the 
selection of certain segments in reassortants (Ward et al., 1988a). In the 
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Table 8: Summary of electropherotypes of progeny clones obtained by 
various methods. 
Methods Parents 
N 
No. of clones 
o. of clon 
UKtc 
es with foll 
OSU 
owing elec 
B223 
tropherotyl2es 
Reassortant 
No selection UKtc x OSUa 110 104 2 4 
UKtc x B223a 97 95 0 2 
B223 x OSUa 43 32 7 4 
UKtc x OSUb 20 19 1 
UKtc x B223b 20 20 0 
B223 x OSUb 20 18 2 
Differing UKtc x OSU 58 51 7 
m. o. i. 
UKtc x B223 46 45 1 
B223 x OSU 23 18 5 
Superinfection UKtc x OSU 42 31 11 
UKtc x B223 33 29 4 
B223 x OSU 18 13 5 
Plaque on UKtc x OSU 30 29 1 
MA104 cells 
UKtc x B223 30 30 0 
In vivo UKtc x OSU 24 22 2 
UKtc x B223 26 26 0 
B223 x OSU 18 18 0 
Reassortant as RS6 x OSU 19 19c 
parent 
apassage one used for genotyping; 
bpassage seven used for genotyping 
cpreformed reassortant parent 
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Figure 35 : Electrophoretic profile of genomic RNA of rotavirus 
reassortants separated on polyacrylamide gel and silver stained. 
BSC-1 cells were infected with various rotavirus strains or reassortants. 
Viral RNA were extracted by optimised method from BSC-1 cells 
infected with various strains of rotavirus. Viral dsRNA were then 
detected by electrophoresis on a 6% polyacrylamide gel and silver 
staining as described in Materials and Methods. The gene segments are 
indicated on the right. 
Lane A= RS 1; lane B= RS7; lane C= RS 12; lane D= OSU; lane E 
= UKtc; lane F= B223; lane G= RS2; lane H= RS9; lane I= RS8; 
lane J= RS6; lane K= RS3; lane L= RS5; lane M= RS4. 
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previous experiments, coinfections were performed using equal 
m. o. i. for each virus strain within a pair. In this set of experiments, the 
m. o. i. of UKtc was reduced to 0.1 pfu per cell involving crosses where 
UKtc was one of the coinfecting parent. The m. o. i. of 0.1 pfu per cell of 
OSU was used in crosses between OSU and B223 strains. No reassortants 
were identified among 127 plaques picked between various pairs of 
coinfecting viruses (Table 8). The UKtc was still found in most of the 
progeny clones when it was one of the coinfecting parent. However, there 
was slight increase in percentage of the progeny showing B223 RNA 
profile in OSU x B223 cross. 
7.4.3 Reassortant construction by superinfection 
Non-dominant parent in a coinfecting pair was superinfected to 
give it growth advantages to increase the probability of dual infection of 
the same cell, thereby increasing the chances of reassortants formation. In 
another set of experiments, the parents were coinfected at equal m. o. i. of 
5 pfu per cell. However, after incubation at 370C for 3 hr, the BSC-1 
cells were infected again with 106 pfu of B223 in crosses involving B223 
as one of the parent, and with 106 pfu of OSU in UKtc x OSU cross. No 
reassortant was identified out of 93 progeny clones derived from various 
crosses. However, following superinfection the relative % OSU and B223 
detected in the progeny clones slightly increased compared to the 
construction method where no selection pressure was applied (Table 8). 
7.4.4 Reassortant construction in MA104 cells 
The results from the above studies showed that reducing the m. o. i. 
of UKtc or superinfecting the non-dominant parent can slightly increase 
the % progeny showing their genotypes. It indicated that UKtc had some 
growth advantages in BSC-l cells. Because, UKtc had routinely been 
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grown in BSC-1 cells in our lab for the last 14 years, whereas the OSU 
or B223 strains were not grown that frequently. Assuming this to be the 
case, a different cell line, MA104, was chosen for coinfection as well as 
for picking progeny clones. MA104 cells were coinfected by different 
pairs of viruses at m. o. i. of 5 pfu per cell. The plaques were picked, 
propagated, and characterised. The UKtc was found in almost all the 
progeny clones (Table 8). 
7.4.5 In vivo reassortment 
Reassortants have been constructed by coinfecting mice with two 
different rotavirus strains (Gombold and Ramig, 1986; 1989; Broome et 
al., 1993) and then picking the plaques from a cell line that has been 
inoculated with intestinal homogenate from the coinfected mice. Seven 
day old seronegative suckling CD-1 pups were orally inoculated with 
5x106 pfu of each virus in a pair. At 24 hr p. i. all the pups were 
sacrificed and the entire intestines were removed. The intestines were 
frozen, thawed, minced, homogenised and sonicated. The intestinal 
homogenates from pups mixedly infected with various pairs of rotavirus 
were inoculated onto BSC-1 cell monolayer in a dilution to give well 
isolated plaques. The plaques were picked, propagated, and characterised 
as described in section 7.4.1. No reassortant was identified in any of the 
crosses. UKtc was found in the majority of the progeny clones (Table 8). 
7.4.6 Reassortant construction by using a preformed 
reassortant as one parent 
The reassortant virus RS6 was used as one of the parents in a cross 
with OSU strain. The progeny plaques all belonged to the reassortant 
parent genotype (Table 8). 
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7.4.7 Reassortant construction under antigenic selection 
pressure 
The passage one coinfected material (described in section 7.4.1) 
was incubated with 1: 100 dilution of monoclonal antibody or 
monospecific antiserum, either singly or in a mixture as shown in Table 
10 before being inoculated onto BSC-1 cell monolayers. In addition the 
monoclonal antibody or the antiserum was also added in the agar overlay. 
The monoclonal antibody #5632 ((x UKtc VP7) had a neutralisation titre 
(reciprocal) of > 2560 against homologous UKtc, whereas the 
monoclonal antibody # 4907 (a OSU VP7) had a neutralisation titre 
(reciprocal) of 1280-2560 against homologous OSU strain of rotavirus. 
The antiserum # 5925 (a UKtc VP4) had a neutralisation titre 
(reciprocal) of 160 against homologous UKtc. A few reassortants were 
identified. The number of various electropherotypes obtained is shown in 
Table 10. 
" All of the above experiments were conducted after activating the 
viruses with trypsin and also incorporating trypsin in the medium. 
Another set of experiments was conducted in which the trypsin was 
present only in the agar overlay medium. The coinfected virus inoculum 
was incubated with appropriate monoclonal antibodies (a UKtc VP4), 
which were also incorporated in the medium. The rationale was that only 
UKtc can form plaques in the absence of trypsin (McCrae and Faulkner- 
Valle, 1981) and the use of antibodies against VP4 of the UKtc would 
increase the chances of reassortant formation, as VP4 has been shown to 
be responsible for protease enhanced plaque formation (Kalica et al., 
1983). The progeny clones were picked, propagated, and characterised by 
usual methods. No reassortant was isolated. The summary of the various 
electropherotypes obtained is shown in table 10. 
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Table 10 : Summary of electropherotypes of clones derived under antigenic 
selection pressurea 
Parents Antibodies No. of 
clones 
UKtc OSU B223 Reassortant 
UKtc x OSU a UKtc VP7 75 21 53 1 
UKtc x OSU a UKtc VP4 84 25 57 2 
UKtc x B223 a UKtc VP7 67 62 2 3 
UKtc x B223 a UKtc VP4 48 43 5 
UKtc x OSU a OSU VP7 38 35 1 2 
OSU x B223 a OSU VP7 25 19 4 2 
UKtc x OSU a UKtc VP7 + 26 9 17 
a UKtc VP4 
UKtc x OSU a OSU VP7 + 27 20 5 2 
a UKtc VP4 
UKtc x OSUb a UKtc VP4 20 20 0 
aThe passage one coinfected material was incubated with 1: 100 dilution of monoclonal antibody or 
monospecific antiserum, either singly or in a mixture before being plated onto BSC-1 cells. The 
monoclonal antibody or monospecific antiserum were also added in the agar overlay. Plaques were 
randomly picked and the RNA profile determined by PAGE-SS. 
b trypsin was not used at any stage 
4ý 
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7.5 Genotypes of various reassortants 
A total of 22 reassortants were identified out of 1068 progeny 
clones picked by various methods. The 22 reassortants belonged to 15 
different genotypes (Table 9, Figure 35). Four different genotypes, 
resembling the genotypes of the reassortants, RS1, RS3, RS6, and RS8 
were isolated more than once. The reassortants RS2, RS3, RS 10, and 
RS 12 had a single band at the triplet. The origin of the VP7 gene of these 
reassortants was determined by restriction enzyme analysis of amplified 
cDNA copies in RT-PCR. 
In addition to the electropherotypes of the clones shown in tables 8 
and 10; 56 progeny showed 12 or more segments and 63 progeny clones 
did not show any band in the PAGE-SS. 
7.6 Discussion 
Three different rotavirus strains UKtc, B223, and OSU were used 
in pairs to construct rotavirus reassortants. Initially, no external pressure 
was exerted for the generation of reassortants. Ten reassortants were 
identified in more than 300 progeny clones. Four of these had identical 
genotype indicating that they may be the product of the same cell. 
Majority of the progeny showed UKtc parental genotype when it was one 
of the parents in the cross. OSU parental genotype was isolated in 
majority of the progeny in crosses between OSU and B223. Even after 
six blind passages, no more reassortants were identified in the progeny 
clones. The UKtc was dominant over OSU and B223, whereas OSU was 
dominant over B223parent. It was therefore, thought to apply some kind 
of external antigenic or non-antigenic selection pressure to suppress the 
growth of the dominant parent. Temperature-sensitive mutants have been 
used in some of the early rotavirus reassortant experiments (Greenberg et 
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al., 1981; Kalica et al., 1983). The genetic selection pressure, in the 
form of using a is mutant of the dominant parent and then selecting the 
progeny at non-permissive temperature, was not used in the present study 
because of three reasons. First, it has been reported that the is mutant 
interferes with the growth of wild-type virus (Ramig, 1983). Second, 
because all rotavirus is mutants have been selected following mutagenesis 
of wild-type virus, the potential exists for the presence of a non- 
temperature-sensitive mutation in these mutants and the associated 
problems of unexpected phenotypes with non-temperature-sensitive 
mutation (Rubin and Fields, 1980). Third, non-availability of is mutants 
for many of the gene segments of OSU, and B223 strains. 
Reducing the m. o. i. of the dominant parent slightly increased the 
percentage of the other parent genotype in the progeny clones. However, 
percentage of the progeny showing the genotype of the dominant parent 
was still very high. Moreover, no reassortants could be identified in the 
progeny clones. Superinfection with the non-dominant parent in a cross 
slightly increased progeny showing its genotype but did not tilt the 
percentage in its favour. However, no reassortant could be identified and 
the progeny clones showing the genotype of the dominant parent was still 
high. Rotavirus reassortants have been isolated by superinfecting with a 
second virus 24 hr after the first infection (Ramig, 1990). 
UKtc was still found in all the progeny clones even in MA 104 
cells. Host cell factors have been shown to play a significant role in 
selecting reassortants and parents even under conditions of single growth 
cycle and high m. o. i. of both parents (Graham et al., 1987). In crosses 
between UKtc and a human rotavirus with rearranged segments, UKtc 
was isolated in 7.4% plaques on BSC-1 cells and 34.3% on MA104 cells 
in the above studies conducted by Graham et al., (1987). The human 
rotavirus did not form any plaques on any cell lines and the remaining 
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were reassortants. They routinely used MA104 cells for growing their 
rotaviruses. Host cells were also shown to influence the origin of the 
segments from the parents in the reassortants. 
No reassortants could be isolated in in vivo experiments. Others 
have been successful in isolating reassortants in in vivo experiments 
(Gombold and Ramig, 1986; 1989; Broome et al., 1993). During the 
course of development of an animal model in the present study, very little 
infectious virus was isolated on most occasions 12 hr p. i. Gombold and 
Ramig, (1986) have reported that all clones were reassortants at 96 hr p. i. 
even though very little infectious virus was detected at that time by them. 
A method used to force selection of reassortants with desired 
genome segments which code for specific VP4 or VP7 proteins has been 
the treatment of the progeny of coinfection with monoclonal or polyclonal 
antibodies directed at the neutralisation proteins of coinfecting strains 
(Greenberg et al.,, 1981; Midthun et al., 1985; 1986; Urasawa et al., 
1986; Hoshino et al., 1987b; Broome et al., 1993). In the present study, 
the antigenic selection pressure resulted in the production of a few more 
reassortants. The percentage of the OSU genotype found in the progeny 
clones was higher than UKtc in the coinfection which were treated with 
antibodies specific for VP4 and/ or VP7 of UKtc and which were also 
included during plaque picking. However, percentage of the progeny 
clones showing B223 genotype did not increase dramatically when 
antibodies against the other coinfecting parent were used. The basis of 
this is not known. The progeny clones showing parental genotype against 
which the antibodies were used appear to be the breakthrough plaques 
and not neutralisation escape mutants. Because, some of them when 
tested by PRN were neutralised by the homologous antibodies. The titre 
of antibodies used for giving antigenic selection pressure may not have 
been high enough. 
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In some experiments where antibodies to VP4 and VP7 of UKtc 
were used in combination also gave similar results to those obtained when 
they were used singly i. e. percentage of the progeny showing OSU 
genotype was found to be higher than UKtc. However, when antibodies 
to OSU VP7 and UKtc VP4 were used simultaneously in OSU and UKtc 
crosses, more UKtc genotype was found in the progeny clones. 
The UKtc strain can form plaques even in the absence of trypsin 
(McCrae and Faulkner-Valle, 1981) whereas B223 and OSU strains can 
not form plaques in its absence. The UKtc has been reported not to form 
plaques in the absence of trypsin (Kalica et al., 1983). In all of the above 
experiments in the present study, the viruses were treated with trypsin 
prior to inoculation onto the cells and trypsin was also incorporated in the 
overlay medium. Another set of experiments was conducted in which 
trypsin was not used at any stage except in the agar overlay medium 
during plaque picking. However, the coinfected material was incubated 
with the antibodies to VP4 of UKtc which were also incorporated in the 
overlay medium. It was hoped that all the progeny plaques would contain 
VP4 of OSU. However, no reassortants were isolated. 
In another experiment, one preformed reassortant from the present 
study was used as one of the parents in a cross with OSU. However, only 
the reassortant parent genotype was observed in the progeny clones 
indicating that it is a stable reassortant. 
In the present study, only about 2% progeny clones out of more 
than 1000 plaques, picked from different methods of reassortant 
construction, were reassortants. Reassortant frequency varying from 0% 
to 100% in rotaviruses has been documented. Formation and detection of 
reassortants is probably most efficient when the coinfecting strains are 
closely related. This is expected since the genome segments or the 
proteins they encode must function together. Studies with influenza 
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viruses have indicated that more closely the gene products are related, the 
more likely a replacement will be tolerated (Klenk and Rott, 1988). In 
rotaviruses, no reassortant has been isolated between rotaviruses 
belonging to different rotavirus groups (Yolken et al., 1988). The 
progeny of coinfection between subgroup I and subgroup II rotavirus 
strains yielded comparatively smaller % reassortants, <1% (Urasawa et 
al., 1986), < 3.5 % (Garbarg-Chenon et al., 1984), or 14 % (Ward and 
Knowlton, 1989). In contrast, coinfection with cultured cells with 
different pairs of subgroup II human rotaviruses resulted in high % (33- 
48%) of plaque picked colony being a reassortant (Ward et al., 1988a). 
The reassortant frequency observed in the present study is very low even 
though the pairs of viruses used belonged to subgroup I. 
Reassortant frequency, between two serotype G3 strains, of 5% 
(Broome et al., 1993), and 38-100% (Gombold and Ramig, 1986) have 
been reported from in vivo crosses. No reassortant could be isolated from 
the in vivo crosses. It has been reported that no reassortant was detected 
among progeny clones examined from mixedly infected, homotypic 
immune mice. Whereas about 11 % were identified among progeny clones 
from mixedly infected, heterotypically immune mice. Reassortment was 
reduced more than 50-fold by homotypic immunity and approximately 
three fold by heterotypic immunity relative to the frequency observed in 
non-immune mice (Gombold and Ramig, 1986; 1989). The immune 
status of the pups cannot be the reason for not getting any reassortant, as 
the in vivo crosses were performed in seronegative animals. Reduced 
m. o. i. has been shown to affect the frequency of reassortment in vivo 
(Gombold and Ramig, 1989). However, sufficiently high m. o. i. of each 
parent was used in the present study in our in vivo crosses. 
Multiple blind passages have been shown to increase the 
reassortant frequency (Ward et al., 1988a) or replace the preformed 
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reassortants by one or the other parent when passaged in the presence of 
their parental viruses (Ward and Knowlton, 1989). However, the results 
of passage one and passage seven were not different in the present study. 
The reason for finding very less number of reassortants even under 
antigenic selection pressure could be due to the low neutralisation titre of 
the antibodies used. In the present study antibodies had been used both 
prior to inoculation onto the cells and in the overlay medium. It has been 
reported that addition of antibody to the progeny of coinfection prior to 
inoculation could result in the loss of most desired reassortants (Ward et 
al., 1988b). It is not known if that could be the reason for low 
reassortant frequency. It is also not known if reassortant exclusion 
occurred between the parents used. Superinfection exclusion and 
prevention of reassortment has been reported for blue tongue virus 
(Ramig et al., 1989; El Hussein et al., 1989). Finally, the author is not 
aware of any report in which pairs used in the present study have been 
used by others for construction of reassortants. Although they have been 
used as a parent independently with some other parent not used in the 
present study for reassortant construction e. g. B223 (Chen et al., 1989), 
OSU (Hoshino et al., 1987), and UKtc (Greenberg et al., 1981; Kalica et 
al., 1983; Midthun et al., 1985; 1986). 
Some of the other reasons of getting only 2% reassortants may be 
the inability to pick up the right kind of plaque, or the reassortants were 
never formed or they were formed but did not form a plaque because they 
were non-infectious or segments from one of the parents were selected 
because they are dominant as a group. 
The plaque size and morphology has been used for characterisation 
of rotaviruses (Kalica et al., 1983; Chen et al., 1989). However, 
different strains could not be differentiated on that basis, though the 
plaques formed by UKtc were more sharp. 
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In addition to the electropherotypes of the clones shown in tables 8 
and 10; 56 progeny showed 12 or more segments and 63 progeny clones 
did not show any band in the PAGE-SS. However, they were excluded 
while calculating the reassortant frequency. Most of the PAGE-SS 
negative clones belonged to the category where no CPE or very little 
CPE was observed at the end of 5 day incubation at 370C in 24 wells. 
One reason can be that the plaques were missed while picking from the 
agar overlay. However, some of these PAGE-SS negative clones were 
positive for VP7 amplification in RT-PCR. The RT-PCR has been 
reported to be 105 times more sensitive than PAGE-SS for detection of 
rotavirus (Xu et al., 1990). A few of them showed rotavirus specific 
RNA profile in PAGE-SS after three passages in BSC-1 cells. However, 
no attempt was made to propagate the remaining PAGE-SS negative 
clones as the main aim was to screen large number of clones. Therefore, 
there is a chance that some of these PAGE-SS negative clones might have 
turned out to be a reassortant when tested later after growing them to 
higher titres. PAGE-SS negative clones have been reported by others also 
(Gombold and Ramig, 1986). 
Isolates containing more than 11 segments have been reported 
(Lourenco et al., 1981; Spencer et al., 1983; Garbarg-Chenon et al., 
1984; Nicolas et al., 1984; Gombold and Ramig, 1986). These may 
represent progeny of two different clones or an intermediate step in the 
establishment of a stable reassortant (Garbarg-Chenon et al., 1984). 
Some of the progeny clones containing more than 11 segments were used 
to pick progeny clones. Some of the reassortants were obtained in this 
way. 
The number of reassortants obtained is very small to apply some 
statistics. However, a few points are obvious. Although gene 4 has been 
related to growth restriction of rotaviruses in cultured cells (Greenberg et 
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al., 1983a), it did not always come from the better growing parent. The 
gene 4 from OSU was present in all the reassortants except one, in UKtc 
x OSU cross, although UKtc was observed to be the dominant and better 
growing parent. Similar findings have been reported by others (Ward et 
al., 1988a). Gene segment 4, and 5 never came from B223, however, 
gene 5 was derived almost equally from UKtc or OSU. The VP7 gene 
never came from OSU. Among the remaining separable segments, the 
segments from all three parents were represented at least once. The origin 
of the VP7 gene of reassortants that had a single band at the triplet was 
determined by restriction enzyme analysis of amplified cDNA copies in 
RT-PCR. The reasons of migration of the segments 7 and 9 different than 
their parents could be due to the rearrangement phenomenon (Tian et al., 
1993) and needs further investigations. Reassortment is a random 
process. However, non-random selection of single gene as well as gene 
association have been reported (Gombold and Ramig, 1986; Graham et 
al., 1987; Ward et al., 1988a). 
7.7 Conclusions 
Very few rotavirus reassortants could be identified between the 
pairs of rotaviruses used to generate them indicating that reassortment is a 
random process and the reassortment frequency depends upon the parents 
used. 
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Chapter 8 
Mapping of rotavirus virulence to its gene(s) 
8.1 Introduction 
The 22 monotypic reciprocal reassortants that had been sought as a 
first step to segregate rotavirus virulence to individual gene(s) in animal 
studies could not be obtained, from any of the crosses with three different 
pairs of rotavirus parents. Despite genotyping more than 1100 progeny 
clones, it was possible to identify only 22 reassortants, and these 
belonged to 15 different genotypes (Table 9; chapter 7). Published reports 
on rotavirus virulence are scanty, the VP4, or VP5 are considered to be 
important candidates in those reports. Therefore, reassortants containing 
VP4, VP5, or VP7 genes were selected for virulence mapping studies, 
which are described in this chapter. 
8.2 Results 
The reassortants, RS 1, RS2, RS3, RS4, RS5, RS6, RS8, RS 10, 
and RS12, were chosen to conduct the virulence mapping studies. The 
genotype of these reassortants can be seen in Table 9 of chapter 7. The 
reassortants were purified plaque to plaque three times in BSC-1 cells 
before being grown into high titre stocks for use in the virulence studies. 
Seronegative litters of 7 day old suckling CD-1 pups were orally 
inoculated with 107 pfu per pup of the reassortant viruses or control 
preparations derived from uninfected cells administered in an equal 
volume. At various times post inoculation the animals were examined for 
the clinical signs of the diarrhoea. At each time point a pair of pups was 
sacrificed and examined for internal signs of disease. Also, the entire gut 
was aseptically collected in PBS for infectivity titration and determination 
of RNA profile. 
The induction of the diarrhoea by three different reassortants RS 1, 
RS4, and RS5 obtained from the OSU x B223 cross, was similar to that 
of OSU parent. These three reassortants had the gene 4 from OSU parent 
on a B223 background. In addition to the OSU gene 4, the RS4 had the 
OSU gene 5, and reassortant RS 1 had both genes 5 and 6 from OSU on 
B223 background. The onset of diarrhoea occurred at 24 hr p. i. and 
reached a peak at 36 hr p. i. in RS1, and on day 2 in other two 
reassortants (Figure 36), when 100% pups showed overt (+3) diarrhoea. 
The diarrhoea observed was bright yellow and opaque. Post mortem 
revealed distension of the colon and yellow coloured liquid faeces. The 
duration of diarrhoea observed with all three reassortants was four days, 
i. e. from day 1 through day 4 p. i. The RNA profile of all the three 
reassortants determined from the intestinal homogenates of pups 
sacrificed on day 2 either directly or after passaging once in BSC-1 cells, 
was identical to the respective inoculated reassortant profile (data not 
shown). 
The induction of diarrhoea by reassortants derived from OSU x 
UKtc crosses is shown in Figure 37. The diarrhoea induced by the 
reassortants containing gene 4 of OSU on UKtc background (RS8, RS 10) 
or OSU gene 4 on OSU background with VP6 and VP7 from UKtc 
(RS 12) was similar to the OSU strain. The diarrhoea started at 24 hr p. i. 
and reached a peak at 36 hr p. i. The duration of diarrhoea was three days 
in RS10 or four days (in RS8, and RS12 ). Overt diarrhoea (+3) was 
observed on day 2 and day 3, and diarrhoea of considerable severity (+2) 
was observed on day 1 and day 4. The colon was distended containing 
liquid faeces. However, in the reassortant RS3 which had VP4, VP7 and 
gene 5 from UKtc on the OSU background behaved like UKtc parent in 
its induction of diarrhoea in CD-1 suckling pups. The colon was less 
distended and contained semiformed faeces. The RNA profile of the 
inoculated material and of the RNA obtained from day 2 intestinal 
homogenates was identical for each reassortant virus (data not shown). 
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Figure 36 : Diarrhoea produced by rotavirus reassortants derived from 
OSU x B223 cross. 
Seronegative 7 day old suckling CD-1 pups were orally inoculated with 107 
pfu of various rotavirus reassortants derived from OSU x B223 cross on day 
0. At various times post inoculation over the next 6 day period, the animals 
were examined for the clinical signs of diarrhoea. At each time point post 
inoculation a pair of pups was sacrificed and examined for internal signs of 
disease. Plotted are the mean from 2 experiments and in each experiment rn = 
5-8. The standard deviation for various values ranged from 0-7.6. 
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Figure 37 : Diarrhoea produced by rotavirus reassortants derived froiu 
OSU x UKtc cross. 
Seronegative 7 day old suckling CD-1 pups were orally inoculated with 1O7 
pfu of various rotavirus reassortants derived from OSU x tJKtc cross on day 
0. At various times post inoculation over the next 6 day period, the animals 
were examined for the clinical signs of diarrhoea. At each time point post 
inoculation a pair of pups was sacrificed and examined fror internal signs Of 
disease. Plotted are the mean from 2 experiments and in each experiment n 
5-8. The standard deviation for various values ranged From 0- 6.4. 
165 
The diarrhoea induced by the reassortants from the B223 x UKtc cross 
was similar to the UKtc parent (Figure 38). The RNA profile of the 
inoculated material and that obtained from the intestinal homogenates at 
day 2 was identical to respective reassortant (data not shown). 
The infectivity titration with all the reassortants revealed that the 
inoculated material rapidly disappeared from the gut. No replication of 
the virus was observed though a minor increase was observed at 12 hr 
p. i. or 24 hr p. i. similar to that observed with parent strains (data not 
shown). 
8.3 Discussion 
Analysis of co-segregation of genome segments with biological 
phenotype in reassortants has been the method of choice for mapping 
gene function in viruses with segmented genomes. In these studies the 
phenotype has generally been seen to segregate with one segment or some 
constellations of genome segments. Reassortants are generated between 
two parent viruses by coinfection and the parental origin of gene is 
determined. If a group of reassortants are examined that all possess the 
phenotype of interest, the genome segment responsible for that phenotype 
must be present in all the reassortant progeny clones and the parent which 
show that phenotype. Conversely, a group of reassortants lacking that 
phenotype will always derive one segment from the parental virus that did 
not display that phenotype. Two requirements must be met if the 
segregation analysis is to successful. First, the phenotype of the parental 
viruses must be distinguishable. This was established in chapter 5. 
Second, the genotype of the parents be different. This was established in 
chapter 6. 
The desired 22 monotypic reciprocal reassortants could not be 
obtained, from crosses with three different pairs of viruses, for carrying 
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Figure 38 : Diarrhoea produced by rotavirus reassortants derived from 
UKtc x B223 cross. 
Seronegative 7 day old suckling CD-1 pups were orally inoculated with IO7 
pfu of' various rotavirus reassortants derived from I.! Ktc x 13223 cross on day 
0. At various times post inoculation over the next 6 day period, the aniinals 
were examined for the clinical signs of' diarrhoea. At each time j)OIit lust 
inoculation a pair of pups was sacrificed and examined for internal signs ()I, 
disease. Plotted are the mean from 2 experiments and in each experiment ºº 
5-8. The standarddeviation for various values ranged from 0-4.2. 
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out a complete segregation analysis of virulence phenotype of rotaviruses. 
However, the construction of one set of 11 monotypic reassortants by 
substitution of one segment at a time from the avirulent DS-1 strain on 
the background of the virulent SB-lA rotavirus strain for virulence and 
immune response studies has recently been reported (Hoshino and 
Kapikian, 1994). In the absence of the desired 22 monotypic reciprocal 
reassortants, the reassortants carrying VP4, VP5, or VP7 substitutions 
were chosen for conducting virulence mapping studies. 
The OSU strain was found to be more virulent than UKtc or B223 
strains of rotaviruses (chapter 5). The OSU gene 4 was found to confer 
the virulence phenotype of OSU to B223 strain (Figure 36). The presence 
of gene 5 did not affect the virulence. Similarly, the OSU gene 4 on UKtc 
background segregated with the virulence phenotype of OSU, whereas the 
reassortant containing gene 4 from UKtc on OSU background behaved 
like UKtc parent (Figure 37). This reassortant also had gene 5, VP7 gene 
from UKtc. Another reassortant (RS12) which had only VP6 and VP7 
from UKtc on OSU background behaved like OSU parent. This indicates 
that gene 4 of the OSU strain is heavily involved, if not wholly 
responsible for determining its virulence phenotype. 
Rotavirus gene 4 has been associated with its virulence in animal 
studies (Offit et al., 1986; Bridger et al., 1992; Burke et al., 1994a; 
1994b; Hoshino and Kapikian, 1994; Ijaz et al., 1994). The gene 4 has 
also been implicated with rotavirus virulence indirectly due to the 
observed differences in the gene 4 of rotaviruses isolated from 
symptomatic and asymptomatic children by electropherotyping (Parez- 
Schael et al., 1984), RNA: RNA hybridisation (Flores et al., 1986), and 
sequence analysis (Gorziglia et al., 1986; 1988b). VP4 has also been 
found to have several biologically important properties that might be 
linked to virulence. The cleavage of VP4 by trypsin into VP5* and VP8* 
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enhances infectivity in vitro (Clark et al., 1981; Espejo et al., 1981; 
Estes et al., 1981) by facilitating the entry of rotaviruses into the cells 
(Fukuhara et al., 1988; Kaijot et al., 1988). VP4 is the viral 
haemagglutinin, involved in neutralisation, growth restriction in cell 
culture, and is important in protease-enhanced plaque formation 
(Greenberg et al., 1983a; Kalica et al., 1983; Offit and Blavat, 1986). 
However, genes other than gene 4 have also been shown to be 
associated with rotavirus virulence. The gene 3, gene 10, and the gene 
encoding VP7 have all been shown to play an independent role in 
virulence of a porcine rotavirus in its natural host (Hoshino and Kapikian, 
1994). The VP4 and VP7 genes were not found to be primarily 
responsible for virulence in the mouse model using homologous murine 
rotavirus. Rather, gene 5 followed by gene 7 (encoding NS 35) were 
found to be the main determinants of murine rotavirus virulence. 
However, this association was not absolute, as many reassortants had 
gene 5 or gene 7 from murine rotavirus and yet behaved like simian 
parent used in these crosses (Broome et al., 1993). This is in contrast to 
another recent study in which the murine rotavirus VP4 was reported to 
be associated with virulence (Ijaz et al., 1994). Also, though the 
virulence was seen to segregate with four different genes independently in 
porcine rotavirus in its natural host, neither gene 5 nor gene 7 were found 
to be associated with virulence (Hoshino and Kapikian, 1994). Similarly, 
whereas single monotypic reciprocal reassortants of gene 4 from SA 11 
and NCDV rotaviruses were observed to be associated with virulence 
phenotypes of their respective parents, single monotypic reassortant 
containing gene 5 of NCDV did not confer it the virulence phenotype of 
NCDV rotavirus in mouse (Offit et al., 1986). However, Broome et al., 
(1993) observed that the reassortant containing gene 4 and gene 5 of RRV 
on murine rotavirus (EDIM-RW) background behaved like RRV, whereas 
169 
the reassortant containing gene 4 only from RRV behaved like murine 
rotavirus parent. Besides the association of single genes, a combination of 
two genes has also been reported to be statistically associated with 
virulence. Broome et al., (1993) observed that the gene pair 5+2 to be 
strongly associated with virulence. This pair was found to be present in 
all fully virulent parents but was found to be absent in the intermediate 
reassortant which showed DD50 similar to EDIM-RW but did not spread 
as EDIM-RW. Another pair 5+7 was also found to be strongly 
associated with virulence. However, this pair was also found in the 
intermediate reassortant as well as many non-virulent reassortants. 
Recently, while implicating gene 4 in the pathogenicity of a 
porcine rotavirus, it was reported that a cell culture grown porcine 
rotavirus became highly pathogenic during serial pig to pig passage due 
to a single as change from a hydrophilic residue, glutamine to a 
hydrophobic residue, leucine at residue 469 (Burke et al., 1994a). This 
virus was reported to be adapted to cell culture from the faeces of a 
diarrhoeic pig. The residue at 469 of gene 4 from the original faeces 
would have shown if it became attenuated during initial adaptation in cell 
culture. This is important because after pig to pig passage, the virus was 
readapted to cell culture and still retained the mutation at residue 469. It 
would be interesting to see if the readapted cell culture virus after 
retaining the mutation is still pathogenic to the same extent in piglets. 
This point mutation at residue 469 also implies that rotavirus causing the 
asymptomatic infection should have glutamine at residue 469 instead of 
leucine. However, this does not appear to be the case. Moreover, it has 
been reported that the VP4 of the standard strain of NCDV (Cody) which 
is virulent for cows differs in only one as (23, Gln to Lys) from the VP4 
of a NCDV mutant (RIT 4237, Lincoln) which is attenuated for both 
cows and children (Nishikawa et al., 1988). 
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The reassortant containing VP7 from B223 on UKtc background 
(Figure 38) behaved like the UKtc parent. The VP7 of B223 has been 
shown to give replication advantages in vitro (Xu and Woode, 1994) and 
may affect the phenotype (Chen et al., 1989), and antigenicity of VP4 
(Chen et al., 1992). However, the VP7 of B223 was not found to affect 
the segregation of virulence phenotype with VP4 on either UKtc 
background (see reassortant RS6, Figure 38), or OSU (see reassortant 
RS4, Figure 36) in the present study. 
The host range restriction which is associated with the spread of 
the virus amongst the population, has been suggested not to be entirely 
related with virulence. The gene 5, and not the genes encoding VP4 or 
VP7, was indicated to be involved in host range restriction (Broome et 
al., 1993). The support for this observation also comes from the recent 
identification and characterisation of asymptomatic human rotavirus 
strains isolated from neonates in India, which had sequence homology 
with B223 VP4 and VP7 (Sukumaran et al., 1992; Das et al., 1993; 
Dunn et al., 1993) but with gene 5 representative of human rotavirus. 
The gene 5 selection of human rotavirus type over bovine rotavirus type 
presumably helped the Indian strains to survive and circulate in the 
population, albeit asymptomatically without causing disease. In the 
present study OSU gene 4 which segregated with virulence was not found 
to be the determinant of host range restriction as the reassortants with 
OSU gene 4 did not spread to the uninoculated pups housed in the same 
cages. 
8.4 Conclusions 
Gene 4 of OSU and UKtc strains was found to cosegregate with 
rotavirus virulence among the separable segments. Segment 5 of OSU 
and segments 5, and 8 of UKtc strains may also be involved in virulence. 
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Chapter 9 
Studies on murine rotaviruses 
9.1 Introduction 
When this project was started, it was planned to conduct mapping 
studies on rotavirus virulence with murine rotaviruses in a homologous 
system. However, murine rotaviruses could be obtained only after a 
considerable length of time. This chapter describes various experiments 
conducted with them. 
9.2 Results 
Murine rotavirus, EDIM, obtained from Professor R. Ward, James 
N. Gamble Institute of Medical Research, Cincinnati, Ohio, USA, was 
grown in BSC-1 cells. Very little CPE was evident. Amplification of the 
VP7 gene on RNA extracted from passage one in BSC-1 cells by RT- 
PCR gave a very weak band. The RNA profile determined by PAGE-SS 
also gave very weak bands. Five additional blind passages were given 
before testing again for the presence of rotavirus specific RNA. The 
amplification of VP7 gene in RT-PCR and RNA profile of the RNA 
extracted at fifth passage became negative for rotavirus specific RNA. 
Adaptation of EDIM strain in MA104 cells also was negative as evident 
by CPE, RT-PCR amplification, and PAGE-SS. The EDIM strain also 
did not form any plaques in either BSC-1 or MA104 cells. 
The original material obtained was also orally inoculated (100 µl) 
into a7 day old suckling CD-1 pup. The pup was sacrificed 48 hr p. i. 
and gut collected in 2 ml of PBS. After freeze-thawing, homogenisation, 
sonication, centrifugation, this intestinal homogenate was used for a 
number of experiments. It was used for two additional mice to mice 
passages, as inoculum to infect BSC-1 and MA104 cells, as well as for 
extracting viral RNA. 
The RNA extracted from intestinal homogenates was used to 
determine the RNA profile (Figure 39) and for amplification of the gene 
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Figure 39 : Electrophoretic profile of genomic RNA of li l)lM separated 
on polyacrylamide gel and silver stained. 
Viral RNA was extracted by the optimised method from BSC-1 cells (i) 
infected with various strains of rotavirus or (ii) lipofected with Et)IM strain. 
Viral dsRNA was then fractionated by electrophoresis un 6% poýlyacrylanuide 
gel and detected by silver staining as described in Materials and Methods. 
Segment numbers are shown on right. 
Lane A= EDIM; lane B= OSU; lane C= UKtc; lane D= B223. 
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encoding VP7 in RT-PCR (Figure 40). By comparison of the RNA 
profile between EDIM and other non-murine rotavirus strains, 7-8 gene 
segments could be differentiated (Figure 39). It was not possible to 
differentiate the parental origin of segments 2,3, and 8 between EDIM 
and UKtc or B223 strains. In addition to above segments, parental origin 
of gene segment 9 could not be distinguished between EDIM and UKtc. 
All segments except 2,8,9, and 10 between EDIM and OSU strains 
could be differentiated using PAGE-SS (figure 39). The amplified VP7 
gene cDNA of EDIM was found to contain an EcoR V and h at'lll 
endonuclease site but not a BamHI endonuclease site. PAGE-SS, and RT- 
PCR followed by restriction enzyme digestion of amplified cDNA copies 
of the gene encoding VP7, were used to genotype the progeny clones 
obtained from EDIM x UKtc cross for reassortant construction. The 
BSC-1 or MA104 cells inoculated with the intestinal homogenates from 
passage one in mice did not show any CPE or rotavirus specific RNA in 
either PAGE-SS or RT-PCR. The intestinal homogenate from passage 
three (M3) in mice was inoculated at various dilutions into 7 day old 
suckling CD-1 pups which were observed for the development of clinical 
signs of disease. The onset of diarrhoea in pups inoculated with M3 
occurred on day 2 p. i. and reached a peak on day 4 when 100% pups 
were found to be suffering from overt (+3) diarrhoea (Figure 41). 
Diarrhoea induced in pups inoculated with various 10-fold dilutions of 
M3 started on 3 day p. i., reached a peak on day 4 p. i., and could he 
observed on day 5 p. i. in all dilutions except 10-3 dilution of M3 (Figure 
41). 
Liposome mediated transfection of rotavirus (Bass et al., 1992a) to 
remove the block at the level of plasma membrane penetration in non- 
permissive cells has been described. Because the EDIM was found not to 
replicate in BSC-1 or MA104 cells when inoculated, a strategy was 
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Figure 40 : Restriction enzyme digestion patterns of cDNA copies of the 
gene encoding VP7 of EDIM and EBR strains of rotavirus. 
The gene encoding VP7 was amplified using RT-PCR on RNA extracted by 
optimised method from BSC-1 cells lipofected with either EDIM or EI3R 
strains of rotavirus and digested by different restriction endonucleases. 
Following digestion, restriction fragments were seperated by clectrohhoresis 
on a 1.5% agarose gel which was then stained with ethidium bromide. 
Lane A= Adeno control; lane B= EDIM VP7 gene control; lane C= 
EDIM+BarnH1; lane D= EBR+BamHI; lane E= EDIM+EcoRV; lane F 
= EBR+EcoRV; lane H= EDIM+HaeIII; lane G= EBR+Hae111; lane I 
= EBR VP7 gene control; lane M= ladder of DNA size markers. 
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Figure 41 : Diarrhoea produced by EDIM in 7 day old suckling CI)-I 
pups. 
Seronegative 7 day old suckling CD-1 pups were orally inoculated with 
various dilutions of 3rd mouse passage EDIM on day 0. At various times 
post inoculation over the next 6 day period, the animals were examined for 
clinical signs of diarrhoea. At each time point post inoculation a pair of, pups 
was sacrificed and examined for internal signs of disease. Plotted are the 
mean from 2 experiments and in each experiment n= 5-8. 
M3 = EDIM passage 3 in 7 day old suckling CD-1 pups; M31,1 = 10-1 
dilution of M3; M3L2 = 10-2 dilution of M3; M3L3 = 10-3 dilution of 
M3. The standard deviation for various values ranged from 0-2.1. 
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planned for liposome mediated transfection. The intestinal homogenates 
obtained from EDIM infected pups when lipofected onto BSC-1 cells 
induced CPE. The RNA extracted from the lipofected BSC-1 cells 
extracted either by phenol/ ethanol or the optimised method (see chapter 
5) showed the presence of rotavirus specific RNA in RT-PCR and PAGE- 
SS. 
No reassortants were obtained from EDIM x UKtc cross by three 
different methods of reassortant construction. CD-1 pups were inoculated 
mixedly with EDIM and UKtc strains per os and sacrificed 24 hr p. L The 
intestinal homogenates obtained from mixedly infected CD-1 pups 
inoculated/ or lipofected onto BSC-1 cells gave no plaques. The EDIM 
and UKtc strains lipofected simultaneously onto BSC-1 cells also did not 
give any plaques. The RNA extracted from intestinal homogenates 
obtained from mixedly infected pups, or from the BSC-1 cytoplasmic 
extracts lipofected with EDIM and UKtc strains, showed only EDIM 
RNA profile. In another experiment, 34 plaques picked from the BSC-1 
cells coinfected with EDIM and UKtc strains showed only UKtc RNA 
profile. 
Another murine rotavirus (EBR) obtained from Birmingham, UK, 
was inoculated into CD-1 pups. The intestinal homogenate obtained was 
lipofected onto the BSC-1 cells and RNA was extracted. The RNA profile 
of EBR strain was found to be different from EDIM strain in that the 
EBR had two bands at 7-8-9 triplet whereas EDIM had only a single 
band. Also the gene segment 2 and 3 were closely migrating in EBR as 
compared to EDIM strain (data not shown). The VP7 gene of EBR was 
found to be different to EDIM strain as revealed by endonuclease 
digestion of the PCR amplified product. The amplified VP7 gene copies 
of cDNA has BamHI and EcoRV sites which were different to EDIM, but 
had an identical HaeIII restriction enzyme digestion pattern (Figure 40). 
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genes encoding VP7 of EDIM and EBR strains were sequenced and the 
deduced amino acid sequences determined. Comparison of the deduced 
amino acid sequence of the first 130 residues of VP7 of EDIM and EBR 
strains showed 41 to 67 % and 41 to 65 % identity, respectively with the 
14 G serotypes (Table 11). The amino acid identity between EDIM and 
EBR strains in the first 130 residues of VP7 was 72%. When deduced 
amino acid sequence of the strains used in the present study were 
compared with previously published five murine rotavirus strains, or 
prototype G3 serotype - SA11 strain, differences were observed over the 
entire sequence as well antigenically important region A (Figure 42). 
9.3 Discussion 
The RNA extracted from passage one in BSC-1 cells showed a 
very weak rotavirus specific RNA in RT-PCR and PAGE-SS, whereas 
the subsequent passages in BSC-1 or MA104 cells became negative for 
rotavirus specific RNA. The carryover RNA present in the original 
material used as inoculum might be responsible for the positive reaction 
in the first passage and there might be some block at the level of plasma 
membrane penetration in subsequent passages in the cultured cells. The 
RNA extracted from the intestinal homogenates from passage one in mice 
showed the presence of rotavirus specific RNA. However, when the 
intestinal homogenate was inoculated onto the BSC-1 or MA104 cells no 
rotavirus specific RNA was evident. The block of EDIM at the plasma 
membrane penetration in cultured cells proved to be the case as the 
lipofected intestinal homogenate gave CPE as well as the extracted RNA 
showed the presence of rotavirus specific RNA in PAGE-SS and RT- 
PCR. Rotaviruses have been shown to replicate in non-permissive cells as 
efficiently as in permissive cells when the block at the plasma membrane 
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Table 11 : Amino acid sequence identities between the first 
130 amino acids of VP7 of murine rotavirus strains and 
strains representing various G serotypes 
G Type 
% identity t 
Strain 
o VP7 of murine 
EBR 
rotavirus strains 
EDIM 
1 Wa 56 (75)a 58 (78)a 
2 hu5 52 (75) 54 (74) 
3 SA11 65 (83) 67 (85) 
4 St3 55 (77) 59 (78) 
5 OSU 64 (83) 65 (82) 
6 UKtc 61(79) 61(81) 
7 Ch2 41(60) 41(65) 
8 69M 57 (78) 61(78) 
9 Wi61 62 (82) 65 (81) 
10 B223 58 (76) 58 (75) 
11 YM 1 60 (79) 64 (80) 
12 L26 57 (76) 59 (78) 
13 L338 57 (77) 58 (79) 
14 F123 58 (82) 63 (83) 
EBR 72 (87) 
a numbers in parentheses indicate % similarity 
The sequence data necessary to construct this Table was taken from 
relevant enteries in the EMBL database. Sequence analysis was done by 
Genetics Computer Group set of programmes (Devereux et al., 1984) 
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Figure 42 : Comparison of the deduced amino acid sequence (first 130 
residues) of VP7 of EDIM and EBR murine rotaviruses. 
Murine rotaviruses EDIM and EBR are compared to murine rotavirus 
strains EW, EB, EHP, EC, and EL and the G3 prototype - SA 11. Amino 
acid residues that are identical to that of EW are shown as dashes (-). 
Gaps in the sequence of EBR are shown by asterisk (*). 
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penetration was removed by liposome mediated transfection (Bass et al., 
1992a). 
The onset and peak of diarrhoea induced by EDIM was found to 
be delayed by 24 hr, when compared with heterologous rotavirus strains. 
However, the induction of diarrhoea by EDIM strain in pups was similar 
to that reported by other investigators (Sheridan et al., 1983; Eydelloth et 
al., 1984; Starkey et al., 1986). In the absence of plaque formation in 
cultured cells (Greenberg et al., 1986), the virus was titrated by mouse 
infectious dose 50% as described by Broome et al., (1993). The EDIM 
strain was found to be infectious even at 1000-fold dilution (Figure 41). 
The attempts to map rotavirus virulence using EDIM in a 
homologous system were not successful as no reasortants could be 
obtained in crosses between EDIM and UKtc. Broome et al., (1993) were 
also unable to identify any reassortant between RRV x EW cross in vitro. 
However, they were able to identify about 5% reassortants from 450 
progeny clones in RRV x EW cross in vivo. In the present study, all the 
34 progeny clones obtained by coinfection of BSC-1 cells with EDIM 
and UKtc strains showed the UKtc genotype, when analysed by PAGE-SS 
and RT-PCR. No plaques were obtained either when the intestinal 
homogenates obtained from mice mixedly infected with UKtc and EDIM 
strains were inoculated onto the BSC-1 cells or when BSC-1 cells were 
mixedly lipofected with UKtc and EDIM strains. The RNA profile 
determined from the intestinal homogenates from mixedly infected pups 
or cytoplasmic extracts of BSC-1 cells mixedly lipofected with EDIM and 
UKtc strains did not show mixed profile, but only EDIM profile. The 
reason for this is not known. The murine rotavirus somehow suppressed 
the replication of UKtc. 
In the absence of getting any reassortants from a cross between 
EDIM and UKtc strains for mapping rotavirus virulence, it was 
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considered to correlate rotavirus virulence indirectly to its genes by 
sequence analysis. Conflicting reports about virulence of murine rotavirus 
have recently been published (Broome et al., 1993; Ijaz et al., 1994). 
The VP7 gene of EDIM and another murine rotavirus strain EBR were 
amplified by RT-PCR. Their amplified VP7 gene appeared to be different 
in BamHI and EcoRV restriction endonuclease pattern. However, their 
HaeIII restriction pattern was same. Similar HaeIII endonuclease pattern 
of the VP7 gene of a murine strain has recently been documented 
(Gouvea et al., 1993). The comparison of the deduced amino acid 
sequence of the first 130 residues of VP7 of EDIM and EBR strains 
showed only 72% identity. This region contains one of the three regions 
(region A; as 87-101) that is known to be involved in neutralisation based 
on mapping the sequence changes in neutralisation escape mutants (Dyall- 
Smith et al., 1986; Mackow et al., 1988b; Taniguchi et al., 1988b). Both 
the sequences were also found to be different from the recently published 
sequences (Dunn et al., 1994) of various murine rotavirus strains. 
Differences were also observed in region A (aa 87-101) among murine 
strains used in the present study and the previously published five murine 
strains (Dunn et al., 1994) as well as G3 prototype (SA 11 strain). 
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Chapter 10 
General discussion 
10.1 Rotavirus virulence :a perspective 
Rotaviruses are the single most important etiological agents of 
severe diarrhoea in infants and young children, as well as in the neonates 
of most mammalian and avian species, in both developed and developing 
countries. The World Health Organisation has identified the development 
of a rotavirus vaccine as a priority area for routine childhood 
immunisation to control rotavirus infections. However, the candidate 
vaccine strains employed to-date have not been very successful due to 
their inability to induce heterotypic immunity. This may be because of the 
multiplicity of serotypes (Hoshino and Kapikian, 1994), resulting from 
the independent segregation of VP4 and VP7 genes (Hoshino et al., 
1985; Offit and Blavat, 1986) responsible for determining serotype 
specificity in rotaviruses. The number of potential serotypes predicted by 
reassortment and cross-neutralisation studies may increase due to masking 
and unmasking of some of the neutralising epitopes (Chen et al., 1992; 
Kool et al., 1992). 
There has been a recent resurgence of interest in the pathogenesis 
of viral infections. The application of molecular methods has made it 
fruitful to re-examine old questions and to ask new ones about the 
determinants of the outcome of the virus-host encounter. The role of 
virus virulence has been one of the major questions explored during this 
renaissance of work on viral pathogenesis. Studies on rotavirus virulence 
will not only help in developing better vaccines, but may also provide a 
' direction for developing antivirals as an alternative strategy for the 
control of rotavirus induced diarrhoea. 
At the start of this project, there was only single report (Offit et 
al., 1986) of work conducted directly on animals. The lack of a suitable 
animal model and the inability to manipulate a gene in vitro and then to 
rescue it into an infectious particle were both identified as major 
limitations to studies on virulence. The aims of this project were 
designed to overcome these limitations to obtain a clearer picture of 
rotavirus virulence. A three step approach was undertaken (i) 
development of an animal model, (ii) construction and characterisation of 
reassortants between rotavirus strains of different virulence, (iii) mapping 
of virulence to specific rotavirus gene segments. 
The mouse model developed in the present study (chapter 5) 
revealed that virus virulence is dependent upon viral dose and viral strain 
in addition to host age and host strain. Mouse models for studying 
rotavirus disease and immune response has been used previously for both 
homologous (Wolf et al., 1981; Little et al., 1982; Sheridan et al., 1983; 
Eydelloth et al., 1984; Greenberg et al., 1986; Starkey et al., 1986), and 
heterologous rotavirus strains (Offit et al., 1984; Gouvea et al., 1986; 
Ramig, 1988; Ward et al., 1990). However, with the exception of one 
study (Ramig, 1988), the other studies were not carried out in a very 
systematic and/or comprehensive fashion. In majority of the cases, 
rotavirus antigen detection in the intestines, and seroconversion were 
taken to represent disease. These parameters only represent infection 
rather than disease. It was clearly demonstrated in the present report that 
adult mice can be infected (adult mice seroconverted) without getting any 
disease. Consequently, observations of the clinical signs of the disease 
should be taken as the end point in virulence studies on rotavirus in 
animal models, which may be supported by seroconversion, virus 
shedding, detection of antigen in intestines, and histopathology. 
Two sets of experiments, one in which different rotavirus strains 
were studied in the same strain of mouse, and another in which the same 
rotavirus strain was studied in different strains of mouse, revealed that 
virulence in this virus system is not tightly linked to host susceptibility. 
The outcome of rotavirus infection was found to depend on the interaction 
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of virus virulence and host resistance/ susceptibility. Also, the duration of 
disease, the percentage of pups affected, and the severity of disease were 
all found to be independent variables of rotavirus virulence. For example, 
the bovine rotavirus B223 strain failed to produce diarrhoea in C57/BL 
pups, whereas the porcine rotavirus OSU strain was able to produce 
diarrhoea in them. By contrast in C3H/HE pups, the B223 strain 
appeared to affect a higher percentage of pups than the OSU strain. 
However, the severity of the disease was only +1 in majority of the pups 
infected with the B223 strain, whereas with the OSU strain the diarrhoea 
induced varied between +2 to +3 (overt diarrhoea), and was observed 
for longer duration. 
The disease induced by the rotavirus strains employed was quite 
different in the three inbred mice strains that were studied in the present 
project. It is not known at present whether MHC haplotype has any 
influence on the outcome of rotavirus infection. The role of MHC 
haplotype is very important in CMI (Zinkernagel and Doherty, 1974). 
The present study also indicates that protection studies with rotavirus 
vaccine candidates should be done or at least compared in the outbred 
CD-1 mice strain so that the results of these experiments can be applied 
in a meaningful way for human and animals. 
The inability to rescue a genetically manipulated gene into an 
infectious virus particle or to swap a specific gene between two rotavirus 
strains 'at will' underscores that reassortants are the only means 
available, at present, to conduct virulence mapping studies on rotaviruses. 
The viral genome consists of 11 gene segments, most of which are 
monocistronic (Mason et al., 1980; Smith et al., 1980; McCrae and 
McCorquodale, 1982). Assuming that virus virulence is completely 
determined by a single gene then virulence in rotaviruses has the 
possibility of being mapped to individual gene segments using segregation 
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analysis, in which a suitable host is infected with 22 monotypic reciprocal 
reassortants derived from two rotavirus parents differing in their 
virulence phenotype. However, reassortment being a random process, a 
very large number of progeny clones need to be genotyped in the absence 
of suitable selection protocols to obtain the desired 22 monotypic 
reciprocal reassortants derived from two rotavirus parents as 2048 
different genotypes are possible. Consequently, both the nucleic acid 
extraction method and genotyping assays have to be both simple and rapid 
with a minimum number of manipulative steps. The nucleic acid 
extraction method developed in the present study (chapter 6) fulfils these 
criteria, as it requires only one centrifugation step and does not require 
the use of any hazardous organic chemicals. 
Putative reassortants were generated using a variety of methods 
and genotyped by determining the relative migration of their gene 
segments on polyacrylamide gels, coupled in the case of genomic segment 
8/9 with restriction enzyme digestion of the PCR amplified products. 
This revealed that only 2% out of more than 1100 progeny clones 
examined were reassortants. Possible reasons for obtaining this low 
number of reassortants are discussed in detail in chapter 7. The general 
points that emerged can be summarised as : (i) other (than the 22 
identified) reassortants were never formed (ii) the right kind of progeny 
clones were missed during plaque picking (iii) the reassortants were 
formed but they did not form the plaques because they were non- 
infectious (iv) the reassortants were formed but they were not able to 
form the plaques on the BSC-1 or MA104 cells (v) reassortants were 
formed in which exchange occurred in those gene segments where it was 
not possible to differentiate the parental origin (vi) segments from one of 
the parents are selected in toto because they are dominant as a group. 
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The observation that the majority of the progeny clones showed a 
UKtc electropherotype when it was one of the coinfecting parent, or an 
OSU electropherotype in the cross between OSU x B223 can be explained 
in two ways either (i) their genomes are selected in toto because they are 
dominant as a group (ii) or interference between two rotavirus strains. 
The selection of segments in toto in reassortment experiments has 
been reported by others (Ward and Knowlton, 1989). Interference 
between mutant and wild-type animal viruses following mixed infection is 
a well described phenomenon (Whitaker-Dowling and Youngner, 1987). 
Recently, interference between two wild-type reoviruses following mixed 
infection has been reported (Rozinov and Fields, 1994). Two possible 
explanations for these observations were made. First, the wild-type may 
in fact be a mutant. The definition of wild-type largely refers to its 
growth as an isolate that has not 'intentionally' been mutagenised or 
otherwise selected as a mutant. The passage of viruses in cell culture can 
select mutations that cause the virus to differ from the original virus in 
nature. In fact, the high rate of mutations in RNA viruses provides an 
opportunity for mutations to appear in putative wild-type stocks very 
rapidly (Holland et al., 1982). Thus, interference may be a general 
property of a number of 'wild-type' viruses. Second, viruses that are 
separated in nature are constantly evolving and may change in ways that 
lead to interference. Virion assembly might be quite permissive for 
individual virions, however, the combinations of proteins from two 
parents could lead to inefficient virion assembly or no assembly at all. 
Phenotypic mixing has been suggested (Rozinov and Fields, 1994) as one 
situation which allows the proteins from two different parents to be 
present in some progeny virions, to be responsible for interference. A 
high degree of phenotypic mixing during coinfection of cells with two 
rotavirus strains has been reported (Ward et al., 1988b). The strains used 
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to construct rotavirus reassortants in the present study are laboratory 
strains that are constantly being passaged in cells. These strains may in 
fact be mutants or may have evolved to such an extent where protein- 
protein interactions between the two parents might not allow normal 
assembly as a result of modified conformation. Whether interference was 
responsible for obtaining the UKtc elecropherotype in the majority of 
clones requires further investigation. 
The production of reassortants between the highly virulent EDIM 
strain and other less virulent heterologous rotavirus strains would have 
been highly desirable for virulence mapping attempted in this work. 
However, no reassortants could be identified in crosses which employed 
EDIM as one of the parent viruses. The murine rotavirus strains were 
probably blocked at the level of plasma membrane penetration as no 
infectious virus could be recovered following infection of BSC-1 or 
MA104 cells. However, when they were transfected by LipofectinTM, 
infectious rotavirus could be recovered (chapter 9). When the EDIM and 
UKtc strains were coinfected progeny clones showed only UKtc 
electropherotype. When UKtc and EDIM strains were transfected 
together or coinfected in vivo, no virus plaques were obtained upon 
plating out progeny. However, the nucleic acid extracted from coinfected 
cells or from intestinal homogenates prepared from coinfected mouse, 
showed only the EDIM electropherotype in PAGE-SS. The reasons for 
this suppression of UKtc are not known. 
Preliminary experiments indicated that the VP7 gene sequences of 
EDIM and EBR strains were different than published reports (Dunn et 
al., 1994). Differences were also found in region A which is known to be 
involved in virus neutralisation, based on mapping the sequence changes 
in neutralisation escape mutants (Dyall-Smith et al., 1986; Mackow et 
al., 1988b; Taniguchi et al., 1988b). 
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The 22 reassortants obtained in the present study belonged to 15 
genotypes (chapter 7). The application of statistics to such a small 
number of reassortants is difficult. However, a few points are obvious. 
Thus, although gene 4 has been related to growth restriction of 
rotaviruses in cultured cells (Greenberg et al., 1983a), it did not always 
come from the better growing parent in the reassortants examined in this 
study. The gene 4 from the OSU parent was present in all the reassortants 
except one, in UKtc x OSU cross, although UKtc was observed to be the 
dominant and better growing parent. Similar findings have been reported 
by others (Ward et al., 1988a). Gene segment 4, and 5 never came from 
B223, however, gene 5 was derived almost equally from UKtc or OSU. 
The VP7 gene never came from OSU. Among the remaining separable 
segments, the segments from all three parents were represented at least 
once. Reassortment is a random process. However, non-random selection 
of single gene as'well as gene association have been reported (Gombold 
and Ramig, 1986; Graham et al., 1987; Ward et al., 1988a). 
The analysis of cosegregation of genome segment with phenotype 
in reassortants has been the method of choice for mapping gene function 
in viruses with segmented genomes. Despite considerable efforts, the 
generation of the desired 22 monotypic reciprocal reassortants that were 
sought in the present study, as a first step to segregate rotavirus virulence 
to its genes, was not successful. The virulence mapping studies conducted 
in mice with the reassortants available in the present study indicated that 
gene 4 of the OSU and UKtc strains of rotavirus is involved in virulence 
(chapter 8). Segment 5 of OSU strain and segments 5, and 8 of UKtc 
strain may also be involved in rotavirus virulence. 
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10.2 Reverse genetics in influenza A virus 
10.2.1 Rescue of synthetic gene into influenza A virus genome 
Influenza A viruses are negative stranded viruses that contain eight 
different genome segments (Palese, 1977). These RNAs are tightly 
associated with the viral polymerases and nucleoprotein in the 
ribonucleoprotein (RNP) complex (Lamb, 1989) both in virions and 
infected cells. The genomic RNA needs to be transcribed into mRNA in 
order to direct the synthesis of viral proteins in the host cell. This 
function is controlled by a virally coded RNA-dependent-RNA- 
polymerase, which is also responsible for the replication of the genome. 
In contrast to DNA and positive-strand RNA viruses, influenza viruses 
had until recently been refractory to genetic manipulation. 
The amplification, transfection and rescue of synthetic RNA 
molecules from a RNA virus was first achieved in 1989 (Luytjes et al., 
1989). A biologically active influenza virus RNP complex was 
reconstituted using synthetic RNA and purified viral proteins, and 
amplification and expression of the reporter gene was driven by an 
influenza helper virus. 
Viral RNP cores containing transcriptional activity can be isolated 
from disrupted viruses or from infected cells. The templates for this 
activity are endogenous viral RNA molecules that are tightly associated 
with the purified RNPs. In order to use synthetic RNAs as templates, a 
procedure to separate the viral proteins and RNA from the RNP cores 
was needed. The purification of the three polymerase(P) proteins and/ or 
nucleoprotein (NP) from native RNAs (Honda et al., 1988; Szewczyk et 
al., (1988) helped Parvin et al., (1989) to demonstrate functional 
reconstitution using synthetic RNA and purified NP-P protein complex. 
These reconstituted RNP complexes were able to copy synthetic RNA 
molecules whose 15 3'-terminal nucleotides were identical to those 
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present in the viral RNAs. This reconstitution system was then used 
(Luytjes et al., 1989) for introducing synthetic RNA sequences into the 
genomes of influenza virus particles. 
The RNP transfection method was further improved by coupling 
the in vitro transcription from plasmid derived cDNA with the 
reconstitution (Enami and Palese, 1991) or the use of native RNP cores 
themselves (Yamanka et al., 1990), or coexpression of the P and NP 
proteins in the same cell using vaccinia virus recombinants (Huang et al., 
1990), or the use of NP-P complexes isolated from influenza virus 
infected cells rather than from purified virus (Martin et al., 1992). 
10.2.2 Genetic manipulation of influenza A virus 
The first influenza virus gene exchanged by an in vitro synthesised 
RNA was the neuraminidase (Enami et al., 1990). Recent developments 
have enabled the exchange of HA and NS genes of influenza A virus by 
cDNA-derived RNAs (Enami and Palese, 1991). Transfectant influenza A 
viruses have been constructed that contain chimeric HAs (Li et al., 1992) 
from two different subtypes, or foreign epitopes (Li et al., 1993b) from 
HIV-1. 
10.2.3 Reverse genetics :a powerful tool to study influenza A 
virus virulence 
The cleavage HA of influenza A virus has important role in 
virulence (see chapter 3). Using reverse genetics, it has recently been 
demonstrated directly that influenza virus virulence depends on the 
cleavability of haemagglutinin (Horimoto and Kawaoka, 1994). A 
transfectant virus containing the wild-type HA with Arg-Arg-Arg-Lys- 
Lys-Arg at the cleavage site, which was readily cleaved by endogenous 
proteases in chicken embryo fibroblasts (CEF), was highly virulent in 
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chickens after intramuscular or intranasal/ oral inoculation . In contrast, a 
mutant containing HA of an avirulent- like sequence (Arg-Glu-Thr-Arg) 
at the cleavage site, which was not cleaved by the proteases in CEF, was 
avirulent in chickens, indicating that a genetic alteration confined to the 
HA cleavage site can affect cleavability and hence virulence. It has been 
further proposed that viruses with the Arg-Arg/Lys-Arg-Lys-Thr-Arg 
motif (Wood et al., 1993) should be considered in the same category as 
virulent viruses with xxx-xxx-Arg/Lys-xxx-Arg/Lys-Arg motif based on 
similarity in the virulence for chickens of field isolates and laboratory 
mutants produced by reverse genetics. 
The neurovirulence observed in some influenza A viruses is 
associated with its neuraminidase (see chapter 3). Recently, the absence 
of the glycosylation site at position 130 of the neuraminidase has been 
shown to play a key role in the neurovirulence of influenza virus strain 
WSN in mice (Li et al., 1993a). A glycosylation positive (Glyc+) mutant 
virus was generated using reverse genetics methods, in which the 
glycosylation site at 130 position was introduced into the WSN virus 
neuraminidase. In contrast to wild-type or revertant viruses, the Glyc+ 
mutant neither underwent multiple cycles of replication in MDBK cells 
nor was able to multiply in mouse brain. 
10.3 Application of reverse genetics in rotaviruses :a 
prospective 
Although the 'rescue' of a rotavirus gene was first described 
(Greenberg et al., 1981) 13 years ago, it was only a reassortant 
experiment in which the gene segment was exchanged by reassortment 
using a combination of is mutant and antibody selection pressure. A more 
recent report described conditions under which reovirus RNA was 
infectious (Roner et al., 1990). However, the molecular mechanisms 
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involved are poorly understood and the rescue of a single reovirus gene, 
from a cloned DNA copy into virus particle has yet to be achieved. The 
expression of a synthetic gene flanked by NCR of a rotavirus gene has 
been reported (Gorziglia and Collins, 1992), but the result remains to be 
confirmed by other investigators. Moreover, they were not able to rescue 
it into an infectious rotavirus particle. 
In order to rescue a rotavirus gene in its 'true sense', two things 
need to be achieved i. e. (i) to force an exogenous RNA to enter into the 
pool of RNA molecules available for (re)assortment into infectious 
progeny virus, (ii) to be able to identify the rescued infectious particles 
by appropriate selection systems. 
The first steps should be to identify the genes encoding the 
proteins that form the polymerase complex and then techniques need to be 
developed to be able to separate them. Further experiments may follow 
on the lines of ribonucleoprotein transfection method to allow the 
exogenous RNA to enter into the pool of RNAs available for replication, 
i. e. the synthetic or altered rotavirus genes be reconstituted with rotavirus 
RNA polymerase complex and transfected into appropriate cells. 
Identification and selection of the rescued virus particles is equally 
important, if not more important, to devise methods to introduce 
exogenous RNA to enter into the pool of RNAs available for replication. 
The rescued virus particles can be identified with some of the following 
selection systems (i) CAT expression of synthetic rotavirus- 
chloramphenicol acetyltransferase gene (ii) growth in the presence or 
absence of trypsin (iii) haemagglutination or haemadsorption of the 
haemagglutinating parent (iv) use of is mutant and selection at non- 
permissive temperature (v) selection in the presence of specific 
neutralising antibodies. 
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The majority of the investigators trying to rescue a rotavirus gene 
are following the strategy described below :A transcription vector under 
the control of T7 promotor is constructed by RT-PCR using appropriate 
primers to generate a rotavirus segment specific modified cDNA. This 
cDNA is then linearised and transcribed using T7 RNA polymerase. This 
cDNA derived in vitro transcript is transfected into appropriate cells 
which have simultaneously been infected with another rotavirus strain. 
Progeny clones are then screened for virions containing the rescued gene. 
A method combining the transfection and selection of the 
exogenous RNA containing rotavirus would be highly desirable. 
Ribozymes acting in cis or trans may be helpful in such situations. 
Simultaneous transfection of an exogenous rotavirus transcript, together 
with a ribozyme specific for the equivalent segment from a helper virus 
would greatly enhance the chances of getting virus particles with rescued 
gene. The above experiment may be combined with another experiment 
in which a ribozyme may be ligated into a rotavirus transcript which is to 
be selected against. The simultaneous transfection of this construct 
together with the desired exogenous equivalent transcript derived from 
cloned DNA would allow the amplification of both type of gene 
segments, but only the virion that contained the desired gene without the 
ligated ribozyme would be able to assemble. 
Reverse genetics will open the flood-gates for devising chimeric 
rotaviruses to be used as vaccine candidates. This can be done by epitope 
grafting using T- cell epitopes from different rotavirus strains on the lines 
of influenza A virus (Li et al., 1992). However, the insertion of foreign 
epitope into the as sequence of a viral protein can sometimes alter the 
properties of the protein sufficiently to prevent the generation of viable 
viruses. Rescue of bicistronic rotavirus genes constructed by the use of 
internal ribosomal entry site elements (Garcia-Sastre et al., 1994), or by 
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inserting in frame self cleaving 2A protease sequences (Percy et al., 
1994) on the lines of influenza A virus, will allow the insertion of an 
entire gene. Reverse genetics will also allow rotaviruses to be used as 
expression vector for other pathogens in which mucosal immunity is 
important. 
10.4 Concluding remarks 
The findings of the present project are summarised below : Studies 
on rotavirus virulence can help in achieving the goal set by WHO to 
control rotavirus infections in young children. Rotavirus reassortants are 
the only means available, at present, to conduct studies on virulence. 
However, attempting to map rotavirus virulence by reassortants has its 
own limitations. The generation of desired reassortants for conducting 
virulence studies can be both labour intensive and time consuming. Also 
in the event of getting the desired reassortants by reassortment, the 
experiments with such reassortants will map the virulence phenotype with 
a precision not greater than assigning it to a segment(s). The specific 
domains in general and nucleotides in particular that are involved in 
rotavirus virulence cannot be determined in this type of study. A detailed 
and clearer picture of virulence can only emerge when the techniques of 
reverse genetics to rescue a cloned gene, and genes modified by site- 
directed mutagenesis become available for applying to rotaviruses. 
The reverse genetics techniques, once available for rotaviruses, 
can be used to swap a rotavirus gene 'at will' between the equivalent gene 
segments from two rotavirus strains differing in their virulence for 
identifying the gene segments involved. The modifications of the gene 
segments by site-directed mutagenesis and their subsequent rescue will 
help to identify the amino acid(s) involved in virulence/attenuation. 
195 
References 
Agol; 'V. I., Drozdov, S.. G., Grachev, V. P., Kolesnikova, M. S., 
Kozlov, V. G., Ralph, N. M., Romanova, L. I., Tolskaya, E. A., 
Tyufanov, A. V. and Viktorova, E. G. 1985. Recombinants between 
attenuated and virulent strains of poliovirus type 1: derivation and 
characterization of recombinants with centrally located crossover points. 
Virology 143: 467-477. 
Albert, M. J., Unicomb, L. E., Tzipori, S. R. and Bishop, R. F. 1987. 
Isolation and serotyping of animal rotaviruses. Arch. Virol. 93: 123-130. 
Anderson, E. L., Belshe, R. B., Bartram, J., Crookshanks-Newman, F., 
Chanock, R. M. and Kapikian, A. Z. 1986. Evaluation of rhesus- 
rotavirus vaccine (MMU 18006) in infants and young children. J. Infect. 
Dis. 153: 823-831. 
Andrew, M. E., Boyle, D. B., Couper, B. E. H., Whitfield, P. L., Both, 
G. W. and Bellamy, A. R. 1987. Vaccinia virus recombinants expressing 
the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific 
neutralising antibodies. J. Virol. 61: 1054-1060. 
Anthony, I. D., Bullivant, S., Dayal, S., Bellamy, R. and Berriman, J. 
A. 1991. Rotavirus spike structure and polypeptide composition. J. Virol. 
65: 4334-4340. 
Arias, C. F., Lopez, S. and Espejo, R. T. 1982. Gene protein product of 
SA11 simian rotavirus genome. J. Virol. 41: 42-50. 
Arias, C. F., Lizano, M. and Lopez, S. 1987. Synthesis in Escherichia 
coli and immunological characterisation of a polypeptide containing the 
cleavage peptides associated with trypsin enhancement of rotavirus SA11 
infectivity. J. Gen. Virol. 68: 633-642. 
Au, K. S., Chan, W. K., Burns, J. W. and Estes, M. K. 1989. Receptor 
activity of non-structural glycoprotein NS28. J. Virol. 63: 4553-4562. 
Ballard, A., McCrae, M. A. and Desselberger, U. 1992. Nucleotide 
sequence of normal and rearranged RNA segments 10 of human 
rotaviruses. J. Gen. Virol. 73: 633-638. 
Banfield, W. G., Kasnik, G. and Blackwell, J. H. 1968. Further 
observations on the virus of epizootic diarrhoea of infant mice: an 
electron microscopic study. Virology 35: 411-421. 
Barnett, B. B., Egbert, L. N. and Spendlove, R. S. 1978. Characteristics 
of neonatal calf diarrhoea virus ribonucleic acid. Can. J. Comp. Med. 
42: 46-53. 
Bass, D. M., Mackow, E. R. and Greenberg, H. B. 1990. NS35 and vp7 
is the soluble rotavirus protein which binds to target cells. J. Virol. 64: 
322-330. 
Bass, D. M., Mackow, E. R. and Greenberg, H. B. 1991. Identification 
and partial characterisation of a rhesus rotavirus binding glycoprotein on 
murine enterocytes. Virology 183: 602-610. 
Bass, D. M., Balyor, M. R., Chen, C., Mackow, E. M., Bremont, M. 
and Greenberg, H: B. 1992a. Liposome-mediated transfection of intact 
virus particles reveals that plasma membrane penetration determines 
permissivity of tissue culture cells to rotavirus. J. Clin. Invest. 90: 2313- 
2320. 
Bass, D. M., Baylor, M., Broome, R. L. and Greenberg, H. B. 1992b. 
Molecular basis of age dependent gastric inactivation of rhesus rotavirus 
in the mouse. J. Clin. Invest. 89: 1741-1745. 
Baybutt, H. N. and McCrae, M. A. 1984. The molecular biology of 
rotavirus. VII. Detailed structural analysis of gene 10 of bovine rotavirus. 
Virus Res. 1: 533-541. 
Bean, W. J. and Webster, R. G. 1978. Phenotype properties associated 
with influenza genome segments. In: Negative strand viruses and the 
host cell (B. W. J. Mahy and R. D. Barry, eds). pp 685-692. Academic, 
Orlando, Florida. 
Beards, G. M. 1987. Serotyping of rotavirus by NADP-enhanced 
enzyme-immunoassay. J. Virol. Methods 18: 77-85. 
Beards, G. M., Xu, L., Ballard, A., Desselberger, U. and McCrae, M. 
A. 1992. A serotype 10 human rotavirus. J. Clin. Virol. 30: 1432-1435. 
Bican, P., Cohen, J., Charpilienne, A. and Scherrer, A. 1982. 
Purification and characterization of bovine rotavirus cores. J. Virol. 43: 
1113-1117. 
Bishop, R. F., Davidson, G. P., Holmes, I. H. and Ruck, B. J. 1973. 
Virus particles in epithelial cells of duodenum from children with acute 
non-bacterial gastroenteritis. Lancet 2: 1281-1283. 
197 
Bishop, R. F., Davidson, G. P., Holmes, I. H. and Ruck, B. J. 1974. 
Detection of a new virus by electron microscopy of faecal extracts from 
children with acute gastroenteritis. Lancet 2: 149-151. 
Bishop, R. F., Barnes, G. L., Cipiriani, E. and Lund, J. S. 1983. Clinical 
immunity after rotavirus infection: A prospective longitudinal study in 
young children. N. Engl. J. Med. 309: 72-76. 
Bishop, R. F., Tzipori, S. R., Coulson, B. S., Unicomb, L. E., Albert, 
M. J. and Barnes, G. L. 1986. Heterologous protection against rotavirus 
induced disease in gnotobiotic piglets. J. Clin. Microbiol. 24: 1023-1028. 
Bohl, E. H., Theil, K. W. and Saif, L. J. 1984. Isolation and serotyping 
of porcine rotaviruses and antigenic comparision with other rotaviruses. 
J. Clin. Microbiol. 19: 105-111. 
Bosch, F. X., Orlich, M., Klenk, H. -D. and Rott, R. 1979. The structure 
of the haemagglutinin, a determinant for the pathogenicity of influenza 
viruses. Virology 95: 197-207. 
Bosch, F. X., Garten, W., Klenk, H. -D. and Rott, R. 1981. Proteolytic 
cleavage of influenza virus haemagglutinins: Primary structure of the 
connecting peptide between HA l and HA2 determines proteolytic 
cleavability and pathogenicity of avian influenza viruses. Virology 113: 
725-735. 
Both, G. W., Mattick, J. S. and Bellamy, A. R. 1983a. Serotype-specific 
glycoprotein of simian 11 rotavirus: coding assignment and gene 
sequence. Proc. Natl. Acad. Sci. USA 80: 3091-3095. 
Both, G. W., Siegman, L. J., Bellamy, A. R. and Atkinson, P. H. 
1983b. Coding assignments and nucleotide sequence of simian rotavirus 
SA11 gene segment 10: location of glycosylation sites suggests that the 
signal peptide is not cleaved. J. Virol. 48: 335-339. 
Boyle, J. F. and Holmes, K. V. 1986. RNA-binding proteins of bovine 
rotavirus. J. Virol. 58: 561-568. 
Bridger, J. C. and Pocock, D. H. 1986. Variation in the virulence of 
bovine rotaviruses. J. Hyg. 96: 257-264. 
Bridger, J. C. 1987. Novel rotaviruses in animals and man. CIBA Found. 
Symp. 128: 6-23. 
198 
J. C. and Oldham, G. 1987. Avirulent rotavirus infection Bridger, 
protects calves from disease with and without inducing high levels of 
neutralizing antibodies. J. Gen. Virol. 68: 2311-2317. 
Bridger, J. C., Burke, B., Beards, G. M. and Desselberger, U. 1992. 
The pathogenicity of two porcine rotaviruses differing in their in vitro 
growth characteristics and genes 4. J. Gen. Virol. 73: 3011-3015. 
Bridger, J. C. 1994. A definition of bovine rotavirus virulence. J. Gen. 
Virol. 75: 2807-2812. 
Broome, R. L., Vo, P. T., Ward, R. L., Clark, H. F. and Greenberg, 
H. B. 1993. Murine rotavirus genes encoding outer capsid proteins VP4 
and VP7 are not major determinants of host range restriction and 
virulence. J. Virol. 67: 2448-2455. 
Brown, D. W. G., Mathan, M. M., Mathew, M., Beards, G. M. and 
Mathan, V. I. 1988. Rotavirus epidemiology in Vellore, South India: 
group, subgroup, serotype, and electropherotype. J. Clin. Microbiol. 26: 
2410-2414. 
Brown, E. G. 1990. Increased virulence of a mouse adapted variant of 
influenza A/FM/1/47 virus is controlled by mutations in the genome 
segments 4,5,7, and 8. J. Virol. 64: 4523-4533. 
Browning, G. F., Chalmers, R. M., Fitzgerald, T. A., and Snodgrass, 
D. R. 1991a. Serological and genomic characterization of L338, a novel 
equine group A rotavirus G serotype. J. Gen. Virol. 72: 1059-1064. 
Browning, G. F., Fitzgerald, T. A., Chalmers, R. M. and Snodgrass, D. 
R. 1991b. A novel group A rotavirus G serotype: serological and 
genomic characterization of equine isolate F123. J. Clin. Microbiol. 29: 
2043-2046. 
Bryden, A. S., Davis, H. A., Hadley, R. E., -Flewett, T. H., Morris, C. 
A. Oliver, P. 1975. Rotavirus enteritis in West Midlands during 1974. 
Lancet 2: 241-243. 
Burke, B., Bridger, J. C. and Desselberger, U. 1994a. Temporal 
correlation between a single amino acid change in the VP4 of a porcine 
rotavirus and a marked change in pathogenicity. Virology 202: 754-759. 
199 
i{ 
tE 
iK4 
Burke, B., McCrae, M. A. and Desselberger, U. 1994b. Sequence 
analysis of two porcine rotaviruses differing in their growth in vitro and 
in pathogenicity: Distinct VP4 sequences and conservation of NS53, VP6 
and VP7 genes. J. Gen. Virol. 75: 2205-2212. 
Burns, J. W., Greenberg, H. B., Shaw, R. D. and Estes, M. K. 1988. 
Functional and topographical analyses of epitopes on the haemagglutinin 
(VP4) of the simian rotavirus SA11. J. Virol. 62: 2164-2172. 
Cann, A. J., Stanway, G., Hughes, P. J., Minor, P. D., Evans, D. M. 
A., Schild, G. C. and Almond, J. W. 1984. Reversion to neurovirulence 
of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids 
Res. 12: 7787-7792. 
Cash, P. 1982. Human rotavirus RNA prepared from stool samples by a 
simple procedure suitable for determination of eletropherotypes. J. Virol. 
Methods 4: 107-115. 
Chanock, S. J., Wenske, E. A. and Fields, B. N. 1983. Human 
rotaviruses and genome RNA. J. Infect. Dis. 148: 49-50. 
Chantler, J. K., Ford, D. K. and Tingle, A. J. 1982. Persistent rubella 
infection and rubella-associated arthritis. Lancet 1: 1323-1325. 
Chasey, D. and Labran, J. 1983. Electron microscopy of tubular 
assemblies associated with naturally occurring bovine rotavirus. J. Gen. 
Virol. 64: 863-872. 
Cheever, F. S. and Muller, J. H. 1947. Epidemic diarrhoeal disease of 
suckling mice. I. Manifestation, epidemiology and attempts to transmit 
the disease. J. Exp. Med. 85: 405-416. 
Chen, D., Burns, J. W., Estes, M. K. and Ramig, R. F. 1989. The 
phenotypes of rotavirus reassortants depend upon the recipient genetic 
background. Proc. Natl. Acad. Sci. USA 86: 3743-3747. 
Chen, D., Estes, M. K. and Ramig, R. F. 1992. Specific interaction 
between rotavirus outer capsid VP4 and VP7 determine expression of a 
cross-reactive neutralising VP4 specific epitope. J. Virol. 66: 432-439. 
Christodoulou, C., Colbere-Garapin, F., Macadam, A., Taffs, L. F., 
Marsden, S., Minor, P. D. and Horaud, F. 1990. Mapping of mutations 
associated with monkey neurovirulence of Sabin 1 poliovirus revertants 
selected at high temprature. J. Virol. 64: 4922-4929. 
200 
Clapp, L. L. and Patton J. T. 1991. Rotavirus morphogenesis: Domains 
in the major inner capsid protein essential for binding to single-shelled 
particles and for trimerization. Virology 180: 697-708. 
Clark, S. M., Roth, J. R., Clark, M. L., Barnett, B. B. and Spendlove, 
R. S. 1981. Trypsin enhancement of rotavirus infectivity: mechanism of 
enhancement. J. V irol . 39: 816-822. 
Clark, B. and Desselberger, U. 1988. Myristylation of rotavirus proteins. 
J. Gen. Virol. 69: 2681-2686. 
Clark, H. F., Borian, F. E., Bell, L. M., Modesto, K., Gouvea, V. and 
Plotkin, S. A. 1988. Protective effects of WC3 vaccine against rotavirus 
diarrhoea in infants during a predominantly serotype 1 rotavirus season. 
J. Infect. Dis. '158: 570-587. 
Clark, H. F., Borian, F. E., and Plotkin, S. A. 1990. Immune protection 
of infants against rotavirus gastroenteritis by a serotype 1 reassortant of 
bovine rotavirus WC3. J. Infect. Dis. 161: 1099-1104. 
Clarke, I. N. and McCrae, M. A. 1981. A rapid and sensitive method for 
analysing the genome profiles of field isolates of rotavirus. J. Virol. 
Methods. 2: 203-209. 
Clarke, I. N. and McCrae, M. A. 1982. Structural analysis of 
electrophoretic variation in the genome profiles of rotavirus field isolates. 
Infect. Immunity 36: 492-497. 
Clarke, I. N. -and McCrae, M. A. 1983. The molecular biology of 
rotaviruses. VI. RNA species-specific terminal conservation in 
rotaviruses. J. Gen. Virol. 64: 1877-1884. 
Cohen, J., Laporte, J., Charpilienne, A. and Scherrer, A. 1979. 
Activation of rotavirus RNA polymerase by calcium chelation. Arch. 
Virol. 36: 395-402. 
Cohen, J., Charpilienne, A., Chilmonzyk, S. and Estes, M. K. 1989. 
Nucleotide sequence of bovine rotavirus gene 1 and expression of the 
gene product in baculovirus. Virology 171: 131-140. 
Conner, M. E.; Estes, M. K. and Graham, D. Y. 1988. Rabbit model of 
rotavirus infection. J. Virol. 62: 1625-1633. 
201 
Conner, M. E., Gilger, M. A., Estes, M. K. and Graham, D. Y. 1991. 
Serologic and mucosal immune response to rotavirus infection in the 
rabbit model. J. Virol. 65: 2562-2571. 
Conner, M. E., Crawford, S. E., Barone, C. and Estes, M. K. 1993. 
Rotavirus vaccine administered parenterally induces protective immunity. 
J. Virol. 67: 6633-6641. 
Couderc, T., Martin, A., Wychowski, C., Girard, M., Horaud, F. and 
Crainic, R. '1991. Analysis of neutralization-escape mutants selected from 
a mouse virulent type 1/type 2 chimeric poliovirus: identification of a 
type 1 poliovirus with antigenic site 1 deleted. J. Gen. Virol. 72: 973- 
977. 
Couderc, T., Hogle, J., ' Blay, H. L., Horaud, F. and Blondel, B. 1993. 
Molecular characterization of mouse-virulent poliovirus type 1 Mahoney 
mutants: involvement of residues of polypeptides VP1 and VP2 located 
on the inner surface of the capsid protein shell. J. Virol. 67: 3808-3817. 
Coulson, B. S. 1987. Variation in neutralization epitopes of human 
rotaviruses in relation to genomic RNA polymorphism. Virology 159: 
209-216. 
Coulson, B. - S., Unicomb, L. E., Pitson, G. A. and Bishop, R. F. 1987a. 
Simple and specific enzyme immunoassay using monoclonal antibodies 
for serotyping human rotaviruses. J. Clin. Microbiol. 25: 509-515. 
Coulson, B. S., Fowler, K. J., White, J. R. and Cotton, R. G. 1987b. 
Non-neutralizing monoclonal antibodies to a trypsin-sensitive site on the 
major glycoprotein of rotavirus which discriminates between virus 
serotypes. Arch. Virol. 93: 199-211. 
Council of Euorpean Communities. 1992. Council directive 92/40/EEC 
of May 1992 introducing Community measures for the control of avian 
influenza. Offic. J. Europ. Commun 167: 1-15. 
Crouch, C. R. and Woode, G. N. 1978. Serial studies on virus 
multiplication and intestinal damage in gnotobiotic piglets infected with 
rotavirus. J. Med. Microbiol. 11: 325-334. 
Croxson, M. C. and Bellamy, A. R. 1981. Extraction of rotavirus from 
human faeces by treatment with lithium dodecyl sulphate. Appl. Environ. 
Microbiol. 41: 255-260. 
202 
Cukor, G. and Blacklow, N. R. 1984. Human viral gastroenteritis. 
Microbiol Rev. 48: 157-179. 
Das, M., Dunn, S. J., Woode, G. N., Greenberg, H. B. and Rao, C. D. 
1993. Both surface proteins (VP4 and VP7) of an asymptomatic neonatal 
rotavirus strain (1321) have high levels of sequence identity with the 
homologous proteins of a serotype 10 bovine rotavirus. Virology 194: 
374-379. 
Davidson, G P., Bishop, R. F., Townley, R. R. W., Holmes, I. H. and 
Ruck, B. J. 1975. Importance of a new virus in acute sporadic enteritis in 
children. Lancet 1: 242-245. 
De Zoysa, I. and Feachem, R. G. 1985. Interventions for the control of 
diarrhoeal diseases among young children: Rotavirus and cholera 
immunisation. Bull. WHO 63: 569-583. 
Deshpande, K. L., Fried, V. L., Ando, M. and Webster, R. G. 1987. 
Glycosylation affects cleavage of an H5N2 influenza virus haemagglutinin 
and regulates virulence. Proc. Natl. Acad. Sci. USA 84: 36-40. 
11 - 
Desselberger, U., Nakajima, K., Alfino, P., Pedersen, F. S., Haseltine, 
W. A., Hannoun, C. and Palese, P. 1978. Biochemical evidence that 
"new' influenza virus strains in nature may arise by recombination 
(reassortment). Proc. Natl. Acad. Sci. USA 74: 3341-3345. 
Desselberger, U. and McCrae, M. A. 1994. The rotavirus genome. Curr. 
Top. M icrob iol . Immunol. 185: 31-66. 
Devereux, J., Haeberli, P. and Smithies, 0.1984. A comprehensive set 
of sequence analysis programs for the VAX. Nucleic Acids Res. 12: 387- 
395. 
Dharakul, T., Rott, L. and Greenberg, H. B. 1990. Recovery from 
chronic rotavirus infection in mice with severe-combined 
immunodeficency: virus clearance mediated by adoptive transfer of 
immune Lyt2+ lymphocytes. J. Virol. 64: 4375-4382. 
Dharakul, T., Labbe, M., Cohen, J., Bellamy, A. R., Street, J. E., 
Mackow, E. R. Fiore, L., Rott, L. and Greenberg, H. B. 1991. 
Immunization with baculovirus-expressed recombinant rotavirus proteins 
Vpl, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate 
clearance of chronic rotavirus infection in SCID mice. J. Virol. 65: 5928- 
5932. 
203 
Diamond, D. C., Jameson, B. A., Bonin, J., Kohara, M., Abe, S., Itoh, 
H., Komatsu, T., Arita, M., Kuge, S., Nomoto, A., Osterhaus, 
A. D. M. E., Crainic, R. and Wimmer, E. 1985. Antigenic variation and 
resistance to neutralization in poliovirus type 1. Science 229: 1090-1093. 
t 1, 
Dunn, S. J., Greenberg, H. B., Ward, R. L., Nakagomi, 0., Burns, J. 
W., Pax, K. A., Das, M., Gowda, K. and Rao, C. D. 1993. Serotypic 
and genotypic characterisation of human serotype 10 rotaviruses from 
asymptomatic neonates. J. Clin. Microbiol. 31: 165-169. 
Dunn, S. J., Burns, J. W., Cross, T. L., Vo, P. T., Ward, R. L., 
Bremont, M. and Greenberg, H. B. 1994. Comparison of VP4 and VP7 
of five murine rotavirus strains. Virology 203: 250-259. 
Dyall-Smith, ' M. L. and Holmes, I. H. 1981. Gene-coding assignments of 
rotavirus double-stranded RNA segments 10 and 11. J. Virol. 38: 1099- 
1103. 
Dyall-Smith, M. L. and Holmes, I. H. 1983. Gene mapping of rotavirus 
double-stranded RNA segments by Northern-blot hybridisation: 
applications to segments 7,8, and 9. J. Virol 46: 317-320. 
Dyall-Smith, M. -L., Lazdins, I., Tregear, G. W. and Holmes, I. H. 
1986. Location of the major antigenic sites involved in rotavirus 
serotype-specific neutralization. Proc. Natl. Acad. Sci. USA 83: 3465- 
3468. 
Edelman, R., Flores, J. and Kapikian, A. Z. 1989. Immunity to 
rotaviruses. Curr. Top. Microbiol. Immunol. 146: 123-136. 
Edwards, K., Johnstone, C. and Thompson, C. 1991. A simple and rapid 
method for the preparation of plant genomic DNA for PCR analysis. 
Nucleic Acids Res. 19: 1349. 
E1. Hussain, A., Ramig, R. F., Holbrook, F. R. and Beaty, B. J. 1989. 
Asynchronous mixed infection of Culicoides veriipennis with bluetongue 
virus serotypes 10 and 17. J. Gen. Virol. 70: 3355-3362. 
Enami, M. and Palese, P. 1991. High-efficiency formation of influenza 
virus transfectants. J. Virol. 65: 2711-2713. 
204 
Enami, M., Luyjtes, M., Krystal, M. and Palese, P. 1990. Introduction 
of site-specific mutations into the genome of influenza virus. Proc. Natl. 
Acad. Sci. USA 87: 3802-3805. 
Equestre, M., Genovese, D. Cavalieri, F., Fiore, L. Santoro, R. and 
Perez-Bercoff, H. R. 1991. Identification of a consistent pattern of 
mutations in a neurovirulent variants derived from the Sabin vaccine 
strain of poliovirus type 2. J. Virol. 65: 2707-2710. 
Ericson, B. L., Graham, D. Y., Mason, B. B. and Estes, M. K. 1982. 
Identification, synthesis, and modifications of simian rotavirus SA 11 
polypeptides in infected cells. J. Virol. 42: 825-839. 
Ericson, B. L., Graham, D. Y., Mason, B. B., Hanssen, H. H. and 
Estes, M. K. 1983. Two types of glycoprotein precursors are produced 
by the simian rotavirus SA11. Virology 127: 320-332. 
Espejo, R. T., Lopez, S. and Arias, C. 1981. Structural polypeptides of 
simian rotavirus SA11 and the effect of trypsin. J. Virol. 37: 156-160. 
Estes, M. K., Smith, E. M. and Gerba, C. P. 1979. Rotavirus stability 
and inactivation. J. Gen. Virol. 43: 403-409. 
Estes, M. K., Graham, D. Y. and Mason, B. B. 1981. Proteolytic 
enhancement of rotavirus infectivity: molecular mechanisms. J. Virol. 
39: 879-888. 
Estes, M. K., Palmer, E. L. and Obeijeski, J. F. 1983. Rotaviruses: a 
review. Curr. Top. Microbiol. Immunol. 105: 124-184. 
Estes, M. K., Graham, D. Y. and Dimitrov, D. 1984. The molecular 
epidemiology of rotavirus gastroenteritis. Prog. Med. Virol. 29: 1-24. 
Estes, M. K., Crawford, S. E., Penaranda, M. E., Petrie, B. L., Burns, 
J. W., Chan, W. -K., Ericson, B., Smith, G. E. Summers, G. D. 1987. Synthesis and immunogenicity of the rotavirus major outer capsid antigen 
using a baculovirus expression system. J. Virol. 61: 1488-1494. 
Estes, M. K. and Cohen, J. 1989. Rotavirus gene structure and function. 
Microbiol. Reviews 53: 410-449. 
Evans, D. M. A., Dunn, G., Minor, P. D., Schield, G. C., Cann, A. J., 
Stanway, G., Almond, J. W., Currey, K. and Maizel, J. V. 1985. 
Increased neurovirulence associated with a single nucleotide change in a 
noncoding region of the Sabin type 3 poliovirus vaccine genome. Nature 
(London) 314: 548-550. 
205 
Eydelloth, R. S., Vonderfecht, S. L., Sheridan, J. F., Enders, L. D. and 
Yolken, R. H. 1984. Kinetics of viral replication and local and systemic 
immune respones in experimental rotavirus infection. J. Virol. 50: 947- 
950. 
Fernelius, A. L., Ritchie, A. E., Classik, L. G., Norman, J. E. and 
Mebus, C. A. 1972. Cell culture adaptation and propagation of a 
reovirus-like agent of calf diarrhoea from a field outbreak in Nebraska. 
Arch. Gesamte Virusforsch. 37: 114-130. 
Ferre, F. and Garduno, F. 1989. Prepration of crude cell extract suitable 
for amplification of RNA by the polymerase chain reaction. Nucleic 
Acids Res. 17: 2141. 
Fields, B. N. 1981. Genetics of reovirus. Curr. Top. Microbiol. and 
Immunol. 91: 1-24. 
Fields, B. N. 1982. Molecular basis of reovirus virulence. Arch. Virol. 
71: 97-107. 
Fiore, L., Greenberg, H. B. and Mackow, E. R. 1991. The VP8 
fragment of VP4 is the rhesus rotavirus haemagglutinin. Virology 181: 
553-563. 
Flewett, T. H., Bryden, A. S. and Davis, H. 1973. Virus particles in 
gastroenteritis. Lancet 2: 1497.. . 
Flewett, T. H., Bryden, A. S., Davis, H., Woode, G. N., Bridger, J. C. 
and Derrik J. M. 1974a. Relation between viruses acute gastroenteritis of 
children and newborn calves. Lancet 2: 61-63. 
Flewett, T. H., Davis, H., Bryden, A. S. and Robertson, M. J. 1974b. 
Diagnostic electron microscopy of faeces: II. Acute gastroenteritis 
associated with reo-virus like particles. J. Clin. Pathol. 27: 608-617. 
Flewett, T. H. - and Woode, G. N. 1978. The rotaviruses. Arch. Virol. 
57: 1-23. 
Flores, J., Boeggeman, E., Purcell, R. H., Sereno, M., Perez, M., 
White, L., Wyatt, R. G., Chanock, R. M. and Kapikian, A. Z. 1983. A 
dot hybridisation assay for detection of rotaviruses. Lancet 1: 555-559. 
Flores, J., Midthun, K., Hoshino, Y., . 
Green, K., Gorziglia, M., 
Kapikian, A. Z. and Channock, R. M. 1986. Conservation of the fourth 
206 
gene among rotavirus recovered from asymptomatic newborn infants and 
its possible role in attenuation. J. Virol. 60: 972-979. 
Flores, J., Green, K. Y., Garcia, D., Sears, J., Perez-schael, I., 
Avendano, L. F., Rodriguez, W. B., Taniguchi, K., Urasawa, S. and 
Kapikian, A. Z. 1989a. A dot hybridization assay for distinction of 
human rotavirus serotypes. J. Clin. Microbiol. 27: 29-34. 
Flores, J., Perez-Schael, I., Blanco, M., Vilar, M., Garcia, D., Perez, 
M., Daoud, N., Midthun, K. and Kapikian, A. Z. 1989b. Reactions to 
and antigenicity of two human-rhesus rotavirus reassortant vaccine 
candidates of serotypes 1 and 2 in Venezuelan infants. J. Clin. Microbiol. 
27: 512-517. 
Flores, J., Perez-Schael, I., Blanco, M., White, L., Garcia, D., Perez, 
M., Daoud, N., Cunto, W., Chanock, R. M. and Kapikian, A. Z. 1990. 
Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine 
and rhesus-rotavirus-based quadrivalent vaccine. Lancet 336: 330- 
334. 
Forsey, T., Mawn, J. A., Yates, P. Y., Bentley, M. L. and Minor, P. 
D. 1990. Differentiation of vaccine and wild type mumps viruses using 
polymerase chain reaction and dideoxynucleotide sequencing. J. Gen. 
Virol. 71: 987-990. 
Foster, S. 0., Palmer, E. L., Gary, G. W. Jr., Martin, M. L., Hermann, 
K. L., Beasley, P. and Sampson, J. 1980. Gastroenteritis due to rotavirus 
in an isolated Pacific island group: an epidemic of 3439 cases. J. Infect. 
Dis. 141: 32-39. 
Franco, M. A., Prieto, I., Labbe, M., Poncet, D., Borras-Cuesta, F. and 
Cohen, J. 1993. An immunodominant cytotoxic T cell epitope on the VP7 
rotävirus protein overlaps the H2 signal peptide. J. Gen. Virol. 74: 2579- 
2586. 
Fuk-dhara, N., Yoshie, 0., Kitaoka, S. and Konno, T. 1988. Role of VP3 
in human rotavirus internalization after target cell attachment via VP7. J. 
Virol. 62: 2209-2218. 
Garbarg-Chenon, A., Bricout, F. Nicolas, J. -C. 1984. Study of genetic 
reassortment between two human rotaviruses. Virology 139: 358-365. 
Garcia-Sastre, A., Muster, T., Barclay, W. S., Percy, N. and Palese, P. 
1994. Use of mammalian internal ribosomal entry site element for 
207 
expression of a foreign protein by a transfectant influenza virus. J. Virol. 
68: 6254-6261. 
Garten, W., Bosch, F. X., Linder, D., Rott, R. and Kllenk, H. -D. 1981. 
Proteolytic activation of the influenza virus haemagglutinin: The structure 
of the cleavage site and the enzymes involved in cleavage. Virology 115: 
361-374. 
Gentsch, -J. R., Glass, R. I., Woods, P., Gouvea, V., Gorziglia, M., 
Flores, J., Das, B. K. and Bhan, M. K. 1992. Identification of group A 
rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 
30: 1365-1373. 
Gerna, G., Passarani, N., Sarasini, A. and Battaglia, A. 1985. 
Characterization of serotypes of human rotavirus strains by solid-phase 
immune electron microscopy. J. Infect. Dis. 152: 1143-1151. 
Gerna, G., Foster, J., Parea, M., Sarasini, A., di Mattio, F., Baldanti, 
B., Langosch, B., Schmidt, S. and Battaglia, M. 1990. Nosocomial 
outbreak of neonatal gastroenteritis caused by a new serotype 4, subtype 
4b human rotavirus. J. Med. Virol. 31: 175-182. 
Gething, M. J., White, J. M. and Waterfield, M. D. 1978. Purification 
of fusion protein of Sendai virus: Analysis of the NH2-terminal sequence 
generated during precursor activation. Proc. Natl. Acad. Sci. USA 75: 
2737-2740. 
Giesendorf, B., Bosch, F. X., Orlich, M., Schollstessik, C. and Rott, R. 
1986. Studies on the temperature sensitivity of influenza A virus 
reassortants non-pathogenic for chicken. Virus Res. 5: 27-42. 
Glass, R. I., Gentsch, J. and Smith, J. C. 1994. Rotavirus vaccines: 
success by reassortment? Science 265: 1389-1391. 
Gombold, J. L., Estes, M. K. and Ramig, R. F. 1985. Assignment of 
simian rotavirus SA11 temperature-sensitive mutant groups B and E to 
genome segments. Virology 143: 309-320. 
Gombold, J. L. and Ramig, R. F. 1986. Analysis of reassortment of 
genome segments in mice mixedly infected with rotaviruses SA 11 and 
RRV. J. Virol. 57: 110-116. 
208 
Gombold, J. L. and Ramig, R. F. 1989. Passive immunity modulates 
genetic reassortment between rotaviruses in mixedly infected mice. J. 
Virol. 63: 4525-4532. 
Gonzalez, S. A. and Burrone, O. R. 1991. Rotavirus NS26 is modified 
by addition of single O-linked residues of N-acetylglucosamine. Virology 
182: 8-16. 
Gorziglia, M., Larrea, C., Liprandi, F. and Esparza, J. 1985. 
Biochemical evidence for the oligomeric possible trimeric structure of the 
major inner capsid polypeptide (45K) of rotaviruses. J. Gen. Virol. 66: 
1889-1900. 
Gorziglia, M., Hoshino, Y., Midthun, K., Buckler-White, A., 
Blumentals, I., Glass, R., Flores, J., Kapikian, A. Z. and Channock, R. 
M. 1986. Conservation of amino acid sequence of VP8 and cleavage 
region of 84KDa outer capsid protein among rotavirus recovered from 
asymptomatic neonatal infection. Proc. Natl. Acad. Sci. USA 83: 7039- 
7043. 
Gorziglia; M., Hoshino, Y., Nishikawa, K., Maloy, W. L., Jones, R. 
W., Kapikian, A. Z. and Chanock, R. M. 1988a. Comparative sequence 
analysisof the genomic segment 6 of four rotaviruses each with a different 
subgroup specificity. J. Gen. Virol. 69: 1659-1669. 
Gorziglia, M., Green, K., Nishikawa, K., Tanaguchi, K., Jones, R., 
Kapiluan, A.. Z. and R. M. Chanock. 1988b. Sequence of the fourth 
gene of human rotaviruses recovered from asymptomatic or symptomatic 
infections. J. Virol. 62: 2978-2984. 
Gorziglia, M., Nishikawa, K., Hoshino, Y. and Taniguchi, K. 1990b. 
Similarity of the outer capsid protein VP4 of the Gottfried strain of 
porcine rotavirus to that of asymptomatic human rotavirus strains. J. 
Virol. 64: 414-418. ' 
Gorziglia, M. L. and Collins, P. L. 1992. Intracellular amplification and 
expression of a synthetic analog of rotavirus genomic RNA bearing a 
foreign marker gene: mapping cis-acting nucleotides in the 3'-noncoding 
region. Proc. Natl. Acad. Sci. USA 89: 5784-5788. 
Gouvea, V. S., Alenkar, A. A., Barth, 0. M., Castro, L. De., Fialho, 
A. M., Araoja, H. P., Majerowicz, S. and Pereira, H. G. 1986. 
Diarrhoea in mice infected with human rotavirus. J. Gen. Virol. 67: 577- 
581. 
209 
Gouvea, V., Glass, R. I., Woods, P., Taniguchi, K., Clark, H. F., 
Forrester, B. and Fang, Z. -Y. 1990. -Polymerase chain reaction 
amplification and typing of rotavirus nucleic acid from stool specimens. 
J. Clin. Microbiol. 28: 276-282. 
Gouvea, V., Allen, J. R., Glass, R. I., Fang, Z. -Y., Bremont, M., 
Cohen, J., McCrae, M. A., Saif, L. J., Sanarachatanant, P. and Caul, E. 
0.1991. Detection of group B and C rotaviruses by polymerase chain 
reaction. J. Clin. Microbiol. 29: 519-523. 
Gouvea, V., Ramirez, C., Li, B., Santos, N., Saif, L., Clarke, H. F. 
and Hoshino, Y. 1993. Restriction endonuclease analysis of the VP7 
genes of human and animal rotaviruses. J. Clin. Microbiol. 31: 917-923. 
Graham, A., Kudesia, G., Allen, A. M. and Desselberger, U. 1987. 
Reassortment of human rotaviruses possessing genome rearrangements 
with bovine rotavirus: non-randomness and evidence for host cell 
selection. J. Gen. Virol. 68: 115-122. 
Graham, D. Y. -, Estes, M. K. and Sackman, J. W. 1982. Rotavirus 
induces an osmotic diarrhoea in miniature swine. Gastroentrology 82: 
1072-1079. 
Grauballe, P. C., Vestergaard, B. F., Meyling, A. Genner, J. 1981. 
Optimized enzyme-linked immunosorbent assay for detection of human 
and bovine rotavirus in stools: comparison with electron microscopy, 
immunoelectroosmophoresis, and fluorescent antibody techniques. J. 
Med. Virol. 7: 29-40. 
Green, K. Y., Midthun, K., Gorziglia, M., Hoshino, Y., Kapikian, A. 
Z., Chanock, R. M. and Flores, J. 1987. Comparison of the amino acid 
sequences of the major neutralisation protein of four human rotavirus 
serotypes. Virology 161: 153-159. 
Green, K. Y., Sears, J. F., Taniguchi, K., Midthun, K., Hoshino, Y., 
Gorziglia, M., Nishikawa, K., Urasawa, S., Kapikian, A. Z., Chanock, 
R. M. and Flores, J. 1988. Prediction of human rotavirus serotype by 
nucleotide sequence analysis of the VP7 protein gene. J. Virol. 62: 1819- 
1823. 
Green, K. Y., Hoshino, Y. and Ikegami, N. 1989. Sequence analysis of 
the gene encoding the serotype-specific glycoprotein (VP7) of two new 
human rotavirus serotypes. Virology 168: 429-433. 
210 
Green, K. Y., Taniguchi, K., Mackow, E. and Kapikian, A. Z. 1990. 
Homotypic and heterotypic epitope-specific antibody response in adult 
and infant rotavirus vaccinees: implications for vaccine development. J. 
Infect. Dis. 61: 667-669. 
Green, K. Y. and Kapikian, A. Z. 1992. Identification of VP7 epitopes 
associated with protection against human rotavirus illness or shedding in 
volunteers. J: Virol. 66: 548-553. 
Green, K. Y., Sarasini, A., Quin, Y. and Gerna, G. 1992. Genetic 
variation in rotavirus serotype 4 subtypes. Virology 188: 362-368. 
Greenberg, H. B., Kalica, A. R., Wyatt, R. W., Jones, R. W., 
Kapikian, A. Z. and Channock, R. M. 1981. Rescue of noncultivable 
human rotavirus by gene reassortment during mixed infection with is 
mutants of a cultivable bovine rotavirus. Proc. Natl. Acad. Sci. USA 78: 
420-424. 
Greenberg, H. B., Flores, J., Kalica, A. R., Wyatt, R. G. and Jones, R. 
1983a. Gene cloning assignments for growth restriction, neutralization 
and subgroup specificities in the W and DS-1 strains of human rotavirus. 
J. Gen. Virol. 64: 313-320. 
Greenberg, H. B., Valdesuso, J., Van Wyke, K., Midthun, K., Walsh, 
M., McAuliffe, V., Wyatt, R. G., Kalica, A. R. and Flores, J. 1983b. 
Production and preliminary characterization of monoclonal antibodies 
directed at two surface proteins of 'rhesus rotavirus. J Virol. 47: 267-275. 
Greenberg, H. B., Vo, P. T. and Jones, R. 1986. Cultivation and 
characterization of three strains of murine rotavirus. J. Virol. 57: 585- 
590. 
Gunn, P. R., Sato, F., Powell, K. F. W., Bellamy, A. R., Napier, J. R., 
Harding, D. R. K., Hancock, W. S., Seigman, L. J. and Both, G. W. 
1985. Rotavirus neutralizing protein VP7: antigenic determinants 
investigated by sequence analysis and peptide synthesis. J. Virol. 54: 
791-797. 
Gurwith, M., Wenman, W., Hinde, D., Feltham, S. and Greenberg, H. 
B. 1981. A prospective study of rotavirus infection in infants and young 
children. J. Infect. Dis. 144: 218-224. 
Hagen, C. W. 1974. Colony husbandry. pp 23-47. In: Weisbroth, S. H., 
Flatt, R. E. and Kraus, A. L. (eds. ) The biology of laboratory rabbit. 
Academic Press Inc. New York. 
211 
Hall, G. A:, Bridger, J. C., Chandler, R. L. and Woode, G. N. 1976. 
Gnotobiotic piglets experimentally infected with neonatal calf diarrhoea 
reovirus-like agent (rotavirus). Vet. Pathol. 13: 197-210. 
Haller, O. , Arnheiter, H., Gresser, I. and 
Lindenmann, J. 1979. 
Genetically determined, interferon dependent resistance to influenza virus 
in mice. J. Exp. Med. 149: 601-612. 
Hardy, M., Gorziglia, M. and Woode, G. N. 1992. Amino acid sequence 
analysis of bovine rotavirus B223 reveals a unique outer capsid protein 
VP4 and confirms a third bovine VP4 type. Virology 191: 291-300. 
Heiber, J. P., Shelton, S., Nelson, J. D., Leon, J., Mohs, E. 1978. 
Comparison of human rotavirus disease in tropical and temperate settings. 
Am. J. Dis. Child. 132: 853-858. 
Helmberger-Jones, M. and Patton, J. T. 1986. Characterisation of 
subviral particles in cells infected with simian rotavirus SA11. Virology 
155: 655-665. 
Herring, A. J., Inglis, N. F., Ojeh, C. K., Snodgrass, D. R. and 
Menzies, J. D. 1982. Rapid diagnosis of rotavirus by direct detection of 
viral nucleic acid in silver-stained polyacrylamide gels. J. Clin. 
Microbiol. 16: 473-477. 
Hiti, A. L. and Nayak, D. P. 1982. Complete nucleotide sequence of the 
neuraminidase gene of human influenza virus A/WSN/33 J. Virol. 41: 
730-734. 
Hodes, H. L. 1977. Viral gastroenteritis. Am. J. Dis. Child 131: 729- 
731. 
Holland, J., Spindler, K., Horodyski, S., Grabau, E., Nichol, S. and 
VandePol, S. 1982. Rapid evolution of RNA genomes. Science 215: 
1577-1585. 
Holmes, I. H. 1983.. Rotaviruses. pp 359-423. In: Joklik, W. K. (ed. ) 
The Reoviridae. Plenum Publishing Corp. New York. 
Honda, A., Ueda, K., Nakata, K. and Ishihama, A. 1988. RNA 
polymerase of influenza virus : role of NP in RNA chain elongation. J. 
Biochem. 104: 1021-1026. 
212 
Horimoto, T. and Kawaoka, Y. 1994. Reverse genetics provides direct 
evidence for a correlation of haemagglutinin cleavibility and virulence of 
an avian influenza A virus. J. Virol. 68: 3120-3128. 
Hoshino, Y., Wyatt, R. G., Greenberg, H. B., Flores, J., and kapikian, 
A. Z. 1984. Serotypic similarity and diversity of rotaviruses of 
mammalian and avian origin as studied by plaque reduction 
neutralization. J. Infect. Dis. 149: 694-702. 
Hoshino, Y., Sereno, M., Midthun, M., Flores, J. and Kapikian, A. Z. 
1985a. Independent segregation of two antigenic specificities (VP3 and 
VP7) involved in neutralization of rotavirus infectivity. Proc. Natl. Acad. 
Sci., USA 82: 8701-8704. 
Hoshino, Y., Wyatt, R. G., Flores, J., Midthun, K. and Kapikian, A. 
Z. 1985b. Serotypic characterization of rotaviruses derived from 
asymptomatic human neonatal infection. J. Clin. Microbiol. 21: 425-430. 
Hoshino, Y., Gorziglia, M., Valdesuso, J., Askaa, J., Glass, R. I. and 
Kapikian, A. Z. 1987a. An equine rotavirus (FI-14 strain) which bears 
both subgroup I and subgroup II specificities on its VP6. Virology 157: 
488-496. 
Hoshino, Y., Sereno, M. M., Midthun, K., Flores, J., Kapikian, A. Z. 
and Chanock, R. M. 1987b. Analysis of plaque reduction neutralisation 
assay of intertypic rotaviruses suggests that gene reassortment occurs in 
vivo. J. Clin. Microbiol. 25: 290-294. 
Hoshino, 'Y., Saif, L. J., Sereno, M. M., Kapikian, A. Z. and Chanock, 
R. M. 1988. Infection immunity of piglets to either VP3 or VP7 outer 
capsid proteins confers resistance to challenge with a virulent rotavirus 
bearing the corressponding antigen. J. Virol. 62: 744-748. 
Hoshino, Y. and Kapikian, A. Z. 1994. Rotavirus vaccine development 
for the prevention of severe diarrhoea in infants and young children. 
Trends in Microbiol. 2: 242-249. 
Hrdy, D. B., Rubin, D. H. and Fields, B. N. 1982. Molecular basis of 
reovirus neurovirulence: role of M2 gene in avirulence. Proc. Natl. 
Acad. Sci. USA 79: 1298-1302. 
Huang, 'T. S., Palese, P. and Krystäl, M. 1990. Determination of 
influenza virus proteins required for genome replication. J. Virol. 64: 
5669-5673. 
213 
Hundley, F., McIntyre, M., Clark, B., Beards, G. M., Wood, D., 
Chrystie, I. and Desselberger, U. 1987. Heterogeneity of genome 
rearrangements in rotaviruses isolated from a chronically infected 
immunodeficient child. J. Virol. 61: 3365-3372. 
Ijaz, M. K., Attah-Poku, S. K., Redmond, M. J., Parker, M. D., 
Sabara, M. I. and Babiuk, L. A. 1991. Heterotypic passive protection 
induced by synthetic peptides corresponding to VP7 and VP4 of bovine 
rotavirus. J. Virol. 65: 3106-3113. 
Ijaz, M. °K.,, Sabara, M. I., Alkarmi, T., Frenchick. P. J., Ready, K. F., 
Dar, F. K. and Babiuk, L. A. 1994. Molecular determinants of rotavirus 
virulence - Localisation of a potential virulence site in a murine rotavirus 
VP4. Comp. Immunol. Microbiol. Infect. Dis. 17: 99-110. 
Institute of Medicine. 1985. New vaccine development, establishing 
priorities. Vol. I. Washington, DC, National Academy Press. 
Institute of Medicine. 1986. New vaccine development, establishing 
priorties. Vol. II. Washington, DC, National Academy Press. 
Johnson, M. A. and McCrae, M. A. 1989. Molecular biology of 
rotaviruses. VIII. Quatitative analysis of regulation of gene expresion 
during virus replication. J. Virol. 63: 2048-2055. 
Jones, C. D. 1993. The development, of a murine T-cell model for 
analysing the Th-cell response to a bovine rotavirus. Ph. D thesis, 
University of Warwick, Coventry, UK. 
Kabcenell, A. K. and Atkinson, -P. H. 1985. Processing of the rough 
endoplasmic reticulum membrane glycoproteins of rotavirus SA11. J. 
Cell . Biol., 101: 1270-1280. 
Kalica, A. R., Garon, C. F., Wyatt, R. G., Mebus, C. A., Van Kirk, D. 
H., Chanock, R. M. and Kapikian, A. Z. 1976. Differentiation of calf 
reovirus like agents associated with diarrhoea using polyacrylamide 
electrophorosis of RNA. Virology 74: 86-92. 
Kalica, A. R., Sereno, M. M., Wyatt, R. G., Mebus, C. A., Chanock, 
R. M. and Kapikian, A. Z. 1978. Comparision of human and animal 
rotavirus strains by gel electrophoresis of viral RNA. Virology 87: 247- 
255. 
214 
Kalica, A. R., Greenberg, H. B., Wyatt, R. G., Flores, J., Sereno, M. 
M., Kapikian, A. Z., and Chanock, R. M. 1981. Genes of human (strain 
Wa) and bovine (strain UK) rotavirus that code for neutralization and 
subgroup antigens. Virology 112: 385-390. 
Kalica, A. R., Flores, J. and Greenberg, H. B. 1983. Identification of 
rotavirus gene that codes for haemagglutination and protease enhanced 
plaque formation. Virology 125: 194-205. 
Kaijot, K. T., Shaw, R. D., Rubin, D. H. Greenberg, H. B. 1988. 
Infectious rotavirus enter cells by direct cell membrane penetration, not 
by endocytosis. J. Virol. 62: 1136-1144. 
Kang, S. Y., Nagaraja, K. V. and Newman, J. A. 1985. Rapid 
cöagglutination test for detection of rotaviruses in turkeys. Avian Dis. 29: 
640-648. 
Kapikian, A. Z., Kim, H. W., Wyatt, R. G., Rodriguez, W. J., Ross, 
S., Cline, W. L., Parrot, R. H. and Chanock, R. M. 1974. Reovirus-like 
agent in stools: Association with infantile diarrhoea and development of 
serologic tests. Science 185: 1049-1053. 
Kapikian, A. Z., C1ine, W.., L., Greenberg, H. B., Wyatt, R. G., Kalica, 
A. R., Banks, C. E., James, H. D. Jr., Flores, J. and Chanock, R. M. 
1981. Antigenic characterization of human and animal rotavirus by 
immune adherence haemagglutination assay ((IAHA): evidence for 
distinctness of IAHA and neutralization antigens. Infect. Immun. 33: 415- 
425. 
Kapikian, A. Z., Flores, J.,, Hoshino, Y., Glass, R. I., Midthun, K., 
Gorziglia, M. and Chanock, R. M. 1986. Rotavirus: the major etiologic 
agent of severe infantile diarrhoe may be controlled by a' Jennerian' 
approach to vaccination. J. Infect. Dis. 153: 815-822. 
Kapikian, A. Z. and Chanock, R. M. 1990. Rotaviruses. In: Virology. 
eds, B. N. Fields et al. (Raven Press Ltd. New York) pp 1353-1404. 
Katchikian, D., Orlich, M. and Rott, R. 1989. Increased viral 
pathogenicity after insertion of a 28S ribosomal RNA sequence into the 
haemagglutinin gene of an influenza virus. Nature (London) 340: 156- 
157., 
Kattoura, M. D., Clapp, L. L. and Patton, J. T. 1992. The rotavirus 
nonstructural protein, NS35, possesses RNA-binding activity in vitro and 
in vivo. Virology 191: 698-708. 
215 
Kawaoka, Y., Naeve, C. W. and Webster, R. G. 1984. Is virulence of 
H5N2 influenza viruses in chickens associated with loss of carbohydrate 
from the haemagglutinin? Virology 139: 303-316. 
Kawaoka, Y. and Webster, R. G. 1988. Sequence requirements for 
cleavage activation of influenza virus haemagglutinin expressed in 
mammalian cells. Proc. Natl. Acad. Sci. USA 85: 321-328. 
Kawaoka, Y. and Webster, R. G. 1989. Interplay between carbohydrate 
in the stalk and the length of the connecting peptide determines the 
cleavibility of influenza virus haemagglutinin. J. Virol. 63: 3296-3300. 
Kaye, K. M., Spriggs, D. R., Bassel-Duby, R., Fields, B. N. and Tyler, 
K. L. 1986. Genetic basis of altered pathogenesis of an immune-selected 
antigenic variant of reovirus type 3 Dearing. J. Virol. 59: 90-97. 
Kilham, L. and Margolis, G. 1969. Hydrocephalus in hamsters, ferrets, 
rats and mice following inoculation with reovirus typet. II. Pathologic 
studies. Lab. Invest. 21: 189-198. 
Kitaoka, S., Kono, T. and DeClercq, E. 1986. Comparative efficacy of 
broad-spectrum antiviral agents as inhibitors of rotavirus replication in 
vitro. Antiviral Res. 6: 57-65. 
Klenk, H. -D., Rott, R., Orlich, M. and Blodorn, J. 1975. Activation of 
influenza A virus by trypsin treatmment. Virology 68: 426-439. 
Klenk, H. -D. and Rott, R. 1980. Cotranslational and post-translational 
processing of viral glycoproteins. Curr. Top. Microbiol. Immunol. 90: 
19-48. 
Klenk, H. -D. and Rott, R. 1988. The molecular biology of influenza 
virus pathogenicity. Adv. Virus Res. 34: 247-281. 
Koike, S., Taya, C., Kurata, T., Abe, S., Ise, I., Yonekawa, H. and 
Nomoto, A. 1991. Transgenic mice susceptible to poliovirus. Proc. Natl. 
Acad. Sci. USA 88: 951-955. 
Kool, D. A., Matsui, S. M., Greenberg, H. B. and Holmes, I. H. 1992. 
Isolation and characterisation of anovel reassortant between avian Ty-1 
and simian RRV rotaviruses. J. Virol. 66: 6836-6839. 
216 
Kraft, L. M. 1957. Studies on the etiology and transmission of epidemic 
diarrhoea of infant mice. J. Exp. Med. 101: 743-755. 
Kumar, A., Charpilienne, A. and Cohen, J. 1989. Nucleotide sequence 
of the gene encoding for the RNA-binding protein (VP2) of RF bovine 
rotavirus. - Nucleic Acid Res. 17: 2126. 
La Monica, N., Meriam, C. and Racaniello, V. R. 1986. Mapping of 
sequences required for mouse neurovirulence of poliovirus type 2 
Lansing. J. Virol. 57: 515-525. 
La Monica, N., Kupsky, W. J. and Racaniello, V. R. 1987. Reduced 
mouse neurovirulence of poliovirus type 2 Lansing antigenic variants 
selected with monoclonal antibodies. Virology 161: 429-437. 
Labbe, M., Charpilenne, A., Crawford, S. E., Estes, M. K. and Cohen, 
J. 1991. Expression of rotavirus VP2 produces empty corelike particles. 
J. Virol. 65: 2946-2952. 
Laemmli, U. K. 1970. Cleavage of the structural proteins during the 
assembly of the head of bacteriophage T4. Nature (London) 227: 680- 
685. 
Laird, P. J., Ziderveld, A., Linders, K., Rudniki, M. A., Jaenisch, R. 
and Berns, A. 1991. Simplified mammalian DNA isolation procedure. 
Nucleic Acids Res. 15: 4293. 
Lamb, R. A. 1983. The influenza virus RNA segments and their encoded 
proteins. In: "Genetics of influenza viruses" (P. Palese and D. W. 
Kingsbury, eds. ), pp 21-69. Springer-Verlag, New York. 
Lamb, R. A. 1989. Genes and proteins of the influenza viruses. In : The 
influenza viruses (Krug, R. M. ed. ) Plennum, New York. 
Lanata, C., F., Black, R. E., del Aguila, R., Gil, A., Verastigui, H., 
Gerna, G., Flores, J., Kapikian, A. Z. and Andre, F. E. 1989. 
Protection of Peruvian children against rotavirus diarrhoea of specific 
serotypes by one, two, or three doses of RIT 4237 attenuated bovine 
rotavirus vaccine. J. Infect. Dis. 159: 452-459. 
Landschulz, W. H., Johnson, P. F. and McKnight, S. L. 1988. The 
leucine zipper: A hypothetical structure common to a new class of DNA 
binding proteins. Science 240: 1759-1764. 
217 
Larralde, G., Li, B., Kapikian, A. Z. and Gorziglia, M. 1991. Serotype- 
specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein. 
J. V irol . 65: 3213-3218. 
Larralde, G. and Gorziglia, M. 1992. Distribution of conserved and 
specific epitopes on the VP8 subunit of rotavirus VP4. J. Virol. 66: 
7438-7443. 
Li, S., Orlich, M. and Rott, R. 1990. Generation of seal influenza virus 
variants pathogenic for chickens because of haemagglutinin cleavage 
sites. J. Virol. 64: 3297-3303. 
Li, S., Schulman, J., Moran, T., Bona, C. and Palese, P. 1992. 
Influenza A virus transfectants with chimeric haemagglutinins containing 
epitopes from different subtypes. J. Virol. 66: 399-404. 
Li, S., Schulman, J., Itamura, S. and Palese, P. 1993a. Glycosylation of 
neuraminidase determines the neurovirulence of influenza A/WSN/33 
virus. J. Virol. 67: 6667-6673. 
Li, S., Polonis, V., Isobe, H., Zaghouani, H., Guinea, R., Moran, T., 
Bona, C. and Palese, P. 1993b. Chimeric influenza virus induces 
neutralising antibodies and cytotoxic T cells against human 
immunodeficiency virus type 1. J. Virol. 67: 6659-6666. 
Light, J. S. and Hodes, H. L. 1943. Studies on the epidemic diarrhoea of 
the newborn: isolation of a filterable agent causing diarrhoea in calves. 
Am. J. Public Health 33: 1451-1454. 
Light, J. S. and Hodes, H. L. 1949. Isolation from cases of infantile 
diarrhoea of a filterable agent causing diarrhoea in calves. J. Exp. Med. 
90: 113-135. 
Lin, M., Imai, M., Ikegami, N., Bellamy, A. R., Summers, D., Nuss, 
D. L., Diebel, R. and Furuichi, Y. 1987. cDNA probes of individual 
genes of human rotaviruses distinguish viral subgroups and serotypes. J. 
Virol. Methods 15: 285-289. 
Lindenmann, J. 1962. Resistance of mice to mouse adapted influenza A 
virus. Virology 16: 203-204. 
Lindenmann, J. 1964. Inheritance of resistance to influenza in mice. 
Proc. Soc. Exp. Biol. Med. 116: 505-509. 
218 
Liprandi, F.; Roderiguez, I., Pina, C., Larralde, G. Gorziglia, M. 1991. 
VP4 monotype specificities among porcine rotavirus strains of the same 
VP4 serotype. 65: 1658-1661. 
Little, L. M. and Shadduck, J. A. 1982. Pathogenesis of rotavirus 
infection in mice. Infect. Immun. 38: 755-763. 
Liu, M., Offit, P. A. and Estes, M. K. 1988. Identification of the Simian 
SAl 1 genome segment 3 product. Virology 163: 26-32. 
Liu, M., Mattion, N. M. and Estes, M. K. 1992. Rotavirus VP3 
expressed in insect cells possesses guanylyltransferase activity. Virology 
188: 77-84. 
Lopez; S., Arias, C. F., Bell, J. R., Strauss, J. H. and Espejo, R. T. 
1985. Primary structure of the cleavage site associated with trypsin 
enhancement of rotavirus SA11 infectivity. Virology 144: 11-19. 
Lopez, S:, Lopez, I., Romero, P., Mendez, E., Soberon, X. and Arias, 
C. F. 1991. Rotavirus YM gene 4: analysis of its deduced amino acid 
sequence and prediction of the secondary structure of the VP4 protein. J. 
Virol. 65: 3738-3745. 
Losonsky, G. A., Vonderfecht, S. L., Eiden, J., Wee, S. -B. and Yolken, 
R. H. 1986. Homotypic and heterotypic antibodies for prevention of 
experimental rotavirus gastroenteritis. J. Clin. Virol. 24: 1041-1044. 
Lourenco, M. H., Nicolas, J. C., Cohen, Scherrer, R. and Bricout, F. 
1981. Study of human rotavirus geriome by electrophoresis: Attempt of 
classification among strains isolated in France. Ann. Virol. 132: 161-173. 
Ludert, J. E., Gil, F., Liprandi, F. and Esparza, J. 1986. The structure 
of rotavirus inner capsid studied by electron microscopy of chemically 
disrupted particles. J. Gen. Virol. 67: 1721-1725. 
Lucknow, V. A. and Summers, M. D. 1988. Trends in the development 
of baculovirus expression vectors. Bio/Technology 6: 47-55. 
Luyjtes, M., Krystal, M., Enami, M., Parvin, J. D. and Palese, P. 1989. 
Amplification, expression , and packaging of a 
foreign gene by influenza 
virus. Cell 59: 1107-1113. 
Macadam, A., Pollard, S. R., Ferguson, G., Dunn, G., Skuce, R., 
Almond, J. W. Minor, P. D. 1991. The 5' non-coding region of type 2 
219 
poliovirus vaccine strain contains determinants of attenuation and 
temperature-sensitivity. Virology 181: 451-458. 
Macadam, A., Ferguson, G., Burlison, J., Stone, D., Skuce, R. Almond, 
J. W. and Minor, P. D. 1992. Correlation of RNA secondary structure 
and attenuation of Sabin vaccine strains of poliovirus in tissue-culture. 
Virology 189: 415-422. 
Macadam, A., Pollard, S. R., Ferguson, G., Skuce, R. Wood, D., 
Skuce, R., Almond, J. W. and Minor, P. D. 1993. Genetic basis of 
attenuation of Sabin type 2 vaccine strain of poliovirus in primates. 
Virology 192: 18-26. 
Mackow, E. R., Shaw, R. D., Matsui, S. M., Vo, P. T., Dang, M. N. 
and Greenberg, H. B. 1988a. The rhesus rotavirus gene encoding protein 
VP3: Location of amino acids involved in homologous and heterologous 
rotavirus neutralization and identification of a putative fusion region. 
Proc. Natl. Acad. `Sci. USA 85: 645-649. 
Mackow, E. R., Shaw, R.. D., Matsui, S. M., Vo, P. T., Benfield, D. 
A. and Greenberg, H. B. 1988b. Characterisation of homotypic and 
heterotypic VP7 neutralisation sites of rhesus rotavirus. Virology 165: 
511-517. ' 
Mackow, E. R., Barnett, J. W., Chan, H. and Greenberg, H. B. 1989. 
The rhesus rotavirus outer capsid protein VP4 functions as a 
haemagglutinin and is antigenically conserved when expressed by a 
baculovirus recombinant. J. Virol. 63: 1661-1668. 
Mackow, E. R., Vo, P. T., Broome, R. Bass, D. and Greenberg, H. B. 
1990. Immunisation with baculovirus expressed VP4 protein passively 
protects against simian and murine rotavirus challenge. J. Virol. 64: 
1698-1703. 
Malherbe, H. and Harwin, H. 1963. The cytopathic effects of vervet 
monkey viruses. S. Afr. Med. J. 37: 407-411. 
Malherbe, H. and Strickland-Cholmley, M. 1967. Simian virus SA11 and 
the related 0 agent. Arch. Virol. 22: 235-245. 
Margolis, G., Kilham, L. and Gonatos, N. 1971. Reovirus type III 
encephalitis: Observations of virus-cell interactions in neural tissues. I. 
Light microscopic studies. Lab. Invest. 24: 91-109. 
220 
Martin, A., Wychowsky, C ., Couderc, T., Crainic, R., Hogle, J., and 
Girard, M. 1988. Engineering a poliovirus type 2 antigenic site on a type 
1 capsid results in a chimeric virus which is neurovirulent for mice. 
EMBO J. 7: 2839-2847. 
Martin, A., Benichou, D., Couderc, T., Hogle, J., Wychowsky, C., van 
der Werf, S. and Girard, M. 1991. Use of typel/type 2 chimeric 
poliovirus to study determinants of poliovirus type 1 neurovirulence in a 
mouse model. Virology 180: 648-658. 
Martin, J., Albo, C., Ortin, J., Melero, J. A. and Portela, A. 1992. In 
vitro reconstitution of active influenza virus ribonucleoprotein complexes 
using viral proteins purified from infected cells. J. Gen. Virol. 73: 1855- 
1859. 
Mason, B. B., Graham, D. Y. and Estes, M. K. 1980. In vitro 
transcription and translation of simian rotavirus SA11 gene products. J. 
Virol. 33: 1111-1121. 
Mason, B. B., Graham, D. Y. and Estes, M. K. 1983. Biochemical 
mapping of simian rotavirus SA11 genome. J. Virol 46: 413-423. 
Mathews, R. E. F. 1979a. The classification and nomenclature of 
viruses. Intervirology 11: 133-135. 
Mathews, R. E. F. 1979b. Classification and nomenclature of viruses. 
Intervirology 12: 196-206. 
Mathews, R. E. F. 1982. Classification and nomenclature of viruses. 
Intervirology 17: 81-88. 
Matsui, S. M., Mackow, E. R. and Greenberg, H. B. 1989. Molecular 
determinants of rotavirus neutralization and protection. Adv. Virus Res. 
36: 181-214. 
Matsuno, S., Murakami, S., Takagi, M., Hayashi, M., Inouye, S., 
Hasegawa, A. and Fukai, K. 1987. Cold-adaptation of human rotavirus. 
Virus Res. 7: 273-280. 
Mattion, N. M., Mitchell, D. B., Both, G. W. and Estes, M. K. 1991. 
Expression of rotavirus proteins encoded by alternative open reading 
frames of genome segment 11. Virology 181: 295-304. 
221 
Mattion, N. M., Cohen, J., Aponte, C. and Estes, M. K. 1992. 
Characterization of an oligomerization domain and RNA-binding 
properties on rotavirus non-structural protein NS34. Virology 190: 68-83. 
McCrae, M. A. and Joklik, W. K. 1978. The nature of the polypeptide 
encoded by each of the ten double-stranded RNA segments of reovirus 
type 3. Virology 89: 578-593. 
McCrae, M. ' A. and Faulkner-Valle, G. P. 1981. Molecular biology of 
rotaviruses I. Characterisation of basic growth parameters and pattern of 
macromolecular synthesis. J. Virol. 39: 490-496. 
McCrae, M. A. and McCorquodale, J. G. 1982. The molecular biology 
of rotaviruses II. Identification of protein coding assignments of calf 
rotavirus genome RNA species. Virology 117: 435-443. 
McCrae, M. A. and McCorquadole, J. G. 1983. The molecular biology 
of rotaviruses. V. Terminal structure of viral RNA species. Virology 
126: 204-212. 
McCrae, M. A. 1985. Double-stranded RNA viruses. In: Virology a 
practical approach, pp 151-168. ed. Mahy, B. W. J. IRL Press, Oxford 
and Washington D. C. 
McCrae, M. A. 1987. Nucleic acid based analysis on non-group A 
rotaviruses. CIBA Synip. 128: 22-48. 
McCrae, M. A. and McCorquodale, J. G. 1987. Expression of the major 
bovine neutralisation antigen (VP7c) in Escherichia coll. Gene 55: 9-18. 
McNulty, M. S. 1978. Rotaviruses. J. Gen. Virol. 40: 1-18. 
McNulty, M. S., Allen, G. M. and Stuart, J. C. 1978. Rotavirus 
infection in avian species. Vet. Rec. 103: 319-320. 
McNulty, M. S., Allen, G. M., Todd, G. and McFerran, J. B. 1979. 
Isolation and cell culture propagation of rotaviruses from turkeys and 
chickens. Arch. V irol . 61: 13-21. 
Mebus, C. A., Underdahl, N. R., Rhodes, M. B. and Twiehaus, M. J. 
1969. Calf diarrhoea (scours): reproduced with a virus from a field 
outbreak. Bull. Neb. Agric. Exp. Station 233: 1-16. 
222 
Mebus, C. A., Kono, M., Underdahl, N. R. and Twiehaus, M. J. 1971. 
Cell culture propagation of neonatal calf diarrhoea (scours) virus. Can. 
Vet. J. 12: 69-72. 
Mebus, C. A., White, R. G., Bass, E. P. and Twiehaus, M. J. 1973. 
Immunity to neonatal calf diarrhoea virus. J. Am. Vet. Med. Assoc. 163: 
880-887. 
Mebus, C. A., Wyatt, R. G., Sharpee, R. L., Sereno, M. M., Kalica, A. 
R., Kapikian, A. Z. and Twiehaus, M. J. 1976. Diarrhoea in gnotobiotic 
calves caused by reovirus-like agent of human infantile gastroenteritis. 
Infect. immun. 14: 471-474. 
Mebus, C. A. and Newman, L. E. 1977. Scanning electron, light and 
immunofluoroscent microscopy of gnotobiotic calf infected with reovirus- 
like agent. Am. J. Vet. Res. 38: 553-558. 
Meyer, J. C., Bergmann, C. C. and Bellamy, A. R. 1989. Interaction of 
rotavirus cores with the non-structural glycoprotein NS28. Virology 171: 
98-107. 
Middleton, P. J. ", Szymanski, M. T., Abbott, G. D., Bortolussi, R. and 
Hamilton, J. R. 1974. Orbivirus acute gastroenteritis of infancy. Lancet 
1: 1241-1244. 
Middleton, P. J., Holdaway, M. D., Petric, M., Szymanski, M. T. and 
Tam, J. S. 1977. Solid-phase radioimmuno assay for the detection of 
rotavirus. Infect. Immun. 16: 439-444. 
Middleton, P. J. 1978. Pathogenesis of rotavirus infection. J. Am. Vet. 
Med.. Assoc. 173: 544-546. 
Midthun, K., Greenberg, H. B., Hoshino, Y., Kapikian, A. Z., Wyatt, 
R. G. and Chanock, R. M. 1985. Reassortant rotaviruses as potential live 
rotavirus vaccine candidates. J. Virol. 53: 949-954. 
Midthun, K., Hoshino, Y., Kapikian, A. Z. and Chanock, R. M. 1986. 
Single gene substitution rotavirus reassortants containing the major 
neutralisation protein (VP7) of human rotavirus serotype 4. J. Clin. 
Virol. 24: 822-826. 
Mitchell, D. B. and Both, G. W. 1990a. Completion of the genomic 
sequence of the simian rotavirus SA 11: nucleotide sequences of segments 
1,2, and 3. Virology 177: 324-331. 
223 
Mitchell, D. B. and Both, G. W. 1990b. Conservation of a potential 
metal binding motif despite extensive sequence diversity in the rotavirus 
nonstructural protein NS53. Virology 174: 618-621. 
Miura, K., Onodera, T., Nishida, A., Goto, N. and Fujisaki, Y. 1990. A 
single gene controls resistance to Japanese encephalitis virus in mice. 
Arch. Virol. 112: 261-270.1 1 
Moss, E. G. and Racaniello, V. R. 1990. Host range determinants 
located on the interior of poliovirus capsid. EMBO J. 10: 1067-1074. 
Murakami, Y., Nishioka, N., Watanabe, T. and Kuniyasu, C. 1986. 
Prolonged excretion and failure of cross protection between distinct 
serotypes of bovine rotavirus. Vet Microbiol. 12: 7-14. 
Murrey, M. G., Bradley, J., Yang, X. F., Wimmer, E., Moss, E. G. 
and Racaniello, V. R. 1988. Poliovirus host range is determined by a 
short amino acid sequence in neutralization antigenic site 1. Science 241: 
213-215. 
Nagai, Y., Klenk, H. -D. and Rott, R. 1976. Proteolytic cleavage of the 
viral glycoproteins and its significance for the virulence of Newcastle 
disease virus. Virology 72: 494-508. 
Nakagomi, 0., Nakagomi, T., Hoshino, Y., Flores, J. and Kapikian, A. 
Z. 1987. Genetic analysis of a human rotavirus that belongs to subgroup I 
but has an RNA pattern typical of subgroup II human rotavviruses. J. 
Clin. Microbiol. 25: 1159-1164. 
Nakagomi, 0., Nakagomi, T., Akatani, K. and Ikegami, N. 1989. 
Identification of rotavirus genogroups by RNA: RNA hybridisation. Mol. 
Cell. Probes. 3: 251-261. 
Newman, J. E. F., Brown, F., Bridger, J. C. and Woode, G. N. 1975. 
Characterization of a rotavirus. Nature 258: 631-633. 
Nicolas, J. C., Pothier, P., Cohen, J., Laurenco, M. H., Thompson, R., 
Guimbaud, P. Chenon, A., Dauvergne, M. and Bricout, F. 1984. Survey 
of human rotavirus propagation as studied by electrophoresis of genomic 
RNA. J. Infect. Dis. 49: 688-693. 
Nishikawä, K., Tanaguchi, K., Torres, A., Hoshino, Y., Green, K., 
Kapikian, A. Z., Chanock, R. M. and Gorziglia, M. 1988. 
224 
Comparative analysis of VP3 gene of divergent strains of rotaviruses 
simian SA 11 and Nebraska calf diarrhoea virus. J. Virol. 62: 4022-4026. 
Nomoto, A., Kajigaya, S., Suzuki, K. and Imura, N. 1979. Possible 
point mutation sites in LSc, 2ab poliovirus RNA and a protein covalently 
linked to the 5'-terminus. J. Gen. Virol. 45: 107-117. 
Nomoto, A., Omata, T., Toyoda, H., Kuge, S., Horie, H., Kataoka, Y., 
Genba, Y. and Imura, N. 1982., Complete nucleotide sequence of the 
attenuated poliovirus Sabin 1 strain genome. Proc. Natl. Acad. Sci. USA 
79: 5793-5797. 
Offit, P. A., Clark, H. F. and Plotkin, S. A. 1983. Response of mice to 
rotaviruses of bovine or primate origin assessed by radioimmunoassay, 
radioimmunoprecipitation, and plaque reduction neutralization. Infect. 
Immun. 42: 293-300. 
Offit, P. A., Clark, H. F., Kornstein, M. J. and Plotkin, S. A. 1984. A 
murine model for oral infection with a primate rotavirus (simian SA11). 
J. Virol. 51: 233-236. 
Offit, P. A. and Clark, H. F. 1985a. Protection against rotavirus induced 
gastroenteritis in a murine model by passively acquired gastrointestinal 
but not circulating antibodies. J. Virol. 54: 58-64. 
Offit, P. A. and Clark, H. F. 1985b. Maternal antibody-mediated 
protection against gastroenteritis due to rotavirus in newborn mice is 
dependent on both serotype and antibody titre. J. Infect. Dis. 152: 1152- 
1158. 
Offit, P. A., Blavat, G., Greenberg, H. B. and Clark, H. F. 1986. 
Molecular basis' of rotavirus virulence: role of gene segment 4. J. Virol. 
57: 46-49. 
Offit, P. A. and Blavat, G. 1986. Identification of two rotavirus genes 
determining neutralization specificities. J. Virol. 57: 376-378. 
Offit, P. A., Shaw, R. D. and Greenberg, H. B. 1986b. Passive 
protection against rotavirus induced diarrhoea by monoclonal antibodies 
to surface proteins VP3 and VP7. J. Virol. 58: 700-703. 
Offit, P. A. and Dudzik, K. I. 1988. Rotavirus-specific cytotoxic T 
lymphocytes cross-react with target cells infected with different rotavirus 
serotypes. J. Virol. 62: 127-131. 
225 
Offit, P. A. and Dudzik, K. I. 1989. Rotavirus-specific cytotoxic T 
lymphocytes appear at the intestinal mucosal surface after rotavirus 
infection. J. Virol. 63: 3507-3512. 
Offit, P. A. and Dudzik, K. I. 1990. Rotavirus-specific cytotoxic T 
lymphocytes passively protect against gastroenteritis in suckling mice. J. 
Virol. 64: 6325-6328. 
Offit, P. A. and Svoboda, Y. M. 1989. Rotavirus-specific cytotoxic T 
lymphocytes response of mice after oral inoculation with candidate 
rotavirus vaccine strains RRV or WC3. J. Infect. Dis. 160: 783-788. 
Offit, P. A., Boyle, D. B., Both, G. W., Hill, N. L., Svoboda, Y. M., 
Cunningham, S. L., Jenkins, R. J. and McCrae, M. A. 1991. Outer 
capsid glycoprotein VP7 is recognised by cross-reactive, rotavirus- 
specific, cytotoxic T lymphocytes. Virology 184: 563-568. 
Offit, P. A., Coupar, B. A., Svoboda, Y. M., - Jenkins, R. J., McCrae, 
M. A., Abraham, A., Hill, N. L., Boyle, D. B., Andrew, M. E. and 
Both, G. W. 1994. Induction of rotavirus-specific cytotoxic T 
lymphocytes by vaccinia virus recombinants expressing individual 
rotavirus genes. Virology 198: 10-16. 
Ohuchi, M., Orlich, M., Ouchi, R., Simpson, B. E., Garten, W., Klenk, 
H. -D. and Rott, R. 1989. Mutations at the cleavage site of the 
haemagglutinin alter the pathogenicity of influenza virus A/Chick/Penn/ 
83 (H5N2). Virology 168: 274-280. 
Palese, P. 1977. The genes of influenza virus. Cell 10: 1-10. 
Parvin, J. D., Palese, P., Honda, A., Ishihama, A. and Krystal, M. 
1989. Promotor analysis of influenza virus RNA polymerase. J. Virol. 
63: 5142-5152. 
Pasamontes, L., Gubser, J., Wittek, R. and Viljoen, G. J. 1991. Direct 
identification of recombinant vaccinia virus plaques by PCR. J. Virol. 
Methods 35: 137-141. 
Patton, J. T. and Gallegos, C. 0.1988. Structure and protein 
composition of rotavirus replicase particle. Virology 166: 358-365. 
Pedley, S., Bridger, J. C., Brown, J. F. and McCrae, M. A. 1983. 
Molecular characterization of rotaviruses with distinct group antigens. J. 
Gen. V irol . 64: 2093-2101. 
226 
Pedley, S., Hundley, F., Chrystie, I., McCrae, M. A. and Desselberger, 
U. 1984. The genomes of rotaviruses isolated from chronically infected 
immunodeficient children. J. Gen. Virol. 65: 1141-1150. 
Pedley, S., and McCrae, M. A. 1984. A rapid screening assay for 
detecting individual RNA species in field isolates of rotaviruses. J. Virol. 
Methods 9: 173-181. 
Pedley, S., Bridger, J. C., Chasey, D. and McCrae, M. A. 1986. 
Definition of two new groups of atypical rotaviruses. Arch. Virol. 67: 
131-137. 
Percy, N., Barclay, W. S., Garcia-Sastre, A. and Palese, P. 1994. 
Expression of a foreign protein by influenza A virus. J. Virol. 68: 4486- 
4492. 
Perez-Schael, I., Daoud, G., White, L., Urbina, G., Daoud, N., Perez, 
M. and Flores, J. 1984. Rotavirus shedding by newborn children. J. 
Med. Virol. * 14: 127-136. 
Perez-Schael, I., Blanco, M., Vilar, M., Garcia, D., White, L., 
Gonzalez, R. and Flores, J. 1990. Clinical studies of a quadrivalent 
rotavirus vaccine in Venezuelan infants. J. Clin. Microbiol. 28: 553-558. 
Petric, M., Szymanski, M. T. and Middleton, P. J. 1975. Purification 
and preliminary characterization of infantile gastroenteritis virus 
(orbivirus group). Intervirology 5: 233-238. 
Petrie, B. L., Greenberg, H. B., Graham, D. Y. and Estes, M. K. 1984. 
Ultrastructural localization of rotavirus antigens using colloidal gold. 
Virus Res. 1: 133-152. 
Pizarro, J. L., Sandino, A. M., Pizarro, J. M., Fernandez, J. and 
Spencer, E. 1991. Characterization of rotavirus guanylyltransferase 
activity associated with polypeptide VP3. J. Gen. Virol. 72: 325-332. 
Porter, K. R., Polo, S. L., Long, G. W., Merritt, S. C. and Oprandy, J. 
J. 1991. A rapid membrane based viral RNA isolation method for the 
polymerase'chain reaction. Nucleic Acids Res. 14: 4011. 
Poruchynsky, M. S., Tyndall, C., Both, G. W., Sato, F., Bellamy, A. 
R. and Atkinson, P. A. 1985. Deletions into an NH2-terminal 
hydrophobic domain result in secretion of rotavirus VP7, a resident 
227 
endoplasmic reticulum membrane glycoprotein. J. Cell. Biol. 101: 2199- 
2209. 
Prasad, B. V. V., Wang, G. J., Clerx, J. P. M. and Chiu, W 1988. 
Three-dimensional structure of rotavirus. J. Mol. Biol. 199: 269-275. 
Prasad, B. V. V., Burns, J. W., Marietta, E., Estes, M. K. and Chiu, 
W. 1990. Localization of VP4 neutralization sites in rotavirus by three- 
dimensional cryo-electron microscopy. Nature 343: 476-479. 
Prasad, B., V. V. and Chiu, W. 1994. Structure of rotavirus. Curr. 
Topics Microbiol. Immunol. 185: 9-30. 
Qian, Y. - and Green K. Y. 1991. Human rotavirus strain 69M has a 
unique VP4 as determined by amino acid sequence analysis. Virology 
182: 407-412. 
Racaniello, V. R. and Baltimore, D. 1981. Molecular cloning of 
poliovirus cDNA and determination of complete nucleotide sequence of 
the viral genome. Proc. Natl. Acad. Sci. USA 78: 4887-4891. 
Raine, C. S. and Fields, B. N. 1973. Reovirus type 3 encephalitis -- a 
virological and ultrastructural study. J. Neuropath. Exp. Neurol. 32: 19- 
33. 
Ramig, 'R. F. 1983. Factors that affect genetic interaction during mixed 
infection with temperature-sensitive mutants of simian rotavirus SA 11. 
Virology 127: 91-99. 
Ramig, R. F. 1988. The effects of host age, virus dose, and virus strain 
on heterologous rotavirus infection in suckling mice. Microb. Pathog. 4: 
189-202. 
Ramig, R. F., Garrison, C., Chen, D. -Y. and Bell-Robinson, D. 1989. 
Analysis of reassortment and superinfection during mixed infection of 
Vero cells with bluetongue virus serotypes 10 and 17. J. Gen. Virol. 70: 
2595-2603. 
Ramig, R. F. and Galle, K. L. 1990. Rotavirus gene segment 4 
determines viral replication phenotype in cultured liver cells (HepG2). J. 
Virol. 64: 1044-1049. 
228 
Ramig, R. F. 1990. Superinfecting rotaviruses are not excluded from 
genetic interaction during asynchronous mixed infection in vitro. 
Virology 176: 308-310. 
Redmond, ` M. J., Sabara, M. I. and Babiuk, L. A. 1993. Rotavirus 
vaccinology: current approaches in rotavirus vaccine development. In: 
Control of virus diseases. Kurstak, E. (ed. ) Marcel Dekker Inc. New 
York. pp 387-404. 
Reed, L. J. and Muench, M. 1938. A simple method for estimating fifty 
percent endpoints. Am. J. Hyg. 27: 493-497. 
Ren, R. Costantini, F., Gorgacz, E. J., Lee, J. J. and Racaniello, V. R. 
1990. Transgenic mice expressing a human poliovirus receptor: a new 
model for poliomyelitis. Cell 63: 353-362. 
Ren, R., Moss, E. G. and Racaniello, V. R. 1991. Identification of two 
determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65: 
1377-1382. 
Richardson, C. D., Scheid, A. and Choppin, P. W. 1980. Specific 
inhibition of paramyxovirus and myxovirus replication by oligopeptides 
with amino acid sequences similar to those at the N-termini of the F1 or 
HA2 viral polypeptides. Virology 105: 205-222. 
Richardson, C. D. and Choppin, P. W. 1983. Oligopeptides that 
specifically inhibit membrane fusion by paramyxoviruses: studies on the 
site of action. Virology 131: 518-532. 
Riepenhoff-Talty, M., Lee, P. -C., Carmody, P. J., Barret, H. J. and 
Ogra, I. 1982. Age-dependent rotavirus enterocyte interactions. Proc. 
Soc. Exp. Biol. Med. 170: 146-154. 
Riepenhoff-Talty, M., Dharakul, T., Kowalski, E., Michalak, S. and 
Ogra, P. L. 1987. Persistent rotaviral infection in mice with severe 
combined immunodeficiency. J. Virol. 61: 3345-3348. 
Rodger, S. M., Schnagl, R. D. and Holmes, I. H. 1975. Biochemical and 
biophysical characterization of diarrhoea virus of human and calf origin. 
J. Virol. 16: 1229-1235. 
Rodger, S. M. and Holmes, I. H. 1979. Comparisions of the genomes of 
simian, bovine, and human rotaviruses by gel electrophoresis and 
229 
detection of genomic variation among bovine isolates. J. Virol. 30: 839- 
846. 
Rodriguez, W. J., Kim, H. W., Brandt, C. D., Schwartz, R. H., 
Gardner, M. K., Jeffries, B., Parrott, R. H., Kaslow, R. A., Smith, J. I. 
and Kapikian, A. Z. 1987. Longitudinal study of rotavirus infection and 
gastroenteritis in families served by a pediatric medical practice: Clinical 
and epidemiological observations. Pediatr. Infect. Dis. J. 6: 170-176. 
Roner, M. R., Sutphin, L. A. and Joklik, W. K. 1990. Reovirus RNA is 
infectious. Virology 179: 845-852. 
Rosen, L. 1960. Serologic grouping of reoviruses by haemagglutination- 
inhibition. Am. J. Hyg. 71: 243 
Roseto, A., Esgaig, J., Delain, E., Cohen, J. and Scherrer, R. 1979. 
Structure of rotaviruses as studied by the freeze-drying technique. 
Virology 98: 471-475. 
Rott, R., Orlich, M. and Scholtissek, C. 1979. Correlation of 
pathogenicity and gene constellation of influenza A virus. III. Non- 
pathogenic recombimants derived from highly pathogenic parent strains. 
J. Gen. Virol. 44: 471-477. 
Rott, R., Orlich, M., Klenk, H. -D., Wang M. L., Skehel, J. J. and 
Wiley, D. C. 1984. Studies on the adaptation of influenza viruses to 
MDK cells. EMBO J. 3: 3329-3332. 
Rozinov, M. N. and Fields, B. N. 1994. Interferance following mixed 
infection of reovirus isolates is linked to the M2 gene. J. Virol. 68: 6667- 
6671. 
Rubin, D. and Fields, B. N. 1980. The molecular basis of reovirus 
virulence: the role of M2 gene. J. Exp. Med. 152: 853-868. 
Ruggeri, ' F. M. and Greenberg, H. B. 1991. Antibodies to trypsin peptide 
VP8 neutralize rotavirus by inhibiting binding of the virions to target 
cells in culture. J. Virol. 65: 221-2219. 
Sabara, M., Gilchrist, J. E., Hudson, G. R. and Babiuk, L. A. 1985. 
Preliminary characterization of an epitope involved in neutralization and 
cell attachment that is located on the major bovine rotavirus glycoprotein. 
J. Virol. 53: 58-66. 
230 
Sabara, M. K., Reddy, K. F. M., Frenchick, P. J. and Babiuk, L. A. 
1987. Biochemical evidence for the oligomeric arrangement of bovine 
rotavirus nucleocapsid protein and its possible significance in the 
immunogenicity of this protein. J. Gen. Virol. 68: 123-133. 
Sabin, A. B. and Bougler, L. R. 1973. History of the Sabin attenuated 
poliovirus oral live vaccine strains. J. Biol. Stand. 1: 115-118. 
Sack, D. A., Rhoads, M., Molla, A., Molla, A. M. and Wahed, M. A. 
1982. Carbohydrate malabsorption in infants with rotavirus diarrhoea. 
Am. J. On. Nutr. 36: 1112-1118. 
Saif, L. J., Redman, D. R., Smith, K. L. and Theil, K. W. 1983. 
Passive immunity to bovine rotavirus in newborn calves fed colostrum 
supplements from immunised or non-immunised cows. Infect. Immun. 
41: 1118-1131. 
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, J. T., Erlich, 
H. A. and Arnheim, N. 1985. Enzymatic amplification of ß-globin 
genomic sequences and restriction site analysis for diagnosis of sickle cell 
anemia. Science 230: 1350-1354. 
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S., Higuchi, R., Horn, 
J. T., Mullis, K. B. and Erlich, H. A. 1988. Primer-directed enzymatic 
amplification of DNA with a thermostable DNA polymerase. 239: 487- 
491. 
Sambrook, J., Fritsch, E. F. and Maniatis, T. 1989. Molecular cloning : 
A laboratory mannual, 2nd edition, Cold Spring Harbour Laboratory, 
New York. 
Sandino, A. M., Jashes, M., Faundez, G. and Spencer, E. 1986. Role of 
inner capsid protein on in vitro human rotavirus transcription. J. Virol. 
60: 797-802. 
Sanger, F., Nicklen, S. and Coulson, A. R. 1977. DNA sequencing with 
chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463-5467. 
Sato K., Inaba, Y., Miura, Y., Tokuhisa, S. and Matumoto, M. 1982. 
Antigenic relationships between rotavirus from different species as 
studied by neutralization and immunoflorescence. Arch. Virol. 73: 45-50. 
231 
Schell, K. 1960. Studies in the innate resistance of mice to infection with 
mousepox. I. Resistance and antibody production. Austral. J. Exp. Biol. 
Med. Sci. 38: 271. 
Scholtissek, C., Rott, R., Orlich, M., Harms, E. and Rohde, W. 1977. 
Correlation of pathogenicity and gene constellation of influenza A virus 
(fowl plague). Exchange of a single gene. Virology 81: 74-80. 
Scholtissek, C., Vallbracht, A., Flehmig, B. and Rott, R. 1979. 
Correlation of pathogenicity and gene constellation of influenza A 
viruses. II. Highly neurovirulent recombinants derived from non- 
neurovirulent or weakly neurovirulent parent virus strains. Virology 95: 
492-500. 
Scott, G. S., Tarlow, 0. and McCrae, M. A. 1989. Detailed structural 
analysis of a genome rearrangement in bovine rotavirus. Virus Res. 14: 
119-128. 
Schulman, J. L. and Palese, P. 1977. Virulence factors of influenza 
viruses. WSN virus neuraminidase is required for productive infection of 
MDBK cells. J. Virol. 24: 170-176. 
Schulman, J. L. 1983. Virus-determined differences in the pathogenesis of 
influenza viruses. In: "Genetics of influenza viruses" (P. Palese and D. W. 
Kingsbury, eds. ), pp 305-320. Springer-Verlag, New York. 
Shahrabadi, M. S., Babiuk, L. A. and Lee, P. W. K. 1987. Further 
analysis of the role of calcium in rotavirus morphogenesis. Virology 158: 
103-111. 
Shaw, R. D., Vo, P. T., Offit, P. A., Coulson, B. S. and Greenberg, H. 
B. ý 1986. Antigenic mapping of the surface proteins of rhesus rotavirus 
Virology 155: 434-451. 
Shaw, A. L., Rothnagel, R., Chen, D., Ramig, R. F., Chiu, W. and 
Prasad, B. V. V. 1993. Three-dimensional visualization of the rotavirus 
haemagglutinin structure. Cell 74: 693-701. 
Shen, S., Burke, B. and Desselberger, U. 1993. Nucleotide sequence of 
VP4 and VP7 genes of a chinese lamb rotavirus: evidence for a new P 
type in a G10 type virus. Virology 197: 497-500. 
232 
Sheridan, J. F., Eydelloth, R. S., Vonderfecht, S. L. and Aurelian, L. 
1983. Virus-specific immunity in neonatal and adult rotavirus infection. 
Infect. Immun. 39: 917-927. 
Shirley, J. A., Beards, G. M., Thouless, M. E. and Flewett, T. H. 1981. 
The influence of divalent cations on the stability of human rotavirus. 
Arch. Virol. 67: 1-9. 
Skinner, M. A., Racaniello, V. R., Dunn, G., Cooper, J., Minor, P. D. 
and Almond, J. W. 1989. New model for the secondary structure of 5' 
non-coding RNA of poliovirus is supported by biochemical and genetic 
data that also show that secondary structure is important in 
neurovirulence. J. Mol. Biol. 207: 379-392. 
Smee, D. F., Sidwell, R. W., Clark, S. M., Barnett, B. B. and 
Spendlove, R. S. 1982. Inhibition of rotaviruses by selected antiviral 
substances: mechanism of viral inhibition and in vivo activity. 21: 66-73. 
Smeenk, C. and Brown, E. G. 1994. The influenza virus variant 
A/FM/1/47-MA possess single amino acid replacements in the 
haemagglutinin, controlling virulence, and in the matrix protein, 
controlling virulence as well as growth. J. Virol. 68: 530-534. 
Smith, M. L., Lazdins, I. and Holmes, I. H. 1980. Coding assignments 
of double-stranded RNA segments of SA11 rotavirus established by in 
vitro translation. J. Virol. 33: 976-982. 
Smith, E. M. and Gerba, C. P. 1982. Development of a method for 
detection of human rotavirus in water and sewage. Appl. Environ. 
Microbiol. 43: 1440-1450. 
Snodgrass, D. R. and Wells, P. W. 1976. Rotavirus infection in lambs: 
Studies on passive protection. Arch. Virol. 52: 201-205. 
Snodgrass, D. R. and Herring, J. A. 1977. The activity of disinfectants 
on lamb rotavirus. Vet. Rec. 101: 81. 
Snodgrass, D. R., Angus, K. W. and Gray, E. W. 1977. Rotavirus 
infections in lambs: pathogenesis and pathology. Arch. Virol. 55: 263- 
274. 
Snodgrass, D. R. and Wells, P. W. 1978. Passive immunity in rotavirus 
infections. J. Am. Vet. Med. Assoc. 173: 565-568. 
233 
Snodgrass, D. R., Ojeh, C. K., Campbell, I. and Herring, A. J. 1984. 
Bovine rotavirus serotypes and their significance in immunisation. J. 
Clin. Microbiol. 20: 342-346. 
Snodgrass, D. R., Hoshino, Y., Fitzgerald, T., Browning, G. F. and 
Gorziglia, M. 1992. Identification of four VP4 serological types (P types) 
of bovine rotavirus using viral reassortants. J. Gen. Virol. 73: 2319- 
2325. 
Snyder, J. D. and Merson, M. H. 1982. The magnitude of global 
problem of acute diarrhoea disease: A review of active surveillance data. 
Bull. WHO 60: 605-613. 
Spencer, E. G., Avendano, L. F. and Garcia, B. I. 1983. Analysis of 
human rotavirus mixed electropherotypes. Infect. Immun. 39: 569-574. 
Spriggs, D. R. and Fields, B. N. 1982. Generation of attenuated reovirus 
type 3 strains by selection of haemagglutinin antigenic variants. Nature 
297: 68-70. 
Starkey, W. G., Collins, J., Wallis, T. S., Clarke, G. J., Spencer, A. J., 
Haddon, S. J., Osborne, M. P. , Candy, 
D. C. A. and Stephens, J. 1986. 
Kinetics, tissue specificity and pathological changes in murine rotavirus 
infection in mice. J. Gen. Virol. 67: 2625-2634. 
Steele, A. D., Garcia, D., Sears, J., Gerna, G., Nakagomi, 0. and 
Flores, J. 1993. Distribution of VP4 alleles in human rotaviruses by 
using probes to the hyperdivergent region of the VP4 gene. J. Clin. 
Microbiol. 31: 1735-1740. 
4s 
Stirzaker, S. C., Whitfield, P. L., Christie, D. L., Bellamy, A. R. and 
Both, G. W. 1987. Processing of rotavirus glycoprotein vp7: implications 
for the retention of the protein in the endoplasmic reticulum. J. Cell. 
Biol. 105: 2897-2907. 
Stirzaker, S. C. and Both, G. W. 1989. The signal peptide of the 
rotavirus glycoprotein vp7 is essential for its retention in the ER as an 
integral membrane protein. Cell 56: 741-747. 
Streckert, H. J., Grunet, B. and Werchau, H. 1986. Antibodies specific 
for the carboxy-terminal region of the major surface glycoprotein of 
simian rotavirus (SA11) and human rotavirus (Wa). J. Cell. Biochem. 30: 
41-49. 
234 
Streckert, H. J., Brussow, H. and Werchau, H. 1988. A synthetic 
peptide corresponding to the cleavage region of VP3 from rotavirus SA11 
induces neutralizing antibodies. J. Virol. 62: 4265-4269. 
Sugiura, A. and Ueda, M. 1980. Neurovirulence of influeza virus in 
mice. I. Neurovirulence of recombinants between virulent and avirulent 
strains. Virology 101: 440-449. 
Sukumaran, M., Gowda, K., Maiya, P. P., Srinivas, T. P., Kumar, M. 
S., Aijaz, S., Reddy, R. R., Padilla, L., Greenberg, H. B. and Rao, C. 
D. 1992. Exclusive asymptomatic neonatal infections by human rotavirus 
strains having subgroup I specificities and 'long' RNA electropherotype. 
Arch. V irol . 126: 239-251. 
Svensson, L., Uhnoo, I., Grandien, M. and Wadell, G. 1986. Molecular 
epidemiology of rotavirus infection in Uppsala, Sweden, 1981: 
Disappearance of a pre dominant electropherotype. J. Med. Virol. 18: 
101-111. 
Svensson, L., Shesberadaran, H., Vene, S., Norrby, E., Grandien, M. 
and Wadell, G. 1987. Serum antibody response to individual viral 
polypeptides in human rotavirus infections. J. Gen. Virol 68: 643-651. 
Svensson, L., Grahnquist, L., Petersson, C. A., Granndien, M., 
Stintzing, G. and Greenberg, H. B. 1988. Detection of human rotavirus 
which do not react with subgroup I- and subgroup II-specific monoclonal 
antibodies. J. Clin. Microbiol. 26: 1238-1240. 
Szewczyk, B., Laver, W. G. and Summers D. F. 1988. Purification, 
thioredoxin renaturation and reconstituted activity of three subunits of the 
influenza A virus RNA polymerase. Proc. Natl. Acad. Sci. USA 85: 
7907-7911. 
Tam, J. S., Szymanski, M. T., Middleton, P. J. and Petric, M. 1976. 
Studies on the particles of infantile gastroenteritis virus (orbivirus group). 
Intervirology 7: 181-191. 
Tan, J. A. and Schnagl, R. 1981. Inactivation of a rotavirus by 
disinfectants. Med. J. Aust. 1: 19-23. 
Taniguchi, K., Urasawa, S. and Urasawa, T. 1985. Preparation and 
characterization of neutralization monoclonal antibodies with different 
reactivity patterns to human rotaviruses. J. Gen. Virol. 66: 1045-1053. 
235 
Taniguchi, K., Maloy, W. L., Nishikawa, K., Green, K. Y., Hoshino, 
Y., Kapikian, A. Z., Chanock, R. M. and Gorziglia, M. 1988a. 
Identification of cross-reactive and serotype-specific neutralization 
epitopes on VP3 of human rotavirus. J. Virol. 62: 2421-2426. 
Taniguchi, K., Hoshino, Y., Nishikawa, K., Green, K. Y., Maloy, W. 
L., Morita, Y., Urasawa, S., Kapikian, A. Z. and Chanock, R. M. 
1988b. Cross-reactive and serotype-specific neutralization epitopes on 
VP7 of human rotavirus: Nucleotide sequence analysis of antigenic 
mutants selected with monoclonal antibodies. J. Virol. 62: 1870-1874. 
Tatem, J. M., Weeks-Levy, C., Georgiu, A., DiMichele, S. J., Gorgacz, 
E. J., Racaniello, V. R., Cano; F. R. and Mento, S. J. 1992. A mutant 
present in the amino terminus of Sabin 3 poliovirus VP1 protein is 
attenuating. J. V irol . 66: 3194-3197. 
Theil, K. W., Bohl, E. H., Cross, R. F., Kohler, E. M. and Angus, A. 
G. 1978. Pathogenesis of porcine rotaviral infection in experimentally 
inoculated gnotobiotic pigs. Am. J. Vet. Res. 39: 213-220. 
Thouless, M. E., Beards, G. M. and Flewett, T. H. 1982. Serotyping 
and subgrouping of rotavirus strains by the ELISA test. Arch. Virol. 73: 
219-230. 
Tian, Y., Tarlow, 0., Ballard, A., Desselberger, U. and McCrae, M. A. 
1993. Genomic concatemerisation/ deletion in rotaviruses: a new 
mechanism for generating rapid genetic change of potential 
epidemiological importance. J. Virol. 67: 6625-6632. 
Torres, -A. and Ji-Huang, L. 1986. Diarrhoeal response of gnotobiotic 
pigs after foetal infection and neonatal challenge with homologous and 
heterologous human rotavirus strains. J. Virol. 60: 1107-1112. 
Toyada, T., Sakuguchi, T., Imai, K., Inocencio, N. M., Gotoh, B., 
Hamaguchi, M. and Nagai, Y. 1987. Structural comparison of the 
cleavage-activation site of the fusion glycoprotein between virulent and 
avirulent strains of Newcastle disease virus. Virology 158: 242-247. 
Uhnoo, I., Riepenhoff, T. M., Dharakul, T., Chegas, P., Fiisher, J. E., 
Greenberg, H. B. and Ogra, P. I. 1990. Extramucosal spread and 
development of hepatitis in normal mice infected with rhesus rotavirus. J. 
Virol. 64: 361-368. 
236 
Unicomb, L. E., Coulson, B. S. and Bishop, R. F. 1989. Experience with 
an enzyme immunoassay for serotyping human group A rotaviruses. J. 
Clin. Microbiol. 27: 586-588. 
Urasawa, S., Urasawa, T. and Taniguchi, K. 1986. Genetic reassortment 
between two human rotaviruses having different serotype and subgroup 
specificities. J. Gen. Virol. 67: 1551-1559. 
Ushijima, H., Kono, H., Kim, B., Shinozaki, T., Araki, K. and Fujii, R. 
1986. A new latex agglutination test kit for detecting rotavirus in stool 
from children with gastroenteritis. Pediatr. Infect. Dis. 5: 92-93. 
Valenzuela, S., Pizarro, J., Sandino, A. M., Vasquez, M., Fernandez, J., 
Hernandez, 0., Patton, J. and Spencer, E. 1991. Photoaffinity labelling 
of rotavirus VP1 with 8-azido-ATP: Identification of the viral RNA 
polymerase. J. Virol. 65: 3964-3967. 
Vesikari, T., Rautanen, T., Isolauri, E., Delem, A. and Andre, F. E. 
1987. Immunogenicity and safety of a low passage bovine rotavirus 
candidate vaccine RIT 4256 in human adults and young infants. Vaccine 
5: 105-108. 
Vey, M., Orlich, M., Adler, S., Klenk, H. -D., Rott, R. and Garten, W. 
1992. Haemagglutinin activation of pathogenic avian influenza viruses of 
serotype H7 requires the protease recognition motif R-X-K/R-R. 
Virology 188: 408-413. 
Vonderfecht, S. L., Miskuff, R. L., Wee, S. B., Sato, S., Tidwell, R. 
R., Gertz, J. D. and Yolken, R. H. 1988. Protease inhibitors suppress in 
vitro and in vivo replication of rotavirus. J. Clin. Invest. 82: 2011-2016. 
Walker, J. A. and Kawaoka, Y. 1993. Importance of conserved amino 
acids at the clevage site of haemagglutinin of virulent avian influenza A 
virus. J. Gen. Virol. 74: 311-314. 
Walsh, J. A. and Warren, K. S. 1979. Selective primary health care: An 
interim strategy for disease control in developing countries. N. Eng. J. 
Med. 301: 967-974. 
Ward, R. L., Knowlton, D. R., and Pierce, M. J. 1984. Efficiency of 
human rotavirus propagation in cell culture. J. Clin. Microbiol. 19: 748- 
753. 
237 
Ward, R. L., Bernstein, D. I., Young, E. C., Sherwood, D. I., 
Knowlton, D. R. and Schiff, G. M. 1986. Human rotavirus studies in 
volunteers: determination of infectious dose and serologic response to 
infection. J. Infect. Dis. 154: 871-880. 
Ward, R. L., Knowlton, D. R., and Hurst, P. -F. L. 1988a. Reassortant 
formation and selection following coinfection of cultured cells with 
subgroup 2 human rotaviruses. J. Gen. Virol. 69: 149-162. 
Ward, R. L., Knowlton, D. R., and Greenberg, H. B. 1988b. Phenotypic 
mixing during coinfection of cells with two strains of human rotavirus. J. 
Virol. 62: 4358-4361. 
Ward, R. L., Knowlton, D. R., Schiff, G. M., Hoshino, Y. and 
Greenberg, H. B. 1988c. Relative concentrations of serum neutralizing 
antibodies to VP3 and VP7 proteins in adults infected with a human 
rotavirus. J. Virol. 62: 1543-1549. 
Ward, R. L. and Knowlton, D. R. 1989. Genotypic selection following 
coinfection of cultured cells with subgroup I and subgroup II human 
rotaviruses. J. Gen. Virol. 70: 1691-1699. 
Ward, R. L., Nakagomi, 0., Knowlton, D. R., McNeal, M. M., 
Nakagomi, T., Clemens, J. D., Sack, D. A. and Schiff, G. M. 1990a. 
Evidence of natural reassortants of human rotaviruses belonging to 
different genogroups. J. Virol. 64: 3219-3225. 
Ward, R. L., McNeal, M. and Sheridan, J. F. 1990b. Development of an 
adult mouse model for studies on protection against rotavirus. J. Virol. 
64: 5070-5075. 
Ward, R. L., Sander, D. S., Schiff, G. M., Bernstein, D. I. 1990c. 
Effect of vaccination on serotype-specific antibody response in infants 
administered WC3 bovine rotavirus before or after a natural rotavirus 
infection J. Infect. Dis. 162: 1298-1303. 
Ward, R. L., McNeal, M. M. and Sheridan, J. F. 1992. Evidence that 
active protection following oral immunization of mice with live rotavirus 
is not dependent on neutralizing antibody. Virology 188: 57-66. 
Ward, R. L., McNeal, M., Sander, D. S., Greenberg, H. B. and 
Bernstein, D. I. 1993. Immunodominance of the VP4 neutralisation 
protein of rotavirus in protective natural infections of young children. J. 
Virol. 67: 464-468. 
238 
Waterfield, M. D., Espelie, K., Elder, K. and Skehel, J. J. 1979. 
Structure of the haemagglutinin of influenza virus. Br. Med. Bull. 35: 57- 
63. 
Weiner, H. L., Drayana, D., Averill, D. R. and Fields, B. N. 1977. 
Molecular basis of reovirus virulence: the role of the S1 gene. Proc. 
Natl. Acad. Sci. USA 74: 5744-5748. 
Weiner, H. L., Powers, M. L. and Fields, B. N. 1980. Absolute linkage 
of virulence with the central nervous system cell tropism of reovirus to 
haemagglutinin. J. Infect. Dis. 141: 609-616. 
Welch, A. B. and Twiehaus, M. J. 1973. Cell culture studies of a 
neonatal calf diarrhoea virus. Can. J. Comp. Med. 37: 287-294. 
Welch, S. K. W., Crawford, S. E. and Estes, M. K. 1989. Rotavirus 
SA11 genome segment 11 protein is a non-structural phosphoprotein. J. 
Virol. 63: 3974-3982. 
Westrop, G. D., Evans, D. M. A., Dunn, G., Minor, P. D., Magrath, 
D. I., Taffs, F., Marsden, S., Wareham, K. A., Skinner, M., Schield, 
G. C. and Almond, J. W. 1989. Genetic basis of attenuation of Sabin 
type 3 oral vaccine. J. Virol. 63: 1338-1344. 
Whitaker-Dowling, P. and Youngner, J. S. 1987. Viral interferance- 
dominance of mutant viruses over wild-type virus in mixed infections. 
Microbiol. Rev. 51: 179-191. 
Whitfield, P. L., Tyndall, C., Stirzaker, S. C., Bellamy, A. R. and Both, 
G. W. 1987. Location of signal sequences within the rotavirus SA11 
glycoprotein VP7 which direct it to endoplasmic reticulum. Mol. Cell. 
Biol. 7: 2491-2497. 
WHO. 1984. Third programme report: World Health Organization 
Disease Control Programme, Geneva. 
WHO. 1986. Fifth programme report: World Health Organization 
Disease Control Programme, Geneva. 
WHO. 1989. WHO news and activities: Rotavirus vaccines. Bull. WHO 
67: 583-584. 
239 
Wolf, J. L., Cokor, G., Blacklow, N. R., Dambrauskas, R. and Trier, J. 
S. 1981. Susceptibility of mice to rotavirus infection: effects of age and 
administration of coticosteroids. Infect. Immun. 33: 565-574. 
Wood, G. W., McCauley, J. W., Bashiruddin, J. B. and Alexander, D. J. 
1993. Deduced amino acid sequences at the haemagglutinin cleavage site 
of avian influenza A viruses of H5 and H7 subtypes. Arch Virol. 130: 
209-217. 
Wood, G. W., Banks, J., McCauley, J. W. and Alexander, D. J. 1994. 
Deduced amino acid sequences of haemagglutinin of H5N 1 avian 
influenza virus isolates from an outbreak in turkeys in Norfolk, England. 
Arch Virol. 134: 185-194. 
Woode, G. N., Jones, J. and Bridger, J. C. 1975. Levels of colostral 
antibodies against neonatal calf diarrhoea virus. Vet. Rec. 97: 148-149. 
Woode, G. N., Kelso, N. E., Simpson, T. F., Gaul, S. K., Evans, L. E. 
and Babiuk, L. 1983. Antigenic relationships among some bovine 
rotaviruses: Serum neutralisation and cross protection in gnotobiotic 
calves. J. Clin. Microbiol. 18: 358-364. 
Woode, G. N., Zheng, S., Rosen, B. I., Knight, N., Lelso-Gourley, N. 
E. and Ramig, R. F. 1987. Protection between different serotypes of 
bovine rotavirus in gnotobiotic calves: specificity of serum antibody and 
coproantibody responses. J. Clin. Microbiol. 25: 1052-1058. 
World Health Organization Consultative Group. 1982. The relation 
between acute persisting spinal paralysis and poliomyelitis vaccine: 
results of ten years inquiry. Bull. WHO 60: 231-242. 
Wyatt, R. G., Mebus, C. A., Yolken, R. H., Kalica, A. R., James, H. 
D. Jr., Kapikian, A. Z. and Channock, R. M. 1979. Rotaviral immunity 
in gnotobiotic calves: Heterologous resistance to human virus induced by 
bovine virus. Science 203: 548-550. 
Wyatt, R. G., Greenberg, H. B., James, H. D. Jr., Pittman, A. L., 
Kalica, A. R., Flores, J., Chanock, R. M. and Kapikian, A. Z. 1982. 
Definition of human rotavirus serotypes by plaque reduction assay. 
Infect. Immun. 37: 110-115. 
Wyatt, R. G., Kapikian, A. Z. and Mebus, C. A. 1983. Induction of 
cross-reactive neutralising antibodies to human rotavirus in calves after in 
utero administration of bovine rotavirus. J. Clin. Microbiol. 18: 505-508. 
240 
Xu, L., Harbour, D. and McCrae, M. A. 1990. The application of 
ploymearase chain reaction to the detection of rotaviruses in faeces. J. 
Virol. Methods. 27: 29-38. 
Xu, Z. and Woode, G. N. 1994. Studies on the influence of the VP7 
gene on rotavirus replication. Virology 198: 394-398. 
Yamanka, K., Ishihama, A. and Nagata, K. 1990. Reconstitution of 
influenza virus RNA-nucleoprotein complexes structurally resembling 
native viral ribonucleoprotein cores. J. Biol. Chem. 265: 1151-1155. 
Yeager, M., Dryden, K. A., Olson, N. H., Greenberg, H. B. and Baker, 
T. S. 1990. Three-dimensional structure of rhesus rotavirus by cryo- 
electron microscopy and image reconstruction. J. Cell Biol. 110: 2133- 
2144. 
Yolken, R. H., Barbour, B., Wyatt, R. G., Kalica, A. R., Kapikian, A. 
Z. and Chanock, R. M. 1978. Enzyme-linked immunosorbent assay for 
identification of rotaviruses from different animal species. Science 201: 
259-262. 
Yolken, R. H., Willoughby, R., Wee, S. -B., Miskuff, R. and 
Vonderfecht, S. 1987. Sialic acid glycoproteins inhibit in vitro and in 
vivo replication of rotaviruses. J. Clin. Microbiol. 79: 148-154. 
Yolken, R., Arango-Jaramillo, S., Eiden, J. and Vonderfecht, S. 1988. 
Lack of genomic reassortment following infection of infant rats with 
group A and group B rotaviruses. J. Infect. Immun. 158: 1120-1123. 
Zinkernagel, R. M. and Doherty, P. C. 1974. Restriction of T-cell 
mediated cytotoxicity in lymphocytic choriomeningitis with a syngenic or 
semiallogenic system. Nature (London) 248: 701-702. 
Zissis, G. and Lambert J. P. 1978. Different serotypes of human 
rotavirus. Lancet 1: 38-39. 
Zissis, G. and Lambert J. P. 1980. Enzyme-linked immunosorbent assays 
adapted for serotyping of human rotavirus strains. J. Clin. Microbiol. 11: 
1-15. 
241 
